prediction_file,target_file,field_name,evaluation_method,scoring_type,tp,fp,fn,tn,expected,actual
aas0055-0039.cermine.xml,aas0055-0039.nxml,title,exact,string,1,0,0,0,Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy,Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy
aas0055-0039.cermine.xml,aas0055-0039.nxml,title,levenshtein,string,1,0,0,0,Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy,Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy
aas0055-0039.cermine.xml,aas0055-0039.nxml,abstract,exact,string,0,1,0,0,"Background Hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (CRRT). Phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. This study evaluated the possibility to prevent hypophosphatemia during CRRT treatment by using a new commercially available phosphate-containing dialysis fluid. Methods Forty-two heterogeneous intensive care unit patients, admitted between January 2007 and July 2008, undergoing hemodiafiltration, were treated with a new Gambro dialysis solution with 1.2 mM phosphate (Phoxilium) or with standard medical treatment (Hemosol B0). The patients were divided into three groups: group 1 (n=14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n=14) receiving the phosphate solution as dialysate solution and Hemosol B0 as replacement solution and group 3 (n=14) receiving the phosphate-containing solution as both dialysate and replacement solutions. Results Standard medical treatment resulted in hypophosphatemia in 11 of 14 of the patients (group 1) compared with five of 14 in the patients receiving phosphate solution as the dialysate solution and Hemosol B0 as the replacement solution (group 2). Patients treated with the phosphate-containing dialysis solution (group 3) experienced stable serum phosphate levels throughout the study. Potassium, ionized calcium, magnesium, pH, pCO2 and bicarbonate remained unchanged throughout the study. Conclusion The new phosphate-containing replacement and dialysis solution reduces the variability of serum phosphate levels during CRRT and eliminates the incidence of hypophosphatemia.","Background: Hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (CRRT). Phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. This study evaluated the possibility to prevent hypophosphatemia during CRRT treatment by using a new commercially available phosphate-containing dialysis fluid. Methods: Forty-two heterogeneous intensive care unit patients, admitted between January 2007 and July 2008, undergoing hemodiafiltration, were treated with a new Gambro dialysis solution with 1.2 mM phosphate (Phoxilium) or with standard medical treatment (Hemosol B0). The patients were divided into three groups: group 1 (n 5 14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n 5 14) receiving the phosphate solution as dialysate solution and Hemosol B0 as replacement solution and group 3 (n 5 14) receiving the phosphate-containing solution as both dialysate and replacement solutions."
aas0055-0039.cermine.xml,aas0055-0039.nxml,abstract,levenshtein,string,0,1,0,0,"Background Hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (CRRT). Phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. This study evaluated the possibility to prevent hypophosphatemia during CRRT treatment by using a new commercially available phosphate-containing dialysis fluid. Methods Forty-two heterogeneous intensive care unit patients, admitted between January 2007 and July 2008, undergoing hemodiafiltration, were treated with a new Gambro dialysis solution with 1.2 mM phosphate (Phoxilium) or with standard medical treatment (Hemosol B0). The patients were divided into three groups: group 1 (n=14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n=14) receiving the phosphate solution as dialysate solution and Hemosol B0 as replacement solution and group 3 (n=14) receiving the phosphate-containing solution as both dialysate and replacement solutions. Results Standard medical treatment resulted in hypophosphatemia in 11 of 14 of the patients (group 1) compared with five of 14 in the patients receiving phosphate solution as the dialysate solution and Hemosol B0 as the replacement solution (group 2). Patients treated with the phosphate-containing dialysis solution (group 3) experienced stable serum phosphate levels throughout the study. Potassium, ionized calcium, magnesium, pH, pCO2 and bicarbonate remained unchanged throughout the study. Conclusion The new phosphate-containing replacement and dialysis solution reduces the variability of serum phosphate levels during CRRT and eliminates the incidence of hypophosphatemia.","Background: Hypophosphatemia occurs in up to 80% of the patients during continuous renal replacement therapy (CRRT). Phosphate supplementation is time-consuming and the phosphate level might be dangerously low before normophosphatemia is re-established. This study evaluated the possibility to prevent hypophosphatemia during CRRT treatment by using a new commercially available phosphate-containing dialysis fluid. Methods: Forty-two heterogeneous intensive care unit patients, admitted between January 2007 and July 2008, undergoing hemodiafiltration, were treated with a new Gambro dialysis solution with 1.2 mM phosphate (Phoxilium) or with standard medical treatment (Hemosol B0). The patients were divided into three groups: group 1 (n 5 14) receiving standard medical treatment and intravenous phosphate supplementation as required, group 2 (n 5 14) receiving the phosphate solution as dialysate solution and Hemosol B0 as replacement solution and group 3 (n 5 14) receiving the phosphate-containing solution as both dialysate and replacement solutions."
aas0055-0039.cermine.xml,aas0055-0039.nxml,keywords,exact,set,0,0,0,1,,
aas0055-0039.cermine.xml,aas0055-0039.nxml,keywords,levenshtein,set,0,0,0,1,,
aas0055-0039.cermine.xml,aas0055-0039.nxml,author_surnames,exact,set,0,0,1,0,"BROMAN, CARLSSON, FRIBERG, GODALY, WIESLANDER",
aas0055-0039.cermine.xml,aas0055-0039.nxml,author_surnames,levenshtein,set,0,0,1,0,"BROMAN, CARLSSON, FRIBERG, GODALY, WIESLANDER",
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_author_surname,exact,string,0,0,1,0,BROMAN,
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_author_surname,levenshtein,string,0,0,1,0,BROMAN,
aas0055-0039.cermine.xml,aas0055-0039.nxml,author_full_names,exact,set,0,1,0,0,"A WIESLANDER, G GODALY, H FRIBERG, M BROMAN, O CARLSSON","A. WIESLANDER, G. GODALY, H. FRIBERG, M. BROMAN, O. CARLSSON"
aas0055-0039.cermine.xml,aas0055-0039.nxml,author_full_names,levenshtein,set,1,0,0,0,"A WIESLANDER, G GODALY, H FRIBERG, M BROMAN, O CARLSSON","A. WIESLANDER, G. GODALY, H. FRIBERG, M. BROMAN, O. CARLSSON"
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_author_full_name,exact,string,0,1,0,0,M BROMAN,M. BROMAN
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_author_full_name,levenshtein,string,1,0,0,0,M BROMAN,M. BROMAN
aas0055-0039.cermine.xml,aas0055-0039.nxml,affiliation_strings,exact,set,1,0,0,0,"Department of Anaesthesiology and Intensive Care, Lund University Hospital, Lund, Sweden, Gambro Lundia AB, Lund, Sweden","Department of Anaesthesiology and Intensive Care, Lund University Hospital, Lund, Sweden, Gambro Lundia AB, Lund, Sweden"
aas0055-0039.cermine.xml,aas0055-0039.nxml,affiliation_strings,levenshtein,set,1,0,0,0,"Department of Anaesthesiology and Intensive Care, Lund University Hospital, Lund, Sweden, Gambro Lundia AB, Lund, Sweden","Department of Anaesthesiology and Intensive Care, Lund University Hospital, Lund, Sweden, Gambro Lundia AB, Lund, Sweden"
aas0055-0039.cermine.xml,aas0055-0039.nxml,affiliation_institution,exact,set,1,0,0,0,"Department of Anaesthesiology and Intensive Care, Lund University Hospital, Gambro Lundia AB","Department of Anaesthesiology and Intensive Care, Lund University Hospital, Gambro Lundia AB"
aas0055-0039.cermine.xml,aas0055-0039.nxml,affiliation_institution,levenshtein,set,1,0,0,0,"Department of Anaesthesiology and Intensive Care, Lund University Hospital, Gambro Lundia AB","Department of Anaesthesiology and Intensive Care, Lund University Hospital, Gambro Lundia AB"
aas0055-0039.cermine.xml,aas0055-0039.nxml,section_titles,exact,list,0,1,0,0,"Methods, Fluid composition and study design, Patients and CRRT treatments, Clinical parameters of the patients, Statistics, Results, Discussion","-, Methods, Fluid composition and study design, Patients and CRRT treatments, Clinical parameters of the patients, Statistics, Results, Discussion, Acknowledgements"
aas0055-0039.cermine.xml,aas0055-0039.nxml,section_titles,levenshtein,list,0,1,0,0,"Methods, Fluid composition and study design, Patients and CRRT treatments, Clinical parameters of the patients, Statistics, Results, Discussion","-, Methods, Fluid composition and study design, Patients and CRRT treatments, Clinical parameters of the patients, Statistics, Results, Discussion, Acknowledgements"
aas0055-0039.cermine.xml,aas0055-0039.nxml,tables,exact,table,0,0,1,0,"[[["""", ""Hemosol B0 (mmol/l)"", ""Phosphate containingdialysis solution (mmol/l)""], [""Bicarbonate"", ""32"", ""30""], [""Lactate"", ""3"", ""0""], [""Calcium"", ""1.75"", ""1.25""], [""Magnesium"", ""0.5"", ""0.6""], [""Potassium"", ""0"", ""4""], [""Sodium"", ""140"", ""140""], [""Phosphate"", ""0"", ""1.2""], [""Chloride"", ""109.5"", ""115.9""]], [[""Main diagnoses"", ""Group 1"", ""Group 2"", ""Group 3""], [""Septic shock"", ""5"", ""8"", ""7""], [""Pneumonia"", ""2"", ""1"", ""0""], [""Cardiac insufficiency"", ""0"", ""0"", ""3""], [""Cardiac arrest"", ""1"", ""0"", ""2""], [""Major intoxication"", ""1"", ""0"", ""1""], [""Rupture of aortic aneurysm"", ""0"", ""0"", ""2""], [""Myocardial infarction"", ""0"", ""0"", ""1""], [""Cardiogenic shock"", ""0"", ""0"", ""1""], [""Sclerosis cholangitis"", ""0"", ""0"", ""1""], [""Unspecified respiratory failure"", ""1"", ""0"", ""0""], [""Obstructing malignant intestinal tumour"", ""1"", ""0"", ""0""], [""Epilepsy"", ""1"", ""0"", ""0""], [""Unspecified muscle disease"", ""0"", ""0"", ""1""]], [["""", ""Group 1"", ""Group 2"", ""Group 3""], [""Demographics*""], [""Age (years)"", ""63 (43\u201386)"", ""68 (37\u201388)"", ""67 (53\u201383)""], [""Weight (kg)"", ""80 (53\u2013116)"", ""86 (56\u2013124)"", ""79 (41\u2013130)""], [""Male sex, n (%)"", ""7 (50)"", ""7 (50)"", ""5 (36)""], [""APACHE II*"", ""28.1 (19\u201344)"", ""26 (13\u201336)"", ""23.2 (15\u201329)""], [""RIFLE score, points*,\u2020"", ""37"", ""39"", ""39""], [""Delivered CRRT*""], [""CRRT treatment duration (h)"", ""82 (17\u2013278)"", ""115 (37\u2013207)"", ""96 (29\u2013210)""], [""CRRT treatment mode"", ""CVVHDF"", ""CVVHDF"", ""CVVHDF""], [""Effluent flow (ml/kg/h) calculated on active treatment time*,\u2021"", ""23.7 (13\u201345)"", ""21.9 (15\u201330)"", ""18 (10\u201320)""], [""Proportion of ordered dose delivered*"", ""85.3%"", ""87.5%"", ""91.8%""], [""Anticoagulation*"", ""None 3"", ""None 2"", ""None 2""], ["""", ""Heparine 9"", ""Heparine 11"", ""Heparine 10""], ["""", ""Prostacycline 1"", ""Prostacycline 1"", ""Prostacycline 2""], [""Phosphate supplementation\u00a7 (mmol/CRRT treatment day)"", ""11 (0\u201335)"", ""3 (0\u201313)"", ""0 (0)""]], [[""Group"", ""Group 1"", ""Group 2"", ""Group 3""], ["""", ""Before"", ""During"", ""Before"", ""During"", ""Before"", ""During""], [""Phosphate*"", ""1.90"", ""0.99"", ""1.54"", ""1.20"", ""1.83"", ""1.43""], [""Ionized Ca\u2020"", ""1.10"", ""1.24"", ""1.13"", ""1.19"", ""1.11"", ""1.15""], [""pH\u2021"", ""7.24"", ""7.40"", ""7.30"", ""7.36"", ""7.32"", ""7.36""], [""pCO2\u2021"", ""5.59"", ""5.27"", ""5.81"", ""5.77"", ""6.51"", ""5.27""], [""Bicarbonate\u00a7"", ""18"", ""24"", ""21"", ""23"", ""21"", ""22""]], [[""Day on CRRT"", ""Before"", ""1"", ""2"", ""3"", ""4"", ""5""], [""Sodium*"", ""134.0 \u00b1 5"", ""135.0 \u00b1 3"", ""135.2 \u00b1 2"", ""135.0 \u00b1 2"", ""135.7 \u00b1 2"", ""135.8 \u00b1 3""], [""Potassium\u2020"", ""4.06 \u00b1 0.5"", ""4.10 \u00b1 0.4"", ""4.14 \u00b1 0.3"", ""4.23 \u00b1 0.3"", ""4.39 \u00b1 0.4"", ""4.49 \u00b1 0.5""], [""Ionised calcium\u2021"", ""1.11 \u00b1 0.08"", ""1.10 \u00b1 0.05"", ""1.15 \u00b1 0.07"", ""1.17 \u00b1 0.06"", ""1.16 \u00b1 0.05"", ""1.17 \u00b1 0.06""], [""Magnesium\u2020"", ""1.1 \u00b1 0.4"", ""1.0 \u00b1 0.2"", ""1.1 \u00b1 0.2"", ""0.7 \u00b1 0.2"", ""0.9 \u00b1 0.1"", ""1.0 \u00b1 0.3""]]]",
aas0055-0039.cermine.xml,aas0055-0039.nxml,tables,levenshtein,table,0,0,1,0,"[[["""", ""Hemosol B0 (mmol/l)"", ""Phosphate containingdialysis solution (mmol/l)""], [""Bicarbonate"", ""32"", ""30""], [""Lactate"", ""3"", ""0""], [""Calcium"", ""1.75"", ""1.25""], [""Magnesium"", ""0.5"", ""0.6""], [""Potassium"", ""0"", ""4""], [""Sodium"", ""140"", ""140""], [""Phosphate"", ""0"", ""1.2""], [""Chloride"", ""109.5"", ""115.9""]], [[""Main diagnoses"", ""Group 1"", ""Group 2"", ""Group 3""], [""Septic shock"", ""5"", ""8"", ""7""], [""Pneumonia"", ""2"", ""1"", ""0""], [""Cardiac insufficiency"", ""0"", ""0"", ""3""], [""Cardiac arrest"", ""1"", ""0"", ""2""], [""Major intoxication"", ""1"", ""0"", ""1""], [""Rupture of aortic aneurysm"", ""0"", ""0"", ""2""], [""Myocardial infarction"", ""0"", ""0"", ""1""], [""Cardiogenic shock"", ""0"", ""0"", ""1""], [""Sclerosis cholangitis"", ""0"", ""0"", ""1""], [""Unspecified respiratory failure"", ""1"", ""0"", ""0""], [""Obstructing malignant intestinal tumour"", ""1"", ""0"", ""0""], [""Epilepsy"", ""1"", ""0"", ""0""], [""Unspecified muscle disease"", ""0"", ""0"", ""1""]], [["""", ""Group 1"", ""Group 2"", ""Group 3""], [""Demographics*""], [""Age (years)"", ""63 (43\u201386)"", ""68 (37\u201388)"", ""67 (53\u201383)""], [""Weight (kg)"", ""80 (53\u2013116)"", ""86 (56\u2013124)"", ""79 (41\u2013130)""], [""Male sex, n (%)"", ""7 (50)"", ""7 (50)"", ""5 (36)""], [""APACHE II*"", ""28.1 (19\u201344)"", ""26 (13\u201336)"", ""23.2 (15\u201329)""], [""RIFLE score, points*,\u2020"", ""37"", ""39"", ""39""], [""Delivered CRRT*""], [""CRRT treatment duration (h)"", ""82 (17\u2013278)"", ""115 (37\u2013207)"", ""96 (29\u2013210)""], [""CRRT treatment mode"", ""CVVHDF"", ""CVVHDF"", ""CVVHDF""], [""Effluent flow (ml/kg/h) calculated on active treatment time*,\u2021"", ""23.7 (13\u201345)"", ""21.9 (15\u201330)"", ""18 (10\u201320)""], [""Proportion of ordered dose delivered*"", ""85.3%"", ""87.5%"", ""91.8%""], [""Anticoagulation*"", ""None 3"", ""None 2"", ""None 2""], ["""", ""Heparine 9"", ""Heparine 11"", ""Heparine 10""], ["""", ""Prostacycline 1"", ""Prostacycline 1"", ""Prostacycline 2""], [""Phosphate supplementation\u00a7 (mmol/CRRT treatment day)"", ""11 (0\u201335)"", ""3 (0\u201313)"", ""0 (0)""]], [[""Group"", ""Group 1"", ""Group 2"", ""Group 3""], ["""", ""Before"", ""During"", ""Before"", ""During"", ""Before"", ""During""], [""Phosphate*"", ""1.90"", ""0.99"", ""1.54"", ""1.20"", ""1.83"", ""1.43""], [""Ionized Ca\u2020"", ""1.10"", ""1.24"", ""1.13"", ""1.19"", ""1.11"", ""1.15""], [""pH\u2021"", ""7.24"", ""7.40"", ""7.30"", ""7.36"", ""7.32"", ""7.36""], [""pCO2\u2021"", ""5.59"", ""5.27"", ""5.81"", ""5.77"", ""6.51"", ""5.27""], [""Bicarbonate\u00a7"", ""18"", ""24"", ""21"", ""23"", ""21"", ""22""]], [[""Day on CRRT"", ""Before"", ""1"", ""2"", ""3"", ""4"", ""5""], [""Sodium*"", ""134.0 \u00b1 5"", ""135.0 \u00b1 3"", ""135.2 \u00b1 2"", ""135.0 \u00b1 2"", ""135.7 \u00b1 2"", ""135.8 \u00b1 3""], [""Potassium\u2020"", ""4.06 \u00b1 0.5"", ""4.10 \u00b1 0.4"", ""4.14 \u00b1 0.3"", ""4.23 \u00b1 0.3"", ""4.39 \u00b1 0.4"", ""4.49 \u00b1 0.5""], [""Ionised calcium\u2021"", ""1.11 \u00b1 0.08"", ""1.10 \u00b1 0.05"", ""1.15 \u00b1 0.07"", ""1.17 \u00b1 0.06"", ""1.16 \u00b1 0.05"", ""1.17 \u00b1 0.06""], [""Magnesium\u2020"", ""1.1 \u00b1 0.4"", ""1.0 \u00b1 0.2"", ""1.1 \u00b1 0.2"", ""0.7 \u00b1 0.2"", ""0.9 \u00b1 0.1"", ""1.0 \u00b1 0.3""]]]",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_strings,exact,list,0,0,1,0,"Hemosol B0 (mmol/l) Phosphate containingdialysis solution (mmol/l) Bicarbonate 32 30 Lactate 3 0 Calcium 1.75 1.25 Magnesium 0.5 0.6 Potassium 0 4 Sodium 140 140 Phosphate 0 1.2 Chloride 109.5 115.9, Main diagnoses Group 1 Group 2 Group 3 Septic shock 5 8 7 Pneumonia 2 1 0 Cardiac insufficiency 0 0 3 Cardiac arrest 1 0 2 Major intoxication 1 0 1 Rupture of aortic aneurysm 0 0 2 Myocardial infarction 0 0 1 Cardiogenic shock 0 0 1 Sclerosis cholangitis 0 0 1 Unspecified respiratory failure 1 0 0 Obstructing malignant intestinal tumour 1 0 0 Epilepsy 1 0 0 Unspecified muscle disease 0 0 1, Group 1 Group 2 Group 3 Demographics* Age (years) 63 (43–86) 68 (37–88) 67 (53–83) Weight (kg) 80 (53–116) 86 (56–124) 79 (41–130) Male sex, n (%) 7 (50) 7 (50) 5 (36) APACHE II* 28.1 (19–44) 26 (13–36) 23.2 (15–29) RIFLE score, points*,† 37 39 39 Delivered CRRT* CRRT treatment duration (h) 82 (17–278) 115 (37–207) 96 (29–210) CRRT treatment mode CVVHDF CVVHDF CVVHDF Effluent flow (ml/kg/h) calculated on active treatment time*,‡ 23.7 (13–45) 21.9 (15–30) 18 (10–20) Proportion of ordered dose delivered* 85.3% 87.5% 91.8% Anticoagulation* None 3 None 2 None 2 Heparine 9 Heparine 11 Heparine 10 Prostacycline 1 Prostacycline 1 Prostacycline 2 Phosphate supplementation§ (mmol/CRRT treatment day) 11 (0–35) 3 (0–13) 0 (0), Group Group 1 Group 2 Group 3 Before During Before During Before During Phosphate* 1.90 0.99 1.54 1.20 1.83 1.43 Ionized Ca† 1.10 1.24 1.13 1.19 1.11 1.15 pH‡ 7.24 7.40 7.30 7.36 7.32 7.36 pCO2‡ 5.59 5.27 5.81 5.77 6.51 5.27 Bicarbonate§ 18 24 21 23 21 22, Day on CRRT Before 1 2 3 4 5 Sodium* 134.0 ± 5 135.0 ± 3 135.2 ± 2 135.0 ± 2 135.7 ± 2 135.8 ± 3 Potassium† 4.06 ± 0.5 4.10 ± 0.4 4.14 ± 0.3 4.23 ± 0.3 4.39 ± 0.4 4.49 ± 0.5 Ionised calcium‡ 1.11 ± 0.08 1.10 ± 0.05 1.15 ± 0.07 1.17 ± 0.06 1.16 ± 0.05 1.17 ± 0.06 Magnesium† 1.1 ± 0.4 1.0 ± 0.2 1.1 ± 0.2 0.7 ± 0.2 0.9 ± 0.1 1.0 ± 0.3",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_strings,levenshtein,list,0,0,1,0,"Hemosol B0 (mmol/l) Phosphate containingdialysis solution (mmol/l) Bicarbonate 32 30 Lactate 3 0 Calcium 1.75 1.25 Magnesium 0.5 0.6 Potassium 0 4 Sodium 140 140 Phosphate 0 1.2 Chloride 109.5 115.9, Main diagnoses Group 1 Group 2 Group 3 Septic shock 5 8 7 Pneumonia 2 1 0 Cardiac insufficiency 0 0 3 Cardiac arrest 1 0 2 Major intoxication 1 0 1 Rupture of aortic aneurysm 0 0 2 Myocardial infarction 0 0 1 Cardiogenic shock 0 0 1 Sclerosis cholangitis 0 0 1 Unspecified respiratory failure 1 0 0 Obstructing malignant intestinal tumour 1 0 0 Epilepsy 1 0 0 Unspecified muscle disease 0 0 1, Group 1 Group 2 Group 3 Demographics* Age (years) 63 (43–86) 68 (37–88) 67 (53–83) Weight (kg) 80 (53–116) 86 (56–124) 79 (41–130) Male sex, n (%) 7 (50) 7 (50) 5 (36) APACHE II* 28.1 (19–44) 26 (13–36) 23.2 (15–29) RIFLE score, points*,† 37 39 39 Delivered CRRT* CRRT treatment duration (h) 82 (17–278) 115 (37–207) 96 (29–210) CRRT treatment mode CVVHDF CVVHDF CVVHDF Effluent flow (ml/kg/h) calculated on active treatment time*,‡ 23.7 (13–45) 21.9 (15–30) 18 (10–20) Proportion of ordered dose delivered* 85.3% 87.5% 91.8% Anticoagulation* None 3 None 2 None 2 Heparine 9 Heparine 11 Heparine 10 Prostacycline 1 Prostacycline 1 Prostacycline 2 Phosphate supplementation§ (mmol/CRRT treatment day) 11 (0–35) 3 (0–13) 0 (0), Group Group 1 Group 2 Group 3 Before During Before During Before During Phosphate* 1.90 0.99 1.54 1.20 1.83 1.43 Ionized Ca† 1.10 1.24 1.13 1.19 1.11 1.15 pH‡ 7.24 7.40 7.30 7.36 7.32 7.36 pCO2‡ 5.59 5.27 5.81 5.77 6.51 5.27 Bicarbonate§ 18 24 21 23 21 22, Day on CRRT Before 1 2 3 4 5 Sodium* 134.0 ± 5 135.0 ± 3 135.2 ± 2 135.0 ± 2 135.7 ± 2 135.8 ± 3 Potassium† 4.06 ± 0.5 4.10 ± 0.4 4.14 ± 0.3 4.23 ± 0.3 4.39 ± 0.4 4.49 ± 0.5 Ionised calcium‡ 1.11 ± 0.08 1.10 ± 0.05 1.15 ± 0.07 1.17 ± 0.06 1.16 ± 0.05 1.17 ± 0.06 Magnesium† 1.1 ± 0.4 1.0 ± 0.2 1.1 ± 0.2 0.7 ± 0.2 0.9 ± 0.1 1.0 ± 0.3",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_labels,exact,list,0,0,1,0,"Table 1, Table 2, Table 3, Table 5, Table 4",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_labels,levenshtein,list,0,0,1,0,"Table 1, Table 2, Table 3, Table 5, Table 4",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_captions,exact,list,0,0,1,0,"Fluid composition., Main diagnoses leading to intensive care of the study groups., Baseline characteristics of study patients and delivered CRRT., Serum values (mmol/l, kPa) during CRRT with the phosphate-containing dialysis fluid., Serum solute concentrations (mmol/l) during CRRT with the phosphate containing dialysis fluid for patients in group 3.",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_captions,levenshtein,list,0,0,1,0,"Fluid composition., Main diagnoses leading to intensive care of the study groups., Baseline characteristics of study patients and delivered CRRT., Serum values (mmol/l, kPa) during CRRT with the phosphate-containing dialysis fluid., Serum solute concentrations (mmol/l) during CRRT with the phosphate containing dialysis fluid for patients in group 3.",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_label_captions,exact,list,0,0,1,0,"Table 1 Fluid composition., Table 2 Main diagnoses leading to intensive care of the study groups., Table 3 Baseline characteristics of study patients and delivered CRRT., Table 5 Serum values (mmol/l, kPa) during CRRT with the phosphate-containing dialysis fluid., Table 4 Serum solute concentrations (mmol/l) during CRRT with the phosphate containing dialysis fluid for patients in group 3.",
aas0055-0039.cermine.xml,aas0055-0039.nxml,table_label_captions,levenshtein,list,0,0,1,0,"Table 1 Fluid composition., Table 2 Main diagnoses leading to intensive care of the study groups., Table 3 Baseline characteristics of study patients and delivered CRRT., Table 5 Serum values (mmol/l, kPa) during CRRT with the phosphate-containing dialysis fluid., Table 4 Serum solute concentrations (mmol/l) during CRRT with the phosphate containing dialysis fluid for patients in group 3.",
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'1', u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5', u'15156308']","[u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M.', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5']"
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5', u'15156308']","[u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M.', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5']"
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_reference_title,exact,string,1,0,0,0,Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy,Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy
aas0055-0039.cermine.xml,aas0055-0039.nxml,first_reference_title,levenshtein,string,1,0,0,0,Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy,Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_fields,exact,list,0,1,0,0,"[u'1', u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5', u'15156308'], [u'2', u'Marik', u'PE', u'Bedigian', u'MK', u'Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study', u'Arch Surg', u'1996', u'131', u'1043', u'7', u'8857900'], [u'3', u'Bugg', u'NC', u'Jones', u'JA', u'Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit', u'Anaesthesia', u'1998', u'53', u'895', u'902', u'9849285'], [u'4', u'Skulberg', u'A', u'Sr.', u'Glucose: a potential killer', u'Acta Anaesthesiol Scand', u'2009', u'53', u'684', u'19419367'], [u'5', u'Peppers', u'MP', u'Geheb', u'M', u'Desai', u'T', u'Endocrine crises. Hypophosphatemia and hyperphosphatemia', u'Crit Care Clin', u'1991', u'7', u'201', u'14', u'2007215'], [u'6', u'Elisaf', u'MS', u'Siamopoulos', u'KC', u'Mechanisms of hypophosphataemia in alcoholic patients', u'Int J Clin Pract', u'1997', u'51', u'501', u'3', u'9536603'], [u'7', u'Zazzo', u'JF', u'Troche', u'G', u'Ruel', u'P', u'Maintenant', u'J', u'High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function', u'Intensive Care Med', u'1995', u'21', u'826', u'31', u'8557871'], [u'8', u'Tan', u'HK', u'Bellomo', u'R', u""M'Pis"", u'DA', u'Ronco', u'C', u'Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration', u'Int J Artif Organs', u'2001', u'24', u'186', u'91', u'11394697'], [u'9', u'Baldwin', u'I', u'Naka', u'T', u'Koch', u'B', u'Fealy', u'N', u'Bellomo', u'R', u'A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance', u'Intensive Care Med', u'2007', u'33', u'830', u'5', u'17384931'], [u'10', u'Shor', u'R', u'Halabe', u'A', u'Rishver', u'S', u'Tilis', u'Y', u'Matas', u'Z', u'Fux', u'A', u'Boaz', u'M', u'Weinstein', u'J', u'Severe hypophosphatemia in sepsis as a mortality predictor', u'Ann Clin Lab Sci', u'2006', u'36', u'67', u'72', u'16501239'], [u'11', u'Stoff', u'JS', u'Phosphate homeostasis and hypophosphatemia', u'Am J Med', u'1982', u'72', u'489', u'95', u'7036738'], [u'12', u'Brown', u'GR', u'Greenwood', u'JK', u'Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill', u'Ann Pharmacother', u'1994', u'28', u'626', u'32', u'8069002'], [u'13', u'Bollaert', u'PE', u'Levy', u'B', u'Nace', u'L', u'Laterre', u'PF', u'Larcan', u'A', u'Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock', u'Chest', u'1995', u'107', u'1698', u'701', u'7781370'], [u'14', u'Paterson', u'CR', u'Hypophosphataemia: a dangerous disorder', u'Nutrition', u'1996', u'12', u'540', u'1', u'8878151'], [u'15', u'Paula', u'FJ', u'Plens', u'AE', u'Foss', u'MC', u'Effects of hypophosphatemia on glucose tolerance and insulin secretion', u'Horm Metab Res', u'1998', u'30', u'281', u'4', u'9660090'], [u'16', u'Ravenscroft', u'AJ', u'Valentine', u'JM', u'Knappett', u'PA', u'Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis', u'Anaesthesia', u'1999', u'54', u'198', u'10215720'], [u'17', u'Weber', u'U', u'Huppe', u'T', u'Niehaus', u'L', u'CT and MRI in severe hypophosphataemia with central nervous system involvement', u'Neuroradiology', u'2000', u'42', u'112', u'4', u'10663486'], [u'18', u'Darsee', u'JR', u'Nutter', u'DO', u'Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'867', u'70', u'363007'], [u'19', u'Aubier', u'M', u'Murciano', u'D', u'Lecocguic', u'Y', u'Viires', u'N', u'Jacquens', u'Y', u'Squara', u'P', u'Pariente', u'R', u'Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure', u'N Engl J Med', u'1985', u'313', u'420', u'4', u'3860734'], [u'20', u'Williams', u'JD', u'Topley', u'N', u'Craig', u'KJ', u'Mackenzie', u'RK', u'Pischetsrieder', u'M', u'Lage', u'C', u'Passlick-Deetjen', u'J', u'The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane', u'Kidney Int', u'2004', u'66', u'408', u'18', u'15200450'], [u'21', u'Gatchalian', u'RA', u'Popli', u'A', u'Ejaz', u'AA', u'Leehey', u'DJ', u'Kjellstrand', u'CM', u'Ing', u'TS', u'Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate', u'Am J Kidney Dis', u'2000', u'36', u'1262', u'6', u'11096051'], [u'22', u'Santiago', u'MJ', u'Lopez-Herce', u'J', u'Urbano', u'J', u'Bellon', u'JM', u'del Castillo', u'J', u'Carrillo', u'A', u'Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children', u'Kidney Int', u'2009', u'75', u'312', u'6', u'19002217'], [u'23', u'Janssen van Doorn', u'K', u'Spapen', u'H', u'Geers', u'C', u'Diltoer', u'M', u'Shabana', u'W', u'Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?', u'Acta Anaesthesiol Scand', u'2008', u'52', u'1259', u'64', u'18823466'], [u'24', u'Lentz', u'RD', u'Brown', u'DM', u'Kjellstrand', u'CM', u'Treatment of severe hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'941', u'4', u'102230'], [u'25', u'Vannatta', u'JB', u'Whang', u'R', u'Papper', u'S', u'Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient', u'Arch Intern Med', u'1981', u'141', u'885', u'7', u'7235807'], [u'26', u'Vannatta', u'JB', u'Andress', u'DL', u'Whang', u'R', u'Papper', u'S', u'High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia', u'South Med J', u'1983', u'76', u'1424', u'6', u'6635736'], [u'27', u'Kingston', u'M', u""Al-Siba'i"", u'MB', u'Treatment of severe hypophosphatemia', u'Crit Care Med', u'1985', u'13', u'16', u'8', u'3965243'], [u'28', u'Sacks', u'GS', u'Walker', u'J', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Observations of hypophosphatemia and its management in nutrition support', u'Nutr Clin Pract', u'1994', u'9', u'105', u'8', u'8078444'], [u'29', u'Clark', u'CL', u'Sacks', u'GS', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial', u'Crit Care Med', u'1995', u'23', u'1504', u'11', u'7664552'], [u'30', u'Rosen', u'GH', u'Boullata', u'JI', u""O'Rangers"", u'EA', u'Enow', u'NB', u'Shin', u'B', u'Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia', u'Crit Care Med', u'1995', u'23', u'1204', u'10', u'7600828'], [u'31', u'Perreault', u'MM', u'Ostrop', u'NJ', u'Tierney', u'MG', u'Efficacy and safety of intravenous phosphate replacement in critically ill patients', u'Ann Pharmacother', u'1997', u'31', u'683', u'8', u'9184705'], [u'32', u'Charron', u'T', u'Bernard', u'F', u'Skrobik', u'Y', u'Simoneau', u'N', u'Gagnon', u'N', u'Leblanc', u'M', u'Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia', u'Intensive Care Med', u'2003', u'29', u'1273', u'8', u'12845429'], [u'33', u'Barak', u'V', u'Schwartz', u'A', u'Kalickman', u'I', u'Nisman', u'B', u'Gurman', u'G', u'Shoenfeld', u'Y', u'Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines', u'Am J Med', u'1998', u'104', u'40', u'7', u'9528718'], [u'34', u'Walker', u'K', u'Dallas Hall', u'W', u'Hurst', u'W', u'Stoneham', u'M', u'Serum inorganic phosphate', u'Clinical methods', u'1990', u'London', u'Butterworth Publishers', u'895', u'9'], [u'35', u'Morimatsu', u'H', u'Uchino', u'S', u'Bellomo', u'R', u'Ronco', u'C', u'Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations', u'Int J Artif Organs', u'2002', u'25', u'512', u'9', u'12117290'], [u'36', u'Kraus', u'MA', u'Selection of dialysate and replacement fluids and management of electrolyte and acid\u2013base disturbances', u'Semin Dial', u'2009', u'22', u'137', u'40', u'19426416']","[u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M.', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5'], [u'Marik', u'PE', u'Bedigian', u'MK', u'Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study', u'Arch Surg', u'1996', u'131', u'1043', u'7'], [u'Bugg', u'NC', u'Jones', u'JA', u'Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit', u'Anaesthesia', u'1998', u'53', u'895', u'902'], [u'Skulberg', u'A', u'Glucose: a potential killer', u'Acta Anaesthesiol Scand', u'2009', u'53', u'684'], [u'Peppers', u'MP', u'Geheb', u'M', u'Desai', u'T.', u'Endocrine crises. Hypophosphatemia and hyperphosphatemia', u'Crit Care Clin', u'1991', u'7', u'201', u'14'], [u'Elisaf', u'MS', u'Siamopoulos', u'KC', u'Mechanisms of hypophosphataemia in alcoholic patients', u'Int J Clin Pract', u'1997', u'51', u'501', u'3'], [u'Zazzo', u'JF', u'Troche', u'G', u'Ruel', u'P', u'Maintenant', u'J', u'High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function', u'Intensive Care Med', u'1995', u'21', u'826', u'31'], [u'Tan', u'HK', u'Bellomo', u'R', u""M'Pis"", u'DA', u'Ronco', u'C', u'Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration', u'Int J Artif Organs', u'2001', u'24', u'186', u'91'], [u'Baldwin', u'I', u'Naka', u'T', u'Koch', u'B', u'Fealy', u'N', u'Bellomo', u'R.', u'A pilot randomised controlled comparison of continuous venovenous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance', u'Intensive Care Med', u'2007', u'33', u'830', u'5'], [u'Shor', u'R', u'Halabe', u'A', u'Rishver', u'S', u'Tilis', u'Y', u'Matas', u'Z', u'Fux', u'A', u'Boaz', u'M', u'Weinstein', u'J', u'Severe hypophosphatemia in sepsis as a mortality predictor', u'Ann Clin Lab Sci', u'2006', u'36', u'67', u'72'], [u'Stoff', u'JS', u'Phosphate homeostasis and hypophosphatemia', u'Am J Med', u'1982', u'72', u'489', u'95'], [u'Brown', u'GR', u'Greenwood', u'JK', u'Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill', u'Ann Pharmacother', u'1994', u'28', u'626', u'32'], [u'Bollaert', u'PE', u'Levy', u'B', u'Nace', u'L', u'Laterre', u'PF', u'Larcan', u'A', u'Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock', u'Chest', u'1995', u'107', u'1698', u'701'], [u'Paterson', u'CR', u'Hypophosphataemia: a dangerous disorder', u'Nutrition', u'1996', u'12', u'540', u'1'], [u'Paula', u'FJ', u'Plens', u'AE', u'Foss', u'MC', u'Effects of hypophosphatemia on glucose tolerance and insulin secretion', u'Horm Metab Res', u'1998', u'30', u'281', u'4'], [u'Ravenscroft', u'AJ', u'Valentine', u'JM', u'Knappett PA', u'Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis', u'Anaesthesia', u'1999', u'54', u'198'], [u'Weber', u'U', u'Huppe', u'T', u'Niehaus', u'L', u'CT and MRI in severe hypophosphataemia with central nervous system involvement', u'Neuroradiology', u'2000', u'42', u'112', u'4'], [u'Darsee', u'JR', u'Nutter', u'DO', u'Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'867', u'70'], [u'Aubier', u'M', u'Murciano', u'D', u'Lecocguic', u'Y', u'Viires', u'N', u'Jacquens', u'Y', u'Squara', u'P', u'Pariente', u'R', u'Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure', u'N Engl J Med', u'1985', u'313', u'420', u'4'], [u'Williams', u'JD', u'Topley', u'N', u'Craig', u'KJ', u'Mackenzie', u'RK', u'Pischetsrieder', u'M', u'Lage', u'C', u'Passlick-Deetjen', u'J', u'The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane', u'Kidney Int', u'2004', u'66', u'408', u'18'], [u'Gatchalian', u'RA', u'Popli', u'A', u'Ejaz', u'AA', u'Leehey', u'DJ', u'Kjellstrand', u'CM', u'Ing', u'TS', u'Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate', u'Am J Kidney Dis', u'2000', u'36', u'1262', u'6'], [u'Santiago', u'MJ', u'Lopez-Herce', u'J', u'Urbano', u'J', u'Bellon', u'JM', u'del Castillo', u'J', u'Carrillo', u'A', u'Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children', u'Kidney Int', u'2009', u'75', u'312', u'6'], [u'Janssen van Doorn', u'K', u'Spapen', u'H', u'Geers', u'C', u'Diltoer', u'M', u'Shabana', u'W.', u'Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?', u'Acta Anaesthesiol Scand', u'2008', u'52', u'1259', u'64'], [u'Lentz', u'RD', u'Brown', u'DM', u'Kjellstrand', u'CM', u'Treatment of severe hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'941', u'4'], [u'Vannatta', u'JB', u'Whang', u'R', u'Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient', u'Arch Intern Med', u'1981', u'141', u'885', u'7'], [u'Vannatta', u'JB', u'Andress', u'DL', u'Whang', u'R', u'High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia', u'South Med J', u'1983', u'76', u'1424', u'6'], [u'Kingston', u'M', u""Al-Siba'i MB"", u'Treatment of severe hypophosphatemia', u'Crit Care Med', u'1985', u'13', u'16', u'8'], [u'Sacks', u'GS', u'Walker', u'J', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Observations of hypophosphatemia and its management in nutrition support', u'Nutr Clin Pract', u'1994', u'9', u'105', u'8'], [u'Clark', u'CL', u'Sacks', u'GS', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial', u'Crit Care Med', u'1995', u'23', u'1504', u'11'], [u'Rosen', u'GH', u'Boullata', u'JI', u""O'Rangers"", u'EA', u'Enow', u'NB', u'Shin', u'B', u'Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia', u'Crit Care Med', u'1995', u'23', u'1204', u'10'], [u'Perreault', u'MM', u'Ostrop', u'NJ', u'Tierney', u'MG', u'Efficacy and safety of intravenous phosphate replacement in critically ill patients', u'Ann Pharmacother', u'1997', u'31', u'683', u'8'], [u'Charron', u'T', u'Bernard', u'F', u'Skrobik', u'Y', u'Simoneau', u'N', u'Gagnon', u'N', u'Leblanc', u'M.', u'Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia', u'Intensive Care Med', u'2003', u'29', u'1273', u'8'], [u'Barak', u'V', u'Schwartz', u'A', u'Kalickman', u'I', u'Nisman', u'B', u'Gurman', u'G', u'Shoenfeld', u'Y.', u'Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines', u'Am J Med', u'1998', u'104', u'40', u'7'], [u'Walker', u'K', u'Hurst', u'W.', u'Serum inorganic phosphate', u'Clinical methods. London: Butterworth Publishers', u'1990', u'895', u'9'], [u'Morimatsu', u'H', u'Uchino', u'S', u'Bellomo', u'R', u'Ronco', u'C', u'Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations', u'Int J Artif Organs', u'2002', u'25', u'512', u'9'], [u'Kraus', u'MA', u'Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances', u'Semin Dial', u'2009', u'22', u'137', u'40']"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5', u'15156308'], [u'2', u'Marik', u'PE', u'Bedigian', u'MK', u'Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study', u'Arch Surg', u'1996', u'131', u'1043', u'7', u'8857900'], [u'3', u'Bugg', u'NC', u'Jones', u'JA', u'Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit', u'Anaesthesia', u'1998', u'53', u'895', u'902', u'9849285'], [u'4', u'Skulberg', u'A', u'Sr.', u'Glucose: a potential killer', u'Acta Anaesthesiol Scand', u'2009', u'53', u'684', u'19419367'], [u'5', u'Peppers', u'MP', u'Geheb', u'M', u'Desai', u'T', u'Endocrine crises. Hypophosphatemia and hyperphosphatemia', u'Crit Care Clin', u'1991', u'7', u'201', u'14', u'2007215'], [u'6', u'Elisaf', u'MS', u'Siamopoulos', u'KC', u'Mechanisms of hypophosphataemia in alcoholic patients', u'Int J Clin Pract', u'1997', u'51', u'501', u'3', u'9536603'], [u'7', u'Zazzo', u'JF', u'Troche', u'G', u'Ruel', u'P', u'Maintenant', u'J', u'High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function', u'Intensive Care Med', u'1995', u'21', u'826', u'31', u'8557871'], [u'8', u'Tan', u'HK', u'Bellomo', u'R', u""M'Pis"", u'DA', u'Ronco', u'C', u'Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration', u'Int J Artif Organs', u'2001', u'24', u'186', u'91', u'11394697'], [u'9', u'Baldwin', u'I', u'Naka', u'T', u'Koch', u'B', u'Fealy', u'N', u'Bellomo', u'R', u'A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance', u'Intensive Care Med', u'2007', u'33', u'830', u'5', u'17384931'], [u'10', u'Shor', u'R', u'Halabe', u'A', u'Rishver', u'S', u'Tilis', u'Y', u'Matas', u'Z', u'Fux', u'A', u'Boaz', u'M', u'Weinstein', u'J', u'Severe hypophosphatemia in sepsis as a mortality predictor', u'Ann Clin Lab Sci', u'2006', u'36', u'67', u'72', u'16501239'], [u'11', u'Stoff', u'JS', u'Phosphate homeostasis and hypophosphatemia', u'Am J Med', u'1982', u'72', u'489', u'95', u'7036738'], [u'12', u'Brown', u'GR', u'Greenwood', u'JK', u'Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill', u'Ann Pharmacother', u'1994', u'28', u'626', u'32', u'8069002'], [u'13', u'Bollaert', u'PE', u'Levy', u'B', u'Nace', u'L', u'Laterre', u'PF', u'Larcan', u'A', u'Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock', u'Chest', u'1995', u'107', u'1698', u'701', u'7781370'], [u'14', u'Paterson', u'CR', u'Hypophosphataemia: a dangerous disorder', u'Nutrition', u'1996', u'12', u'540', u'1', u'8878151'], [u'15', u'Paula', u'FJ', u'Plens', u'AE', u'Foss', u'MC', u'Effects of hypophosphatemia on glucose tolerance and insulin secretion', u'Horm Metab Res', u'1998', u'30', u'281', u'4', u'9660090'], [u'16', u'Ravenscroft', u'AJ', u'Valentine', u'JM', u'Knappett', u'PA', u'Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis', u'Anaesthesia', u'1999', u'54', u'198', u'10215720'], [u'17', u'Weber', u'U', u'Huppe', u'T', u'Niehaus', u'L', u'CT and MRI in severe hypophosphataemia with central nervous system involvement', u'Neuroradiology', u'2000', u'42', u'112', u'4', u'10663486'], [u'18', u'Darsee', u'JR', u'Nutter', u'DO', u'Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'867', u'70', u'363007'], [u'19', u'Aubier', u'M', u'Murciano', u'D', u'Lecocguic', u'Y', u'Viires', u'N', u'Jacquens', u'Y', u'Squara', u'P', u'Pariente', u'R', u'Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure', u'N Engl J Med', u'1985', u'313', u'420', u'4', u'3860734'], [u'20', u'Williams', u'JD', u'Topley', u'N', u'Craig', u'KJ', u'Mackenzie', u'RK', u'Pischetsrieder', u'M', u'Lage', u'C', u'Passlick-Deetjen', u'J', u'The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane', u'Kidney Int', u'2004', u'66', u'408', u'18', u'15200450'], [u'21', u'Gatchalian', u'RA', u'Popli', u'A', u'Ejaz', u'AA', u'Leehey', u'DJ', u'Kjellstrand', u'CM', u'Ing', u'TS', u'Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate', u'Am J Kidney Dis', u'2000', u'36', u'1262', u'6', u'11096051'], [u'22', u'Santiago', u'MJ', u'Lopez-Herce', u'J', u'Urbano', u'J', u'Bellon', u'JM', u'del Castillo', u'J', u'Carrillo', u'A', u'Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children', u'Kidney Int', u'2009', u'75', u'312', u'6', u'19002217'], [u'23', u'Janssen van Doorn', u'K', u'Spapen', u'H', u'Geers', u'C', u'Diltoer', u'M', u'Shabana', u'W', u'Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?', u'Acta Anaesthesiol Scand', u'2008', u'52', u'1259', u'64', u'18823466'], [u'24', u'Lentz', u'RD', u'Brown', u'DM', u'Kjellstrand', u'CM', u'Treatment of severe hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'941', u'4', u'102230'], [u'25', u'Vannatta', u'JB', u'Whang', u'R', u'Papper', u'S', u'Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient', u'Arch Intern Med', u'1981', u'141', u'885', u'7', u'7235807'], [u'26', u'Vannatta', u'JB', u'Andress', u'DL', u'Whang', u'R', u'Papper', u'S', u'High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia', u'South Med J', u'1983', u'76', u'1424', u'6', u'6635736'], [u'27', u'Kingston', u'M', u""Al-Siba'i"", u'MB', u'Treatment of severe hypophosphatemia', u'Crit Care Med', u'1985', u'13', u'16', u'8', u'3965243'], [u'28', u'Sacks', u'GS', u'Walker', u'J', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Observations of hypophosphatemia and its management in nutrition support', u'Nutr Clin Pract', u'1994', u'9', u'105', u'8', u'8078444'], [u'29', u'Clark', u'CL', u'Sacks', u'GS', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial', u'Crit Care Med', u'1995', u'23', u'1504', u'11', u'7664552'], [u'30', u'Rosen', u'GH', u'Boullata', u'JI', u""O'Rangers"", u'EA', u'Enow', u'NB', u'Shin', u'B', u'Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia', u'Crit Care Med', u'1995', u'23', u'1204', u'10', u'7600828'], [u'31', u'Perreault', u'MM', u'Ostrop', u'NJ', u'Tierney', u'MG', u'Efficacy and safety of intravenous phosphate replacement in critically ill patients', u'Ann Pharmacother', u'1997', u'31', u'683', u'8', u'9184705'], [u'32', u'Charron', u'T', u'Bernard', u'F', u'Skrobik', u'Y', u'Simoneau', u'N', u'Gagnon', u'N', u'Leblanc', u'M', u'Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia', u'Intensive Care Med', u'2003', u'29', u'1273', u'8', u'12845429'], [u'33', u'Barak', u'V', u'Schwartz', u'A', u'Kalickman', u'I', u'Nisman', u'B', u'Gurman', u'G', u'Shoenfeld', u'Y', u'Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines', u'Am J Med', u'1998', u'104', u'40', u'7', u'9528718'], [u'34', u'Walker', u'K', u'Dallas Hall', u'W', u'Hurst', u'W', u'Stoneham', u'M', u'Serum inorganic phosphate', u'Clinical methods', u'1990', u'London', u'Butterworth Publishers', u'895', u'9'], [u'35', u'Morimatsu', u'H', u'Uchino', u'S', u'Bellomo', u'R', u'Ronco', u'C', u'Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations', u'Int J Artif Organs', u'2002', u'25', u'512', u'9', u'12117290'], [u'36', u'Kraus', u'MA', u'Selection of dialysate and replacement fluids and management of electrolyte and acid\u2013base disturbances', u'Semin Dial', u'2009', u'22', u'137', u'40', u'19426416']","[u'Troyanov', u'S', u'Geadah', u'D', u'Ghannoum', u'M', u'Cardinal', u'J', u'Leblanc', u'M.', u'Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy', u'Intensive Care Med', u'2004', u'30', u'1662', u'5'], [u'Marik', u'PE', u'Bedigian', u'MK', u'Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study', u'Arch Surg', u'1996', u'131', u'1043', u'7'], [u'Bugg', u'NC', u'Jones', u'JA', u'Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit', u'Anaesthesia', u'1998', u'53', u'895', u'902'], [u'Skulberg', u'A', u'Glucose: a potential killer', u'Acta Anaesthesiol Scand', u'2009', u'53', u'684'], [u'Peppers', u'MP', u'Geheb', u'M', u'Desai', u'T.', u'Endocrine crises. Hypophosphatemia and hyperphosphatemia', u'Crit Care Clin', u'1991', u'7', u'201', u'14'], [u'Elisaf', u'MS', u'Siamopoulos', u'KC', u'Mechanisms of hypophosphataemia in alcoholic patients', u'Int J Clin Pract', u'1997', u'51', u'501', u'3'], [u'Zazzo', u'JF', u'Troche', u'G', u'Ruel', u'P', u'Maintenant', u'J', u'High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function', u'Intensive Care Med', u'1995', u'21', u'826', u'31'], [u'Tan', u'HK', u'Bellomo', u'R', u""M'Pis"", u'DA', u'Ronco', u'C', u'Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration', u'Int J Artif Organs', u'2001', u'24', u'186', u'91'], [u'Baldwin', u'I', u'Naka', u'T', u'Koch', u'B', u'Fealy', u'N', u'Bellomo', u'R.', u'A pilot randomised controlled comparison of continuous venovenous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance', u'Intensive Care Med', u'2007', u'33', u'830', u'5'], [u'Shor', u'R', u'Halabe', u'A', u'Rishver', u'S', u'Tilis', u'Y', u'Matas', u'Z', u'Fux', u'A', u'Boaz', u'M', u'Weinstein', u'J', u'Severe hypophosphatemia in sepsis as a mortality predictor', u'Ann Clin Lab Sci', u'2006', u'36', u'67', u'72'], [u'Stoff', u'JS', u'Phosphate homeostasis and hypophosphatemia', u'Am J Med', u'1982', u'72', u'489', u'95'], [u'Brown', u'GR', u'Greenwood', u'JK', u'Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill', u'Ann Pharmacother', u'1994', u'28', u'626', u'32'], [u'Bollaert', u'PE', u'Levy', u'B', u'Nace', u'L', u'Laterre', u'PF', u'Larcan', u'A', u'Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock', u'Chest', u'1995', u'107', u'1698', u'701'], [u'Paterson', u'CR', u'Hypophosphataemia: a dangerous disorder', u'Nutrition', u'1996', u'12', u'540', u'1'], [u'Paula', u'FJ', u'Plens', u'AE', u'Foss', u'MC', u'Effects of hypophosphatemia on glucose tolerance and insulin secretion', u'Horm Metab Res', u'1998', u'30', u'281', u'4'], [u'Ravenscroft', u'AJ', u'Valentine', u'JM', u'Knappett PA', u'Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis', u'Anaesthesia', u'1999', u'54', u'198'], [u'Weber', u'U', u'Huppe', u'T', u'Niehaus', u'L', u'CT and MRI in severe hypophosphataemia with central nervous system involvement', u'Neuroradiology', u'2000', u'42', u'112', u'4'], [u'Darsee', u'JR', u'Nutter', u'DO', u'Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'867', u'70'], [u'Aubier', u'M', u'Murciano', u'D', u'Lecocguic', u'Y', u'Viires', u'N', u'Jacquens', u'Y', u'Squara', u'P', u'Pariente', u'R', u'Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure', u'N Engl J Med', u'1985', u'313', u'420', u'4'], [u'Williams', u'JD', u'Topley', u'N', u'Craig', u'KJ', u'Mackenzie', u'RK', u'Pischetsrieder', u'M', u'Lage', u'C', u'Passlick-Deetjen', u'J', u'The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane', u'Kidney Int', u'2004', u'66', u'408', u'18'], [u'Gatchalian', u'RA', u'Popli', u'A', u'Ejaz', u'AA', u'Leehey', u'DJ', u'Kjellstrand', u'CM', u'Ing', u'TS', u'Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate', u'Am J Kidney Dis', u'2000', u'36', u'1262', u'6'], [u'Santiago', u'MJ', u'Lopez-Herce', u'J', u'Urbano', u'J', u'Bellon', u'JM', u'del Castillo', u'J', u'Carrillo', u'A', u'Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children', u'Kidney Int', u'2009', u'75', u'312', u'6'], [u'Janssen van Doorn', u'K', u'Spapen', u'H', u'Geers', u'C', u'Diltoer', u'M', u'Shabana', u'W.', u'Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?', u'Acta Anaesthesiol Scand', u'2008', u'52', u'1259', u'64'], [u'Lentz', u'RD', u'Brown', u'DM', u'Kjellstrand', u'CM', u'Treatment of severe hypophosphatemia', u'Ann Intern Med', u'1978', u'89', u'941', u'4'], [u'Vannatta', u'JB', u'Whang', u'R', u'Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient', u'Arch Intern Med', u'1981', u'141', u'885', u'7'], [u'Vannatta', u'JB', u'Andress', u'DL', u'Whang', u'R', u'High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia', u'South Med J', u'1983', u'76', u'1424', u'6'], [u'Kingston', u'M', u""Al-Siba'i MB"", u'Treatment of severe hypophosphatemia', u'Crit Care Med', u'1985', u'13', u'16', u'8'], [u'Sacks', u'GS', u'Walker', u'J', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Observations of hypophosphatemia and its management in nutrition support', u'Nutr Clin Pract', u'1994', u'9', u'105', u'8'], [u'Clark', u'CL', u'Sacks', u'GS', u'Dickerson', u'RN', u'Kudsk', u'KA', u'Brown', u'RO', u'Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial', u'Crit Care Med', u'1995', u'23', u'1504', u'11'], [u'Rosen', u'GH', u'Boullata', u'JI', u""O'Rangers"", u'EA', u'Enow', u'NB', u'Shin', u'B', u'Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia', u'Crit Care Med', u'1995', u'23', u'1204', u'10'], [u'Perreault', u'MM', u'Ostrop', u'NJ', u'Tierney', u'MG', u'Efficacy and safety of intravenous phosphate replacement in critically ill patients', u'Ann Pharmacother', u'1997', u'31', u'683', u'8'], [u'Charron', u'T', u'Bernard', u'F', u'Skrobik', u'Y', u'Simoneau', u'N', u'Gagnon', u'N', u'Leblanc', u'M.', u'Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia', u'Intensive Care Med', u'2003', u'29', u'1273', u'8'], [u'Barak', u'V', u'Schwartz', u'A', u'Kalickman', u'I', u'Nisman', u'B', u'Gurman', u'G', u'Shoenfeld', u'Y.', u'Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines', u'Am J Med', u'1998', u'104', u'40', u'7'], [u'Walker', u'K', u'Hurst', u'W.', u'Serum inorganic phosphate', u'Clinical methods. London: Butterworth Publishers', u'1990', u'895', u'9'], [u'Morimatsu', u'H', u'Uchino', u'S', u'Bellomo', u'R', u'Ronco', u'C', u'Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations', u'Int J Artif Organs', u'2002', u'25', u'512', u'9'], [u'Kraus', u'MA', u'Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances', u'Semin Dial', u'2009', u'22', u'137', u'40']"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_title,exact,list,0,1,0,0,"Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy, Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study, Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit, Glucose: a potential killer, Endocrine crises. Hypophosphatemia and hyperphosphatemia, Mechanisms of hypophosphataemia in alcoholic patients, High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function, Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration, A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance, Severe hypophosphatemia in sepsis as a mortality predictor, Phosphate homeostasis and hypophosphatemia, Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill, Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock, Hypophosphataemia: a dangerous disorder, Effects of hypophosphatemia on glucose tolerance and insulin secretion, Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis, CT and MRI in severe hypophosphataemia with central nervous system involvement, Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia, Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure, The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane, Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate, Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children, Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?, Treatment of severe hypophosphatemia, Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient, High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia, Treatment of severe hypophosphatemia, Observations of hypophosphatemia and its management in nutrition support, Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial, Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia, Efficacy and safety of intravenous phosphate replacement in critically ill patients, Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia, Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines, Serum inorganic phosphate, Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations, Selection of dialysate and replacement fluids and management of electrolyte and acid–base disturbances","Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy, Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study, Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit, Glucose: a potential killer, Endocrine crises. Hypophosphatemia and hyperphosphatemia, Mechanisms of hypophosphataemia in alcoholic patients, High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function, Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration, A pilot randomised controlled comparison of continuous venovenous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance, Severe hypophosphatemia in sepsis as a mortality predictor, Phosphate homeostasis and hypophosphatemia, Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill, Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock, Hypophosphataemia: a dangerous disorder, Effects of hypophosphatemia on glucose tolerance and insulin secretion, Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis, CT and MRI in severe hypophosphataemia with central nervous system involvement, Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia, Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure, The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane, Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate, Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children, Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?, Treatment of severe hypophosphatemia, Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient, High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia, Treatment of severe hypophosphatemia, Observations of hypophosphatemia and its management in nutrition support, Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial, Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia, Efficacy and safety of intravenous phosphate replacement in critically ill patients, Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia, Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines, Serum inorganic phosphate, Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations, Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_title,levenshtein,list,1,0,0,0,"Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy, Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study, Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit, Glucose: a potential killer, Endocrine crises. Hypophosphatemia and hyperphosphatemia, Mechanisms of hypophosphataemia in alcoholic patients, High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function, Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration, A pilot randomised controlled comparison of continuous veno-venous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance, Severe hypophosphatemia in sepsis as a mortality predictor, Phosphate homeostasis and hypophosphatemia, Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill, Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock, Hypophosphataemia: a dangerous disorder, Effects of hypophosphatemia on glucose tolerance and insulin secretion, Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis, CT and MRI in severe hypophosphataemia with central nervous system involvement, Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia, Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure, The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane, Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate, Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children, Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?, Treatment of severe hypophosphatemia, Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient, High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia, Treatment of severe hypophosphatemia, Observations of hypophosphatemia and its management in nutrition support, Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial, Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia, Efficacy and safety of intravenous phosphate replacement in critically ill patients, Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia, Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines, Serum inorganic phosphate, Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations, Selection of dialysate and replacement fluids and management of electrolyte and acid–base disturbances","Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy, Refeeding hypophosphatemia in critically ill patients in an intensive care unit. A prospective study, Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit, Glucose: a potential killer, Endocrine crises. Hypophosphatemia and hyperphosphatemia, Mechanisms of hypophosphataemia in alcoholic patients, High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function, Phosphatemic control during acute renal failure: intermittent hemodialysis versus continuous hemodiafiltration, A pilot randomised controlled comparison of continuous venovenous haemofiltration and extended daily dialysis with filtration: effect on small solutes and acid-base balance, Severe hypophosphatemia in sepsis as a mortality predictor, Phosphate homeostasis and hypophosphatemia, Drug- and nutrition-induced hypophosphatemia: mechanisms and relevance in the critically ill, Hemodynamic and metabolic effects of rapid correction of hypophosphatemia in patients with septic shock, Hypophosphataemia: a dangerous disorder, Effects of hypophosphatemia on glucose tolerance and insulin secretion, Severe hypophosphataemia and insulin resistance in diabetic ketoacidosis, CT and MRI in severe hypophosphataemia with central nervous system involvement, Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia, Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure, The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane, Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate, Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children, Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment?, Treatment of severe hypophosphatemia, Efficacy of intravenous phosphorus therapy in the severely hypophosphatemic patient, High-dose intravenous phosphorus therapy for severe complicated hypophosphatemia, Treatment of severe hypophosphatemia, Observations of hypophosphatemia and its management in nutrition support, Treatment of hypophosphatemia in patients receiving specialized nutrition support using a graduated dosing scheme: results from a prospective clinical trial, Intravenous phosphate repletion regimen for critically ill patients with moderate hypophosphatemia, Efficacy and safety of intravenous phosphate replacement in critically ill patients, Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia, Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines, Serum inorganic phosphate, Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations, Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_year,exact,list,1,0,0,0,"2004, 1996, 1998, 2009, 1991, 1997, 1995, 2001, 2007, 2006, 1982, 1994, 1995, 1996, 1998, 1999, 2000, 1978, 1985, 2004, 2000, 2009, 2008, 1978, 1981, 1983, 1985, 1994, 1995, 1995, 1997, 2003, 1998, 1990, 2002, 2009","2004, 1996, 1998, 2009, 1991, 1997, 1995, 2001, 2007, 2006, 1982, 1994, 1995, 1996, 1998, 1999, 2000, 1978, 1985, 2004, 2000, 2009, 2008, 1978, 1981, 1983, 1985, 1994, 1995, 1995, 1997, 2003, 1998, 1990, 2002, 2009"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_year,levenshtein,list,1,0,0,0,"2004, 1996, 1998, 2009, 1991, 1997, 1995, 2001, 2007, 2006, 1982, 1994, 1995, 1996, 1998, 1999, 2000, 1978, 1985, 2004, 2000, 2009, 2008, 1978, 1981, 1983, 1985, 1994, 1995, 1995, 1997, 2003, 1998, 1990, 2002, 2009","2004, 1996, 1998, 2009, 1991, 1997, 1995, 2001, 2007, 2006, 1982, 1994, 1995, 1996, 1998, 1999, 2000, 1978, 1985, 2004, 2000, 2009, 2008, 1978, 1981, 1983, 1985, 1994, 1995, 1995, 1997, 2003, 1998, 1990, 2002, 2009"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_source,exact,list,0,1,0,0,"Intensive Care Med, Arch Surg, Anaesthesia, Acta Anaesthesiol Scand, Crit Care Clin, Int J Clin Pract, Intensive Care Med, Int J Artif Organs, Intensive Care Med, Ann Clin Lab Sci, Am J Med, Ann Pharmacother, Chest, Nutrition, Horm Metab Res, Anaesthesia, Neuroradiology, Ann Intern Med, N Engl J Med, Kidney Int, Am J Kidney Dis, Kidney Int, Acta Anaesthesiol Scand, Ann Intern Med, Arch Intern Med, South Med J, Crit Care Med, Nutr Clin Pract, Crit Care Med, Crit Care Med, Ann Pharmacother, Intensive Care Med, Am J Med, Clinical methods, Int J Artif Organs, Semin Dial","Intensive Care Med, Arch Surg, Anaesthesia, Acta Anaesthesiol Scand, Crit Care Clin, Int J Clin Pract, Intensive Care Med, Int J Artif Organs, Intensive Care Med, Ann Clin Lab Sci, Am J Med, Ann Pharmacother, Chest, Nutrition, Horm Metab Res, Anaesthesia, Neuroradiology, Ann Intern Med, N Engl J Med, Kidney Int, Am J Kidney Dis, Kidney Int, Acta Anaesthesiol Scand, Ann Intern Med, Arch Intern Med, South Med J, Crit Care Med, Nutr Clin Pract, Crit Care Med, Crit Care Med, Ann Pharmacother, Intensive Care Med, Am J Med, Clinical methods. London: Butterworth Publishers, Int J Artif Organs, Semin Dial"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_source,levenshtein,list,0,1,0,0,"Intensive Care Med, Arch Surg, Anaesthesia, Acta Anaesthesiol Scand, Crit Care Clin, Int J Clin Pract, Intensive Care Med, Int J Artif Organs, Intensive Care Med, Ann Clin Lab Sci, Am J Med, Ann Pharmacother, Chest, Nutrition, Horm Metab Res, Anaesthesia, Neuroradiology, Ann Intern Med, N Engl J Med, Kidney Int, Am J Kidney Dis, Kidney Int, Acta Anaesthesiol Scand, Ann Intern Med, Arch Intern Med, South Med J, Crit Care Med, Nutr Clin Pract, Crit Care Med, Crit Care Med, Ann Pharmacother, Intensive Care Med, Am J Med, Clinical methods, Int J Artif Organs, Semin Dial","Intensive Care Med, Arch Surg, Anaesthesia, Acta Anaesthesiol Scand, Crit Care Clin, Int J Clin Pract, Intensive Care Med, Int J Artif Organs, Intensive Care Med, Ann Clin Lab Sci, Am J Med, Ann Pharmacother, Chest, Nutrition, Horm Metab Res, Anaesthesia, Neuroradiology, Ann Intern Med, N Engl J Med, Kidney Int, Am J Kidney Dis, Kidney Int, Acta Anaesthesiol Scand, Ann Intern Med, Arch Intern Med, South Med J, Crit Care Med, Nutr Clin Pract, Crit Care Med, Crit Care Med, Ann Pharmacother, Intensive Care Med, Am J Med, Clinical methods. London: Butterworth Publishers, Int J Artif Organs, Semin Dial"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_volume,exact,list,1,0,0,0,"30, 131, 53, 53, 7, 51, 21, 24, 33, 36, 72, 28, 107, 12, 30, 54, 42, 89, 313, 66, 36, 75, 52, 89, 141, 76, 13, 9, 23, 23, 31, 29, 104, , 25, 22","30, 131, 53, 53, 7, 51, 21, 24, 33, 36, 72, 28, 107, 12, 30, 54, 42, 89, 313, 66, 36, 75, 52, 89, 141, 76, 13, 9, 23, 23, 31, 29, 104, , 25, 22"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_volume,levenshtein,list,1,0,0,0,"30, 131, 53, 53, 7, 51, 21, 24, 33, 36, 72, 28, 107, 12, 30, 54, 42, 89, 313, 66, 36, 75, 52, 89, 141, 76, 13, 9, 23, 23, 31, 29, 104, , 25, 22","30, 131, 53, 53, 7, 51, 21, 24, 33, 36, 72, 28, 107, 12, 30, 54, 42, 89, 313, 66, 36, 75, 52, 89, 141, 76, 13, 9, 23, 23, 31, 29, 104, , 25, 22"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_fpage,exact,list,1,0,0,0,"1662, 1043, 895, 684, 201, 501, 826, 186, 830, 67, 489, 626, 1698, 540, 281, 198, 112, 867, 420, 408, 1262, 312, 1259, 941, 885, 1424, 16, 105, 1504, 1204, 683, 1273, 40, 895, 512, 137","1662, 1043, 895, 684, 201, 501, 826, 186, 830, 67, 489, 626, 1698, 540, 281, 198, 112, 867, 420, 408, 1262, 312, 1259, 941, 885, 1424, 16, 105, 1504, 1204, 683, 1273, 40, 895, 512, 137"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_fpage,levenshtein,list,1,0,0,0,"1662, 1043, 895, 684, 201, 501, 826, 186, 830, 67, 489, 626, 1698, 540, 281, 198, 112, 867, 420, 408, 1262, 312, 1259, 941, 885, 1424, 16, 105, 1504, 1204, 683, 1273, 40, 895, 512, 137","1662, 1043, 895, 684, 201, 501, 826, 186, 830, 67, 489, 626, 1698, 540, 281, 198, 112, 867, 420, 408, 1262, 312, 1259, 941, 885, 1424, 16, 105, 1504, 1204, 683, 1273, 40, 895, 512, 137"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_lpage,exact,list,1,0,0,0,"5, 7, 902, , 14, 3, 31, 91, 5, 72, 95, 32, 701, 1, 4, , 4, 70, 4, 18, 6, 6, 64, 4, 7, 6, 8, 8, 11, 10, 8, 8, 7, 9, 9, 40","5, 7, 902, , 14, 3, 31, 91, 5, 72, 95, 32, 701, 1, 4, , 4, 70, 4, 18, 6, 6, 64, 4, 7, 6, 8, 8, 11, 10, 8, 8, 7, 9, 9, 40"
aas0055-0039.cermine.xml,aas0055-0039.nxml,reference_lpage,levenshtein,list,1,0,0,0,"5, 7, 902, , 14, 3, 31, 91, 5, 72, 95, 32, 701, 1, 4, , 4, 70, 4, 18, 6, 6, 64, 4, 7, 6, 8, 8, 11, 10, 8, 8, 7, 9, 9, 40","5, 7, 902, , 14, 3, 31, 91, 5, 72, 95, 32, 701, 1, 4, , 4, 70, 4, 18, 6, 6, 64, 4, 7, 6, 8, 8, 11, 10, 8, 8, 7, 9, 9, 40"
d-67-00463.cermine.xml,d-67-00463.nxml,title,exact,string,0,1,0,0,Pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening,Pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening research papers
d-67-00463.cermine.xml,d-67-00463.nxml,title,levenshtein,string,1,0,0,0,Pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening,Pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening research papers
d-67-00463.cermine.xml,d-67-00463.nxml,abstract,exact,string,0,1,0,0,"Pi sampling, derived from the incomplete factorial approach, is an effort to maximize the diversity of macromolecular crystallization conditions and to facilitate the preparation of 96-condition initial screens.The Pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. The resulting ‘Pi screens’ have a modular distribution of a given set of up to 36 stock solutions. Maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. The Pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. It is particularly adapted to screens consisting of 96 different conditions. The flexibility and efficiency of Pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.",The Pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. The resulting 'Pi screens' have a modular distribution of a given set of up to 36 stock solutions. Maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. The Pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. It is particularly adapted to screens consisting of 96 different conditions. The flexibility and efficiency of Pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.
d-67-00463.cermine.xml,d-67-00463.nxml,abstract,levenshtein,string,0,1,0,0,"Pi sampling, derived from the incomplete factorial approach, is an effort to maximize the diversity of macromolecular crystallization conditions and to facilitate the preparation of 96-condition initial screens.The Pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. The resulting ‘Pi screens’ have a modular distribution of a given set of up to 36 stock solutions. Maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. The Pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. It is particularly adapted to screens consisting of 96 different conditions. The flexibility and efficiency of Pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.",The Pi sampling method is derived from the incomplete factorial approach to macromolecular crystallization screen design. The resulting 'Pi screens' have a modular distribution of a given set of up to 36 stock solutions. Maximally diverse conditions can be produced by taking into account the properties of the chemicals used in the formulation and the concentrations of the corresponding solutions. The Pi sampling method has been implemented in a web-based application that generates screen formulations and recipes. It is particularly adapted to screens consisting of 96 different conditions. The flexibility and efficiency of Pi sampling is demonstrated by the crystallization of soluble proteins and of an integral membrane-protein sample.
d-67-00463.cermine.xml,d-67-00463.nxml,keywords,exact,set,0,0,1,0,"GPCR, incomplete factorial approach, initial screen formulation, macromolecular crystallization, membrane-protein crystallization, modular distribution",
d-67-00463.cermine.xml,d-67-00463.nxml,keywords,levenshtein,set,0,0,1,0,"GPCR, incomplete factorial approach, initial screen formulation, macromolecular crystallization, membrane-protein crystallization, modular distribution",
d-67-00463.cermine.xml,d-67-00463.nxml,author_surnames,exact,set,0,0,1,0,"Gorrec, Lebon, Palmer, Warne",
d-67-00463.cermine.xml,d-67-00463.nxml,author_surnames,levenshtein,set,0,0,1,0,"Gorrec, Lebon, Palmer, Warne",
d-67-00463.cermine.xml,d-67-00463.nxml,first_author_surname,exact,string,0,0,1,0,Gorrec,
d-67-00463.cermine.xml,d-67-00463.nxml,first_author_surname,levenshtein,string,0,0,1,0,Gorrec,
d-67-00463.cermine.xml,d-67-00463.nxml,author_full_names,exact,set,1,0,0,0,"Colin M. Palmer, Fabrice Gorrec, Guillaume Lebon, Tony Warne","Colin M. Palmer, Fabrice Gorrec, Guillaume Lebon, Tony Warne"
d-67-00463.cermine.xml,d-67-00463.nxml,author_full_names,levenshtein,set,1,0,0,0,"Colin M. Palmer, Fabrice Gorrec, Guillaume Lebon, Tony Warne","Colin M. Palmer, Fabrice Gorrec, Guillaume Lebon, Tony Warne"
d-67-00463.cermine.xml,d-67-00463.nxml,first_author_full_name,exact,string,1,0,0,0,Fabrice Gorrec,Fabrice Gorrec
d-67-00463.cermine.xml,d-67-00463.nxml,first_author_full_name,levenshtein,string,1,0,0,0,Fabrice Gorrec,Fabrice Gorrec
d-67-00463.cermine.xml,d-67-00463.nxml,affiliation_strings,exact,set,0,1,0,0,"MRC Laboratory of Molecular Biology, England","MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, England"
d-67-00463.cermine.xml,d-67-00463.nxml,affiliation_strings,levenshtein,set,0,1,0,0,"MRC Laboratory of Molecular Biology, England","MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 0QH, England"
d-67-00463.cermine.xml,d-67-00463.nxml,affiliation_institution,exact,set,1,0,0,0,MRC Laboratory of Molecular Biology,MRC Laboratory of Molecular Biology
d-67-00463.cermine.xml,d-67-00463.nxml,affiliation_institution,levenshtein,set,1,0,0,0,MRC Laboratory of Molecular Biology,MRC Laboratory of Molecular Biology
d-67-00463.cermine.xml,d-67-00463.nxml,section_titles,exact,list,0,1,0,0,"Introduction, Methods, Pi sampling, Pi Sampler, Pi minimal screen preparation and crystallization assays with commercially available soluble proteins, Pi-PEG screen preparation and crystallization assays with a GPCR, Results, Discussion, Pi sampling, The Pi minimal screen, The Pi-PEG screen, Conclusions","1. Introduction, 2. Methods, 2.1. Pi sampling, 2.3. Pi minimal screen preparation and crystallization assays with commercially available soluble proteins, 2.4. Pi-PEG screen preparation and crystallization assays with a GPCR, 4. Discussion, 4.1. Pi sampling, 4.3. The Pi-PEG screen, 5. Conclusions"
d-67-00463.cermine.xml,d-67-00463.nxml,section_titles,levenshtein,list,0,1,0,0,"Introduction, Methods, Pi sampling, Pi Sampler, Pi minimal screen preparation and crystallization assays with commercially available soluble proteins, Pi-PEG screen preparation and crystallization assays with a GPCR, Results, Discussion, Pi sampling, The Pi minimal screen, The Pi-PEG screen, Conclusions","1. Introduction, 2. Methods, 2.1. Pi sampling, 2.3. Pi minimal screen preparation and crystallization assays with commercially available soluble proteins, 2.4. Pi-PEG screen preparation and crystallization assays with a GPCR, 4. Discussion, 4.1. Pi sampling, 4.3. The Pi-PEG screen, 5. Conclusions"
d-67-00463.cermine.xml,d-67-00463.nxml,tables,exact,table,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,tables,levenshtein,table,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_strings,exact,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_strings,levenshtein,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_labels,exact,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_labels,levenshtein,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_captions,exact,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_captions,levenshtein,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_label_captions,exact,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'J. Appl. Cryst.', u'39']","[u'Berejnov', u'V.', u'Husseini', u'N. S.', u'Alsaied', u'O. A.', u'Thorne', u'R. E.', u'2006', u'J. Appl. Cryst', u'39', u'244', u'251']"
d-67-00463.cermine.xml,d-67-00463.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'J. Appl. Cryst.', u'39']","[u'Berejnov', u'V.', u'Husseini', u'N. S.', u'Alsaied', u'O. A.', u'Thorne', u'R. E.', u'2006', u'J. Appl. Cryst', u'39', u'244', u'251']"
d-67-00463.cermine.xml,d-67-00463.nxml,first_reference_title,exact,string,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,first_reference_title,levenshtein,string,0,0,0,1,,
d-67-00463.cermine.xml,d-67-00463.nxml,reference_fields,exact,list,0,1,0,0,"[u'J. Appl. Cryst.', u'39'], [u'Methods Mol. Biol.', u'363'], [u'J. Appl. Cryst.', u'34'], [u'J. Biol. Chem.', u'254'], [u'Cell', u'141'], [u'J. Appl. Cryst.', u'20'], [u'Proc. Natl Acad. Sci. USA', u'90'], [u'Acta Cryst.', u'58'], [u'Cryst. Growth Des.', u'11'], [u'J. Appl. Cryst.', u'24'], [u'Bioinformatics', u'20'], [u'Proteins', u'51'], [u'Protein Sci.', u'18'], [u'Proc. Natl Acad. Sci. USA', u'93'], [u'Protein Sci.', u'12'], [u'J. Biol. Chem.', u'251'], [u'Eur. J. Biochem.', u'189'], [u'et al.', u'Acta Cryst.', u'67'], [u'J. Struct. Biol.', u'142'], [u'History of Mathematics.'], [u'Prog. Biophys. Mol. Biol.', u'88'], [u'Nature (London)', u'454'], [u'Protein Expr. Purif.', u'65']","[u'Berejnov', u'V.', u'Husseini', u'N. S.', u'Alsaied', u'O. A.', u'Thorne', u'R. E.', u'2006', u'J. Appl. Cryst', u'39', u'244', u'251'], [u'Bergfors', u'T.', u'2007', u'Methods Mol. Biol', u'363', u'131', u'151'], [u'Brzozowski', u'A. M.', u'Walton', u'J.', u'2001', u'J. Appl. Cryst', u'34', u'97', u'101'], [u'Carter', u'C. W.', u'Carter', u'C. W.', u'1979', u'J. Biol. Chem', u'254', u'12219', u'12223'], [u'Clarke', u'O. B.', u'Caputo', u'A. T.', u'Hill', u'A. P.', u'Vandenberg', u'J. I.', u'Smith', u'B. J.', u'Gulbis', u'J. M.', u'2010', u'141', u'1018', u'1029'], [u'Cox', u'M. J.', u'Weber', u'P. C.', u'1987', u'J. Appl. Cryst', u'20', u'366', u'373'], [u'Doudna', u'J. A.', u'Grosshans', u'C.', u'Gooding', u'A.', u'Kundrot', u'C. E.', u'1993', u'Proc. Natl Acad. Sci. USA', u'90', u'7829', u'7833'], [u'Forsythe', u'E. L.', u'Maxwell', u'D. L.', u'Pusey', u'M.', u'2002', u'Acta Cryst. D58', u'1601', u'1605'], [u'Hedderich', u'T.', u'Marcia', u'M.', u'J.', u'Michel', u'H.', u'2011', u'Cryst. Growth Des', u'11', u'488', u'491'], [u'Jancarik', u'J.', u'Kim', u'S.-H.', u'1991', u'J. Appl. Cryst', u'24', u'409', u'411'], [u'Kantardjieff', u'K. A.', u'Rupp', u'B.', u'2004', u'20', u'2162', u'2168'], [u'Kimber', u'M. S.', u'Vallee', u'F.', u'Houston', u'S.', u'Necakov', u'A.', u'Skarina', u'T.', u'Evdokimova', u'E.', u'Beasley', u'S.', u'Christendat', u'D.', u'Savchenko', u'A.', u'Arrowsmith', u'C. H.', u'Vedadi', u'M.', u'Gerstein', u'M.', u'Edwards', u'A. M.', u'2003', u'51', u'562', u'568'], [u'Koszelak-Rosenblum', u'M.', u'Krol', u'A.', u'Mozumdar', u'N.', u'Wunsch', u'K.', u'Ferin', u'A.', u'Cook', u'E.', u'Veatch', u'C. K.', u'Nagel', u'R.', u'Luft', u'J. R.', u'Detitta', u'G. T.', u'Malkowski', u'M. G.', u'2009', u'Protein Sci. 18', u'1828', u'1839'], [u'Landau', u'E. M.', u'Rosenbusch', u'J. P.', u'1996', u'Proc. Natl Acad. Sci. USA', u'93', u'14532', u'14535'], [u'Lemieux', u'M. J.', u'Song', u'J.', u'Kim', u'M. J.', u'Huang', u'Y.', u'Villa', u'A.', u'Auer', u'M.', u'Li', u'X.-D.', u'Wang', u'D.-N.', u'2003', u'Protein Sci', u'12', u'2748', u'2756'], [u'McPherson', u'A.', u'1976', u'J. Biol. Chem', u'251', u'6300', u'6303'], [u'McPherson', u'A.', u'1990', u'Eur. J. Biochem. 189', u'1', u'23'], [u'Morris', u'C.', u'2011', u'Acta Cryst. D67', u'249', u'260'], [u'Rupp', u'B.', u'2003', u'J. Struct. Biol', u'142', u'162', u'169'], [u'Smith', u'D. E.', u'1958'], [u'Stock', u'D.', u'Perisic', u'O.', u'Lo\xa8 we', u'2005', u'Prog. Biophys. Mol. Biol', u'88', u'311', u'327'], [u'Warne', u'T.', u'Serrano-Vega', u'M. J.', u'Baker', u'J. G.', u'Moukhametzianov', u'R.', u'Edwards', u'P. C.', u'Henderson', u'R.', u'Leslie', u'A. G.', u'Tate', u'C. G.', u'Schertler', u'G. F.', u'2008', u'Nature (London)', u'454', u'486', u'491'], [u'Warne', u'T.', u'Serrano-Vega', u'M. J.', u'Tate', u'C. G.', u'Schertler', u'G. F.', u'2009', u'Protein Expr. Purif', u'65', u'204', u'213']"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_fields,levenshtein,list,0,1,0,0,"[u'J. Appl. Cryst.', u'39'], [u'Methods Mol. Biol.', u'363'], [u'J. Appl. Cryst.', u'34'], [u'J. Biol. Chem.', u'254'], [u'Cell', u'141'], [u'J. Appl. Cryst.', u'20'], [u'Proc. Natl Acad. Sci. USA', u'90'], [u'Acta Cryst.', u'58'], [u'Cryst. Growth Des.', u'11'], [u'J. Appl. Cryst.', u'24'], [u'Bioinformatics', u'20'], [u'Proteins', u'51'], [u'Protein Sci.', u'18'], [u'Proc. Natl Acad. Sci. USA', u'93'], [u'Protein Sci.', u'12'], [u'J. Biol. Chem.', u'251'], [u'Eur. J. Biochem.', u'189'], [u'et al.', u'Acta Cryst.', u'67'], [u'J. Struct. Biol.', u'142'], [u'History of Mathematics.'], [u'Prog. Biophys. Mol. Biol.', u'88'], [u'Nature (London)', u'454'], [u'Protein Expr. Purif.', u'65']","[u'Berejnov', u'V.', u'Husseini', u'N. S.', u'Alsaied', u'O. A.', u'Thorne', u'R. E.', u'2006', u'J. Appl. Cryst', u'39', u'244', u'251'], [u'Bergfors', u'T.', u'2007', u'Methods Mol. Biol', u'363', u'131', u'151'], [u'Brzozowski', u'A. M.', u'Walton', u'J.', u'2001', u'J. Appl. Cryst', u'34', u'97', u'101'], [u'Carter', u'C. W.', u'Carter', u'C. W.', u'1979', u'J. Biol. Chem', u'254', u'12219', u'12223'], [u'Clarke', u'O. B.', u'Caputo', u'A. T.', u'Hill', u'A. P.', u'Vandenberg', u'J. I.', u'Smith', u'B. J.', u'Gulbis', u'J. M.', u'2010', u'141', u'1018', u'1029'], [u'Cox', u'M. J.', u'Weber', u'P. C.', u'1987', u'J. Appl. Cryst', u'20', u'366', u'373'], [u'Doudna', u'J. A.', u'Grosshans', u'C.', u'Gooding', u'A.', u'Kundrot', u'C. E.', u'1993', u'Proc. Natl Acad. Sci. USA', u'90', u'7829', u'7833'], [u'Forsythe', u'E. L.', u'Maxwell', u'D. L.', u'Pusey', u'M.', u'2002', u'Acta Cryst. D58', u'1601', u'1605'], [u'Hedderich', u'T.', u'Marcia', u'M.', u'J.', u'Michel', u'H.', u'2011', u'Cryst. Growth Des', u'11', u'488', u'491'], [u'Jancarik', u'J.', u'Kim', u'S.-H.', u'1991', u'J. Appl. Cryst', u'24', u'409', u'411'], [u'Kantardjieff', u'K. A.', u'Rupp', u'B.', u'2004', u'20', u'2162', u'2168'], [u'Kimber', u'M. S.', u'Vallee', u'F.', u'Houston', u'S.', u'Necakov', u'A.', u'Skarina', u'T.', u'Evdokimova', u'E.', u'Beasley', u'S.', u'Christendat', u'D.', u'Savchenko', u'A.', u'Arrowsmith', u'C. H.', u'Vedadi', u'M.', u'Gerstein', u'M.', u'Edwards', u'A. M.', u'2003', u'51', u'562', u'568'], [u'Koszelak-Rosenblum', u'M.', u'Krol', u'A.', u'Mozumdar', u'N.', u'Wunsch', u'K.', u'Ferin', u'A.', u'Cook', u'E.', u'Veatch', u'C. K.', u'Nagel', u'R.', u'Luft', u'J. R.', u'Detitta', u'G. T.', u'Malkowski', u'M. G.', u'2009', u'Protein Sci. 18', u'1828', u'1839'], [u'Landau', u'E. M.', u'Rosenbusch', u'J. P.', u'1996', u'Proc. Natl Acad. Sci. USA', u'93', u'14532', u'14535'], [u'Lemieux', u'M. J.', u'Song', u'J.', u'Kim', u'M. J.', u'Huang', u'Y.', u'Villa', u'A.', u'Auer', u'M.', u'Li', u'X.-D.', u'Wang', u'D.-N.', u'2003', u'Protein Sci', u'12', u'2748', u'2756'], [u'McPherson', u'A.', u'1976', u'J. Biol. Chem', u'251', u'6300', u'6303'], [u'McPherson', u'A.', u'1990', u'Eur. J. Biochem. 189', u'1', u'23'], [u'Morris', u'C.', u'2011', u'Acta Cryst. D67', u'249', u'260'], [u'Rupp', u'B.', u'2003', u'J. Struct. Biol', u'142', u'162', u'169'], [u'Smith', u'D. E.', u'1958'], [u'Stock', u'D.', u'Perisic', u'O.', u'Lo\xa8 we', u'2005', u'Prog. Biophys. Mol. Biol', u'88', u'311', u'327'], [u'Warne', u'T.', u'Serrano-Vega', u'M. J.', u'Baker', u'J. G.', u'Moukhametzianov', u'R.', u'Edwards', u'P. C.', u'Henderson', u'R.', u'Leslie', u'A. G.', u'Tate', u'C. G.', u'Schertler', u'G. F.', u'2008', u'Nature (London)', u'454', u'486', u'491'], [u'Warne', u'T.', u'Serrano-Vega', u'M. J.', u'Tate', u'C. G.', u'Schertler', u'G. F.', u'2009', u'Protein Expr. Purif', u'65', u'204', u'213']"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_title,exact,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ",", , , , , , , , , , , , , , , , , , , , Lo¨ we, , "
d-67-00463.cermine.xml,d-67-00463.nxml,reference_title,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ",", , , , , , , , , , , , , , , , , , , , Lo¨ we, , "
d-67-00463.cermine.xml,d-67-00463.nxml,reference_year,exact,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","2006, 2007, 2001, 1979, 2010, 1987, 1993, 2002, 2011, 1991, 2004, 2003, 2009, 1996, 2003, 1976, 1990, 2011, 2003, 1958, 2005, 2008, 2009"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_year,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","2006, 2007, 2001, 1979, 2010, 1987, 1993, 2002, 2011, 1991, 2004, 2003, 2009, 1996, 2003, 1976, 1990, 2011, 2003, 1958, 2005, 2008, 2009"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_source,exact,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","J. Appl. Cryst, Methods Mol. Biol, J. Appl. Cryst, J. Biol. Chem, , J. Appl. Cryst, Proc. Natl Acad. Sci. USA, Acta Cryst. D58, Cryst. Growth Des, J. Appl. Cryst, , , Protein Sci. 18, Proc. Natl Acad. Sci. USA, Protein Sci, J. Biol. Chem, Eur. J. Biochem. 189, Acta Cryst. D67, J. Struct. Biol, , Prog. Biophys. Mol. Biol, Nature (London), Protein Expr. Purif"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_source,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","J. Appl. Cryst, Methods Mol. Biol, J. Appl. Cryst, J. Biol. Chem, , J. Appl. Cryst, Proc. Natl Acad. Sci. USA, Acta Cryst. D58, Cryst. Growth Des, J. Appl. Cryst, , , Protein Sci. 18, Proc. Natl Acad. Sci. USA, Protein Sci, J. Biol. Chem, Eur. J. Biochem. 189, Acta Cryst. D67, J. Struct. Biol, , Prog. Biophys. Mol. Biol, Nature (London), Protein Expr. Purif"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_volume,exact,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","39, 363, 34, 254, 141, 20, 90, , 11, 24, 20, 51, , 93, 12, 251, , , 142, , 88, 454, 65"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_volume,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","39, 363, 34, 254, 141, 20, 90, , 11, 24, 20, 51, , 93, 12, 251, , , 142, , 88, 454, 65"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_fpage,exact,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","244, 131, 97, 12219, 1018, 366, 7829, 1601, 488, 409, 2162, 562, 1828, 14532, 2748, 6300, 1, 249, 162, , 311, 486, 204"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_fpage,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","244, 131, 97, 12219, 1018, 366, 7829, 1601, 488, 409, 2162, 562, 1828, 14532, 2748, 6300, 1, 249, 162, , 311, 486, 204"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_lpage,exact,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","251, 151, 101, 12223, 1029, 373, 7833, 1605, 491, 411, 2168, 568, 1839, 14535, 2756, 6303, 23, 260, 169, , 327, 491, 213"
d-67-00463.cermine.xml,d-67-00463.nxml,reference_lpage,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , , , , , , , , , ","251, 151, 101, 12223, 1029, 373, 7833, 1605, 491, 411, 2168, 568, 1839, 14535, 2756, 6303, 23, 260, 169, , 327, 491, 213"
e-67-o1363.cermine.xml,e-67-o1363.nxml,title,exact,string,0,1,0,0,"3-Allyl-1-{[3-(4-nitro­phen­yl)-4,5-dihydro-1,3-oxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione","3-Allyl-1-{[3-(4-nitrophenyl)-4,5- dihydro-1,3-oxazol-5-yl]methyl}-1H- anthra[1,2-d]imidazole-2,6,11(3H)- trione"
e-67-o1363.cermine.xml,e-67-o1363.nxml,title,levenshtein,string,1,0,0,0,"3-Allyl-1-{[3-(4-nitro­phen­yl)-4,5-dihydro-1,3-oxazol-5-yl]meth­yl}-1H-anthra[1,2-d]imidazole-2,6,11(3H)-trione","3-Allyl-1-{[3-(4-nitrophenyl)-4,5- dihydro-1,3-oxazol-5-yl]methyl}-1H- anthra[1,2-d]imidazole-2,6,11(3H)- trione"
e-67-o1363.cermine.xml,e-67-o1363.nxml,abstract,exact,string,0,0,1,0,"The mol­ecular structure of the title compound, C28H20N4O6, consists of three fused six-membered rings (A,B,C) and one five-membered ring (D). The latter is linked to an isoxazole ring (E) via a methyl­ene unit. A 4-nitro-phenyl substituent (F) is attached to the isoxazole. The fused five and six-membered rings (C,D) are almost coplanar with an r.m.s. deviation of 0.0345 Å and make a dihedral angle of 9.40 (8)° with ring A. The isoxazole and 4-nitro-phenyl rings (E,F) are also almost coplanar with the imidazole and the fused adjacent ring (C,D), forming a dihedral angle of 11.4 (6)°. The crystal packing displays inter­molecular C—H⋯O hydrogen bonding. An intra­molecular C—H⋯O inter­action also occurs.",
e-67-o1363.cermine.xml,e-67-o1363.nxml,abstract,levenshtein,string,0,0,1,0,"The mol­ecular structure of the title compound, C28H20N4O6, consists of three fused six-membered rings (A,B,C) and one five-membered ring (D). The latter is linked to an isoxazole ring (E) via a methyl­ene unit. A 4-nitro-phenyl substituent (F) is attached to the isoxazole. The fused five and six-membered rings (C,D) are almost coplanar with an r.m.s. deviation of 0.0345 Å and make a dihedral angle of 9.40 (8)° with ring A. The isoxazole and 4-nitro-phenyl rings (E,F) are also almost coplanar with the imidazole and the fused adjacent ring (C,D), forming a dihedral angle of 11.4 (6)°. The crystal packing displays inter­molecular C—H⋯O hydrogen bonding. An intra­molecular C—H⋯O inter­action also occurs.",
e-67-o1363.cermine.xml,e-67-o1363.nxml,keywords,exact,set,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,keywords,levenshtein,set,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,author_surnames,exact,set,0,0,1,0,"Afrakssou, Capet, El Ammari, Haoudi, Rolando",
e-67-o1363.cermine.xml,e-67-o1363.nxml,author_surnames,levenshtein,set,0,0,1,0,"Afrakssou, Capet, El Ammari, Haoudi, Rolando",
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_author_surname,exact,string,0,0,1,0,Afrakssou,
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_author_surname,levenshtein,string,0,0,1,0,Afrakssou,
e-67-o1363.cermine.xml,e-67-o1363.nxml,author_full_names,exact,set,0,1,0,0,"Amal Haoudi, Christian Rolando, Frédéric Capet, Lahcen El Ammari, Zahra Afrakssou","Amal Haoudi, Christian Rolando, Fre´ de´ ric Capet, Lahcen El Ammari, Zahra Afrakssou"
e-67-o1363.cermine.xml,e-67-o1363.nxml,author_full_names,levenshtein,set,0,1,0,0,"Amal Haoudi, Christian Rolando, Frédéric Capet, Lahcen El Ammari, Zahra Afrakssou","Amal Haoudi, Christian Rolando, Fre´ de´ ric Capet, Lahcen El Ammari, Zahra Afrakssou"
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_author_full_name,exact,string,1,0,0,0,Zahra Afrakssou,Zahra Afrakssou
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_author_full_name,levenshtein,string,1,0,0,0,Zahra Afrakssou,Zahra Afrakssou
e-67-o1363.cermine.xml,e-67-o1363.nxml,affiliation_strings,exact,set,0,1,0,0,"France, Morocco","Laboratoire de Chimie Organique Applique ?e, Universite ? Sidi Mohamed Ben Abdallah, Faculte ? des Sciences et Techniques, Route d'Immouzzer, BP 2202 Fe`s, Morocco, Laboratoire de Chimie du Solide Applique ?e, Faculte ? des Sciences, Universite ? Mohammed V-Agdal, Avenue Ibn Battouta, BP 1014, Rabat, Morocco, USR 3290 Miniaturisation pour l'Analyse, la Synthe`se et la Prote ?omique, 59655 Villeneuve d'Ascq Cedex, Universite ? Lille-1, France, Unite ? de Catalyse et de Chimie du Solide (UCCS), UMR 8181, Ecole Nationale Supe ?rieure de Chimie de Lille, France"
e-67-o1363.cermine.xml,e-67-o1363.nxml,affiliation_strings,levenshtein,set,0,1,0,0,"France, Morocco","Laboratoire de Chimie Organique Applique ?e, Universite ? Sidi Mohamed Ben Abdallah, Faculte ? des Sciences et Techniques, Route d'Immouzzer, BP 2202 Fe`s, Morocco, Laboratoire de Chimie du Solide Applique ?e, Faculte ? des Sciences, Universite ? Mohammed V-Agdal, Avenue Ibn Battouta, BP 1014, Rabat, Morocco, USR 3290 Miniaturisation pour l'Analyse, la Synthe`se et la Prote ?omique, 59655 Villeneuve d'Ascq Cedex, Universite ? Lille-1, France, Unite ? de Catalyse et de Chimie du Solide (UCCS), UMR 8181, Ecole Nationale Supe ?rieure de Chimie de Lille, France"
e-67-o1363.cermine.xml,e-67-o1363.nxml,affiliation_institution,exact,set,0,1,0,0,,"Laboratoire de Chimie Organique Applique ?e, Universite ? Sidi Mohamed Ben Abdallah, Faculte ? des Sciences et Techniques, Laboratoire de Chimie du Solide Applique ?e, Faculte ? des Sciences, Universite ? Mohammed V-Agdal, USR 3290 Miniaturisation pour l'Analyse, la Synthe`se et la Prote ?omique, 59655 Villeneuve d'Ascq Cedex, Unite ? de Catalyse et de Chimie du Solide (UCCS), UMR 8181, Ecole Nationale Supe ?rieure de Chimie de Lille"
e-67-o1363.cermine.xml,e-67-o1363.nxml,affiliation_institution,levenshtein,set,0,1,0,0,,"Laboratoire de Chimie Organique Applique ?e, Universite ? Sidi Mohamed Ben Abdallah, Faculte ? des Sciences et Techniques, Laboratoire de Chimie du Solide Applique ?e, Faculte ? des Sciences, Universite ? Mohammed V-Agdal, USR 3290 Miniaturisation pour l'Analyse, la Synthe`se et la Prote ?omique, 59655 Villeneuve d'Ascq Cedex, Unite ? de Catalyse et de Chimie du Solide (UCCS), UMR 8181, Ecole Nationale Supe ?rieure de Chimie de Lille"
e-67-o1363.cermine.xml,e-67-o1363.nxml,section_titles,exact,list,0,1,0,0,"Related literature, Experimental, , Crystal data, Data collection, Refinement, , Supplementary Material","-, Related literature, Experimental, Crystal data, Data collection, Refinement, Comment, Experimental, Refinement Figures"
e-67-o1363.cermine.xml,e-67-o1363.nxml,section_titles,levenshtein,list,0,1,0,0,"Related literature, Experimental, , Crystal data, Data collection, Refinement, , Supplementary Material","-, Related literature, Experimental, Crystal data, Data collection, Refinement, Comment, Experimental, Refinement Figures"
e-67-o1363.cermine.xml,e-67-o1363.nxml,tables,exact,table,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,tables,levenshtein,table,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_strings,exact,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_strings,levenshtein,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_labels,exact,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_labels,levenshtein,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_captions,exact,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_captions,levenshtein,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_label_captions,exact,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'Acta Cryst.', u'66']","[u'Afrakssou', u'Z.', u'Rodi', u'Y. K.', u'Zouihri', u'H.', u'Essassi', u'E. M.', u'Ng', u'S. W.', u'2010', u'Acta Cryst. E66', u'o1851']"
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'Acta Cryst.', u'66']","[u'Afrakssou', u'Z.', u'Rodi', u'Y. K.', u'Zouihri', u'H.', u'Essassi', u'E. M.', u'Ng', u'S. W.', u'2010', u'Acta Cryst. E66', u'o1851']"
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_reference_title,exact,string,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,first_reference_title,levenshtein,string,0,0,0,1,,
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_fields,exact,list,0,1,0,0,"[u'Acta Cryst.', u'66'], [u'J. Ethnopharmacol.', u'72'], [u'Antivir. Res.', u'28'], [u'APEX2', u'SAINT-Plus', u'SADABS'], [u'Food Chem. Toxicol.', u'45'], [u'J. Am. Chem. Soc.', u'97'], [u'J. Appl. Cryst.', u'30'], [u'J. Med. Chem.', u'46'], [u'J. Ethnopharmacol.', u'91'], [u'Cancer Lett.', u'182'], [u'Acta Cryst.', u'64'], [u'Mutat. Res.', u'347'], [u'Biochem. Pharmacol.', u'70'], [u'Thermochim. Acta', u'429'], [u'Food Chem.', u'70']","[u'Afrakssou', u'Z.', u'Rodi', u'Y. K.', u'Zouihri', u'H.', u'Essassi', u'E. M.', u'Ng', u'S. W.', u'2010', u'Acta Cryst. E66', u'o1851'], [u'Agarwal', u'S. K.', u'Singh', u'S. S.', u'Verma', u'S.', u'Kumar', u'S.', u'2000', u'J. Ethnopharmacol', u'72', u'43', u'46'], [u'Barnard', u'D. L.', u'Fairbairn', u'D. W.', u""O'Neill"", u'K. L.', u'Gage', u'T. L.', u'Sidwell', u'R. W.', u'1995', u'Antivir. Res', u'28', u'317', u'321'], [u'Bruker', u'2009', u'APEX2, SAINT-Plus and SADABS. Bruker AXS Inc', u'Madison'], [u'Chen', u'S. H.', u'Lin', u'K. Y.', u'Chang', u'C. C.', u'Fang', u'C. L.', u'Lin', u'C. P.', u'2007', u'Food Chem. Toxicol', u'45', u'2296', u'2303'], [u'Cremer', u'D.', u'Pople', u'J. A.', u'1975', u'J. Am. Chem. Soc', u'97', u'1354', u'1358'], [u'Farrugia', u'L. J.', u'1997', u'J. Appl. Cryst', u'30', u'565'], [u'Haug', u'H. S.', u'Chiou', u'J. F.', u'Fong', u'Y.', u'Hou', u'C. C.', u'Lu', u'Y. C.', u'Wang', u'J. Y.', u'Shih', u'J. W.', u'Pan', u'Y. R.', u'Lin', u'J. J.', u'2003', u'J. Med. Chem', u'46', u'3300', u'3307'], [u'Iizuka', u'A.', u'Iijima', u'O. T.', u'Kondo', u'K.', u'Itakura', u'H.', u'Yoshie', u'F.', u'Miyamoto', u'H.', u'Kubo', u'M.', u'Higuchi', u'M.', u'Takeda', u'H.', u'Matsumiy', u'T.', u'2004', u'J. Ethnopharmacol', u'91', u'89', u'94'], [u'Koyamaa', u'J.', u'Morita', u'I.', u'Tagahara', u'K.', u'Nobukuni', u'Y.', u'Mukainaka', u'T.', u'Kuchide', u'M.', u'Tokuda', u'H.', u'Nishino', u'H.', u'2002', u'Cancer Lett', u'182', u'135', u'139'], [u'Sheldrick', u'G. M.', u'2008', u'Acta Cryst. A64', u'112', u'122'], [u'Simi', u'S.', u'Morelli', u'S.', u'Gervasi', u'P. G.', u'Rainaldi', u'G.', u'1995', u'Mutat. Res', u'347', u'151', u'156'], [u'Su', u'Y. T.', u'Chang', u'H. L.', u'Shyue', u'S. K.', u'Hsu', u'S. L.', u'2005', u'Biochem. Pharmacol', u'70', u'229', u'241'], [u'Wu', u'Y. W.', u'Gao', u'Xiao', u'X. H.', u'Liu', u'Y.', u'2005', u'Thermochim. Acta', u'429', u'167', u'170'], [u'Yen', u'G. C.', u'Duh', u'P. D.', u'Chuang', u'D. Y.', u'2000', u'Food Chem', u'70', u'437', u'441']"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_fields,levenshtein,list,0,1,0,0,"[u'Acta Cryst.', u'66'], [u'J. Ethnopharmacol.', u'72'], [u'Antivir. Res.', u'28'], [u'APEX2', u'SAINT-Plus', u'SADABS'], [u'Food Chem. Toxicol.', u'45'], [u'J. Am. Chem. Soc.', u'97'], [u'J. Appl. Cryst.', u'30'], [u'J. Med. Chem.', u'46'], [u'J. Ethnopharmacol.', u'91'], [u'Cancer Lett.', u'182'], [u'Acta Cryst.', u'64'], [u'Mutat. Res.', u'347'], [u'Biochem. Pharmacol.', u'70'], [u'Thermochim. Acta', u'429'], [u'Food Chem.', u'70']","[u'Afrakssou', u'Z.', u'Rodi', u'Y. K.', u'Zouihri', u'H.', u'Essassi', u'E. M.', u'Ng', u'S. W.', u'2010', u'Acta Cryst. E66', u'o1851'], [u'Agarwal', u'S. K.', u'Singh', u'S. S.', u'Verma', u'S.', u'Kumar', u'S.', u'2000', u'J. Ethnopharmacol', u'72', u'43', u'46'], [u'Barnard', u'D. L.', u'Fairbairn', u'D. W.', u""O'Neill"", u'K. L.', u'Gage', u'T. L.', u'Sidwell', u'R. W.', u'1995', u'Antivir. Res', u'28', u'317', u'321'], [u'Bruker', u'2009', u'APEX2, SAINT-Plus and SADABS. Bruker AXS Inc', u'Madison'], [u'Chen', u'S. H.', u'Lin', u'K. Y.', u'Chang', u'C. C.', u'Fang', u'C. L.', u'Lin', u'C. P.', u'2007', u'Food Chem. Toxicol', u'45', u'2296', u'2303'], [u'Cremer', u'D.', u'Pople', u'J. A.', u'1975', u'J. Am. Chem. Soc', u'97', u'1354', u'1358'], [u'Farrugia', u'L. J.', u'1997', u'J. Appl. Cryst', u'30', u'565'], [u'Haug', u'H. S.', u'Chiou', u'J. F.', u'Fong', u'Y.', u'Hou', u'C. C.', u'Lu', u'Y. C.', u'Wang', u'J. Y.', u'Shih', u'J. W.', u'Pan', u'Y. R.', u'Lin', u'J. J.', u'2003', u'J. Med. Chem', u'46', u'3300', u'3307'], [u'Iizuka', u'A.', u'Iijima', u'O. T.', u'Kondo', u'K.', u'Itakura', u'H.', u'Yoshie', u'F.', u'Miyamoto', u'H.', u'Kubo', u'M.', u'Higuchi', u'M.', u'Takeda', u'H.', u'Matsumiy', u'T.', u'2004', u'J. Ethnopharmacol', u'91', u'89', u'94'], [u'Koyamaa', u'J.', u'Morita', u'I.', u'Tagahara', u'K.', u'Nobukuni', u'Y.', u'Mukainaka', u'T.', u'Kuchide', u'M.', u'Tokuda', u'H.', u'Nishino', u'H.', u'2002', u'Cancer Lett', u'182', u'135', u'139'], [u'Sheldrick', u'G. M.', u'2008', u'Acta Cryst. A64', u'112', u'122'], [u'Simi', u'S.', u'Morelli', u'S.', u'Gervasi', u'P. G.', u'Rainaldi', u'G.', u'1995', u'Mutat. Res', u'347', u'151', u'156'], [u'Su', u'Y. T.', u'Chang', u'H. L.', u'Shyue', u'S. K.', u'Hsu', u'S. L.', u'2005', u'Biochem. Pharmacol', u'70', u'229', u'241'], [u'Wu', u'Y. W.', u'Gao', u'Xiao', u'X. H.', u'Liu', u'Y.', u'2005', u'Thermochim. Acta', u'429', u'167', u'170'], [u'Yen', u'G. C.', u'Duh', u'P. D.', u'Chuang', u'D. Y.', u'2000', u'Food Chem', u'70', u'437', u'441']"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_title,exact,list,0,1,0,0,", , , , , , , , , , , , , , ",", , , APEX2, SAINT-Plus and SADABS. Bruker AXS Inc, , , , , , , , , , , "
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_title,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , ",", , , APEX2, SAINT-Plus and SADABS. Bruker AXS Inc, , , , , , , , , , , "
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_year,exact,list,0,1,0,0,", , , , , , , , , , , , , , ","2010, o1851, 2000, 1995, 2009, 2007, 1975, 1997, 2003, 2004, 2002, 2008, 1995, 2005, 2005, 2000"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_year,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , ","2010, o1851, 2000, 1995, 2009, 2007, 1975, 1997, 2003, 2004, 2002, 2008, 1995, 2005, 2005, 2000"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_source,exact,list,0,1,0,0,", , , , , , , , , , , , , , ","Acta Cryst. E66, J. Ethnopharmacol, Antivir. Res, , Food Chem. Toxicol, J. Am. Chem. Soc, J. Appl. Cryst, J. Med. Chem, J. Ethnopharmacol, Cancer Lett, Acta Cryst. A64, Mutat. Res, Biochem. Pharmacol, Thermochim. Acta, Food Chem"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_source,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , ","Acta Cryst. E66, J. Ethnopharmacol, Antivir. Res, , Food Chem. Toxicol, J. Am. Chem. Soc, J. Appl. Cryst, J. Med. Chem, J. Ethnopharmacol, Cancer Lett, Acta Cryst. A64, Mutat. Res, Biochem. Pharmacol, Thermochim. Acta, Food Chem"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_volume,exact,list,0,1,0,0,", , , , , , , , , , , , , , ",", 72, 28, , 45, 97, 30, 46, 91, 182, , 347, 70, 429, 70"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_volume,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , ",", 72, 28, , 45, 97, 30, 46, 91, 182, , 347, 70, 429, 70"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_fpage,exact,list,0,1,0,0,", , , , , , , , , , , , , , ",", 43, 317, , 2296, 1354, 565, 3300, 89, 135, 112, 151, 229, 167, 437"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_fpage,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , ",", 43, 317, , 2296, 1354, 565, 3300, 89, 135, 112, 151, 229, 167, 437"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_lpage,exact,list,0,1,0,0,", , , , , , , , , , , , , , ",", 46, 321, , 2303, 1358, , 3307, 94, 139, 122, 156, 241, 170, 441"
e-67-o1363.cermine.xml,e-67-o1363.nxml,reference_lpage,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , , ",", 46, 321, , 2303, 1358, , 3307, 94, 139, 122, 156, 241, 170, 441"
f-67-00344.cermine.xml,f-67-00344.nxml,title,exact,string,1,0,0,0,"Refolding, crystallization and preliminary X-ray crystallographic study of the whole extracellular regions of nectins","Refolding, crystallization and preliminary X-ray crystallographic study of the whole extracellular regions of nectins"
f-67-00344.cermine.xml,f-67-00344.nxml,title,levenshtein,string,1,0,0,0,"Refolding, crystallization and preliminary X-ray crystallographic study of the whole extracellular regions of nectins","Refolding, crystallization and preliminary X-ray crystallographic study of the whole extracellular regions of nectins"
f-67-00344.cermine.xml,f-67-00344.nxml,abstract,exact,string,0,0,1,0,"The whole extracellular regions of nectin-1 (nectin-1-EC) and nectin-2 (nectin-2-EC) were expressed in E. coli as inclusion bodies, solubilized in 8 M urea and then refolded by rapid dilution. Refolded nectin-1-EC and nectin-2-EC were subsequently purified using three chromatographic steps and crystallized by the hanging-drop vapour-diffusion method.The nectin family of Ca2+-independent immunoglobulin-like cell–cell adhesion molecules contains four members. Nectins, which have three Ig-like domains in their extracellular region, form cell–cell adherens junctions cooperatively with cadherins. The whole extracellular regions of nectin-1 (nectin-1-EC) and nectin-­2 (nectin-2-EC) were expressed in Escherichia coli as inclusion bodies, solubilized in 8 M urea and then refolded by rapid dilution into refolding solution. The refolded proteins were subsequently purified by three chromatographic steps and crystallized using the hanging-drop vapour-diffusion method. The nectin-1-EC crystals belonged to space group P213 and the nectin-2-EC crystals belonged to space group P6122 or P6522.",
f-67-00344.cermine.xml,f-67-00344.nxml,abstract,levenshtein,string,0,0,1,0,"The whole extracellular regions of nectin-1 (nectin-1-EC) and nectin-2 (nectin-2-EC) were expressed in E. coli as inclusion bodies, solubilized in 8 M urea and then refolded by rapid dilution. Refolded nectin-1-EC and nectin-2-EC were subsequently purified using three chromatographic steps and crystallized by the hanging-drop vapour-diffusion method.The nectin family of Ca2+-independent immunoglobulin-like cell–cell adhesion molecules contains four members. Nectins, which have three Ig-like domains in their extracellular region, form cell–cell adherens junctions cooperatively with cadherins. The whole extracellular regions of nectin-1 (nectin-1-EC) and nectin-­2 (nectin-2-EC) were expressed in Escherichia coli as inclusion bodies, solubilized in 8 M urea and then refolded by rapid dilution into refolding solution. The refolded proteins were subsequently purified by three chromatographic steps and crystallized using the hanging-drop vapour-diffusion method. The nectin-1-EC crystals belonged to space group P213 and the nectin-2-EC crystals belonged to space group P6122 or P6522.",
f-67-00344.cermine.xml,f-67-00344.nxml,keywords,exact,set,0,0,1,0,"adherens junctions, cell-adhesion molecules, immunoglobulin-like domains",
f-67-00344.cermine.xml,f-67-00344.nxml,keywords,levenshtein,set,0,0,1,0,"adherens junctions, cell-adhesion molecules, immunoglobulin-like domains",
f-67-00344.cermine.xml,f-67-00344.nxml,author_surnames,exact,set,0,0,1,0,"Nakagawa, Narita, Sakisaka, Suzuki, Takai, Yamamoto",
f-67-00344.cermine.xml,f-67-00344.nxml,author_surnames,levenshtein,set,0,0,1,0,"Nakagawa, Narita, Sakisaka, Suzuki, Takai, Yamamoto",
f-67-00344.cermine.xml,f-67-00344.nxml,first_author_surname,exact,string,0,0,1,0,Narita,
f-67-00344.cermine.xml,f-67-00344.nxml,first_author_surname,levenshtein,string,0,0,1,0,Narita,
f-67-00344.cermine.xml,f-67-00344.nxml,author_full_names,exact,set,0,1,0,0,"Atsushi Nakagawa, Hirotaka Narita, Mamoru Suzuki, Toshiaki Sakisaka, Yasunori Yamamoto, Yoshimi Takai",Laboratory of Supramolecular Crystallography
f-67-00344.cermine.xml,f-67-00344.nxml,author_full_names,levenshtein,set,0,1,0,0,"Atsushi Nakagawa, Hirotaka Narita, Mamoru Suzuki, Toshiaki Sakisaka, Yasunori Yamamoto, Yoshimi Takai",Laboratory of Supramolecular Crystallography
f-67-00344.cermine.xml,f-67-00344.nxml,first_author_full_name,exact,string,0,1,0,0,Hirotaka Narita,Laboratory of Supramolecular Crystallography
f-67-00344.cermine.xml,f-67-00344.nxml,first_author_full_name,levenshtein,string,0,1,0,0,Hirotaka Narita,Laboratory of Supramolecular Crystallography
f-67-00344.cermine.xml,f-67-00344.nxml,affiliation_strings,exact,set,0,1,0,0,"Kobe University Graduate School of Medicine, Japan, Osaka University, Japan","Division of Membrane Dynamics, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan, Division of Molecular and Cellular Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan, Hirotaka Narita, Research Center for Structural and Functional Proteomics, Institute for Protein Research, Osaka University, Suita 565-0871, Japan, Yasunori Yamamoto"
f-67-00344.cermine.xml,f-67-00344.nxml,affiliation_strings,levenshtein,set,0,1,0,0,"Kobe University Graduate School of Medicine, Japan, Osaka University, Japan","Division of Membrane Dynamics, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan, Division of Molecular and Cellular Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan, Hirotaka Narita, Research Center for Structural and Functional Proteomics, Institute for Protein Research, Osaka University, Suita 565-0871, Japan, Yasunori Yamamoto"
f-67-00344.cermine.xml,f-67-00344.nxml,affiliation_institution,exact,set,0,1,0,0,"Kobe University Graduate School of Medicine, Osaka University","Division of Membrane Dynamics, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine, Division of Molecular and Cellular Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Hirotaka Narita, Research Center for Structural and Functional Proteomics, Institute for Protein Research, Osaka University, Yasunori Yamamoto"
f-67-00344.cermine.xml,f-67-00344.nxml,affiliation_institution,levenshtein,set,0,1,0,0,"Kobe University Graduate School of Medicine, Osaka University","Division of Membrane Dynamics, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine, Division of Molecular and Cellular Biology, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Hirotaka Narita, Research Center for Structural and Functional Proteomics, Institute for Protein Research, Osaka University, Yasunori Yamamoto"
f-67-00344.cermine.xml,f-67-00344.nxml,section_titles,exact,list,0,1,0,0,"Introduction, Materials and methods, Protein expression and purification of inclusion bodies, Optimization of refolding conditions and protein purification, Crystallization, Data collection, Results and discussion","1. Introduction, 2. Materials and methods, 3. Results and discussion"
f-67-00344.cermine.xml,f-67-00344.nxml,section_titles,levenshtein,list,0,1,0,0,"Introduction, Materials and methods, Protein expression and purification of inclusion bodies, Optimization of refolding conditions and protein purification, Crystallization, Data collection, Results and discussion","1. Introduction, 2. Materials and methods, 3. Results and discussion"
f-67-00344.cermine.xml,f-67-00344.nxml,tables,exact,table,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,tables,levenshtein,table,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_strings,exact,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_strings,levenshtein,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_labels,exact,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_labels,levenshtein,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_captions,exact,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_captions,levenshtein,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_label_captions,exact,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'J. Virol.', u'72']","[u'Cocchi', u'F.', u'Menotti', u'L.', u'Mirandola', u'P.', u'Lopez', u'M.', u'Campadelli-Fiume', u'G.', u'1998', u'J. Virol', u'72', u'9992', u'10002']"
f-67-00344.cermine.xml,f-67-00344.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'J. Virol.', u'72']","[u'Cocchi', u'F.', u'Menotti', u'L.', u'Mirandola', u'P.', u'Lopez', u'M.', u'Campadelli-Fiume', u'G.', u'1998', u'J. Virol', u'72', u'9992', u'10002']"
f-67-00344.cermine.xml,f-67-00344.nxml,first_reference_title,exact,string,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,first_reference_title,levenshtein,string,0,0,0,1,,
f-67-00344.cermine.xml,f-67-00344.nxml,reference_fields,exact,list,0,1,0,0,"[u'J. Virol.', u'72'], [u'Acta Cryst.', u'50'], [u'Science', u'280'], [u'Nature Rev. Mol. Cell Biol.', u'11'], [u'J. Virol.', u'74'], [u'Proc. Jpn Acad. Ser. B Phys. Biol. Sci.', u'86'], [u'IUBMB Life', u'58'], [u'Methods Enzymol.', u'276'], [u'J. Virol.', u'75'], [u'Annu. Rev. Cell Dev. Biol.', u'24'], [u'Cancer Sci.', u'94'], [u'Nature Rev. Mol. Cell Biol.', u'9'], [u'Virology', u'246'], [u'Proc. Natl Acad. Sci. USA', u'105']","[u'Cocchi', u'F.', u'Menotti', u'L.', u'Mirandola', u'P.', u'Lopez', u'M.', u'Campadelli-Fiume', u'G.', u'1998', u'J. Virol', u'72', u'9992', u'10002'], [u'Collaborative Computational Project, Number', u'4', u'1994', u'Acta Cryst. D50', u'760', u'763'], [u'Geraghty', u'R. J.', u'Krummenacher', u'C.', u'Cohen', u'G. H.', u'Eisenberg', u'R. J.', u'Spear', u'P. G.', u'1998', u'280', u'1618', u'1620'], [u'Harris', u'T. J.', u'Tepass', u'U.', u'2010', u'Nature Rev. Mol. Cell Biol', u'11', u'502', u'514'], [u'Lopez', u'M.', u'Cocchi', u'F.', u'Menotti', u'L.', u'Avitabile', u'E.', u'Dubreuil', u'P.', u'CampadelliFiume', u'G.', u'2000', u'J. Virol', u'74', u'1267', u'1274'], [u'Ogita', u'H.', u'Rikitake', u'Y.', u'Miyoshi', u'J.', u'Takai', u'Y.', u'2010', u'Proc. Jpn Acad. Ser. B Phys. Biol. Sci', u'86', u'621', u'629'], [u'Ogita', u'H.', u'Takai', u'Y.', u'2006', u'IUBMB Life', u'58', u'334', u'343'], [u'Otwinowski', u'Z.', u'Minor', u'W.', u'1997', u'Methods Enzymol', u'276', u'307', u'326'], [u'Sakisaka', u'T.', u'Taniguchi', u'T.', u'Nakanishi', u'H.', u'Takahashi', u'K.', u'Miyahara', u'M.', u'Ikeda', u'W.', u'Yokoyama', u'S.', u'Peng', u'Y.-F.', u'Yamanishi', u'K.', u'Takai', u'Y.', u'2001', u'J. Virol', u'75', u'4734', u'4743'], [u'Takai', u'Y.', u'Ikeda', u'W.', u'Ogita', u'H.', u'Rikitake', u'Y.', u'2008', u'Annu. Rev. Cell Dev. Biol', u'24', u'309', u'342'], [u'Takai', u'Y.', u'Irie', u'K.', u'Shimizu', u'K.', u'Sakisaka', u'T.', u'Ikeda', u'W.', u'2003', u'Cancer Sci', u'94', u'655', u'667'], [u'Takai', u'Y.', u'Miyoshi', u'J.', u'Ikeda', u'W.', u'Ogita', u'H.', u'2008', u'Nature Rev. Mol. Cell Biol', u'9', u'603', u'615'], [u'Warner', u'M. S.', u'Geraghty', u'R. J.', u'Martinez', u'W. M.', u'Montgomery', u'R. I.', u'Whitbeck', u'J. C.', u'Xu', u'R.', u'Eisenberg', u'R. J.', u'G. H.', u'Spear', u'P. G.', u'1998', u'246', u'179', u'189'], [u'Zhang', u'P.', u'Mueller', u'S.', u'Morais', u'M. C.', u'Bator', u'C. M.', u'Bowman', u'V. D.', u'Hafenstein', u'S.', u'Wimmer', u'E.', u'Rossmann', u'M. G.', u'2008', u'Proc. Natl Acad. Sci. USA', u'105', u'18284', u'18289']"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_fields,levenshtein,list,0,1,0,0,"[u'J. Virol.', u'72'], [u'Acta Cryst.', u'50'], [u'Science', u'280'], [u'Nature Rev. Mol. Cell Biol.', u'11'], [u'J. Virol.', u'74'], [u'Proc. Jpn Acad. Ser. B Phys. Biol. Sci.', u'86'], [u'IUBMB Life', u'58'], [u'Methods Enzymol.', u'276'], [u'J. Virol.', u'75'], [u'Annu. Rev. Cell Dev. Biol.', u'24'], [u'Cancer Sci.', u'94'], [u'Nature Rev. Mol. Cell Biol.', u'9'], [u'Virology', u'246'], [u'Proc. Natl Acad. Sci. USA', u'105']","[u'Cocchi', u'F.', u'Menotti', u'L.', u'Mirandola', u'P.', u'Lopez', u'M.', u'Campadelli-Fiume', u'G.', u'1998', u'J. Virol', u'72', u'9992', u'10002'], [u'Collaborative Computational Project, Number', u'4', u'1994', u'Acta Cryst. D50', u'760', u'763'], [u'Geraghty', u'R. J.', u'Krummenacher', u'C.', u'Cohen', u'G. H.', u'Eisenberg', u'R. J.', u'Spear', u'P. G.', u'1998', u'280', u'1618', u'1620'], [u'Harris', u'T. J.', u'Tepass', u'U.', u'2010', u'Nature Rev. Mol. Cell Biol', u'11', u'502', u'514'], [u'Lopez', u'M.', u'Cocchi', u'F.', u'Menotti', u'L.', u'Avitabile', u'E.', u'Dubreuil', u'P.', u'CampadelliFiume', u'G.', u'2000', u'J. Virol', u'74', u'1267', u'1274'], [u'Ogita', u'H.', u'Rikitake', u'Y.', u'Miyoshi', u'J.', u'Takai', u'Y.', u'2010', u'Proc. Jpn Acad. Ser. B Phys. Biol. Sci', u'86', u'621', u'629'], [u'Ogita', u'H.', u'Takai', u'Y.', u'2006', u'IUBMB Life', u'58', u'334', u'343'], [u'Otwinowski', u'Z.', u'Minor', u'W.', u'1997', u'Methods Enzymol', u'276', u'307', u'326'], [u'Sakisaka', u'T.', u'Taniguchi', u'T.', u'Nakanishi', u'H.', u'Takahashi', u'K.', u'Miyahara', u'M.', u'Ikeda', u'W.', u'Yokoyama', u'S.', u'Peng', u'Y.-F.', u'Yamanishi', u'K.', u'Takai', u'Y.', u'2001', u'J. Virol', u'75', u'4734', u'4743'], [u'Takai', u'Y.', u'Ikeda', u'W.', u'Ogita', u'H.', u'Rikitake', u'Y.', u'2008', u'Annu. Rev. Cell Dev. Biol', u'24', u'309', u'342'], [u'Takai', u'Y.', u'Irie', u'K.', u'Shimizu', u'K.', u'Sakisaka', u'T.', u'Ikeda', u'W.', u'2003', u'Cancer Sci', u'94', u'655', u'667'], [u'Takai', u'Y.', u'Miyoshi', u'J.', u'Ikeda', u'W.', u'Ogita', u'H.', u'2008', u'Nature Rev. Mol. Cell Biol', u'9', u'603', u'615'], [u'Warner', u'M. S.', u'Geraghty', u'R. J.', u'Martinez', u'W. M.', u'Montgomery', u'R. I.', u'Whitbeck', u'J. C.', u'Xu', u'R.', u'Eisenberg', u'R. J.', u'G. H.', u'Spear', u'P. G.', u'1998', u'246', u'179', u'189'], [u'Zhang', u'P.', u'Mueller', u'S.', u'Morais', u'M. C.', u'Bator', u'C. M.', u'Bowman', u'V. D.', u'Hafenstein', u'S.', u'Wimmer', u'E.', u'Rossmann', u'M. G.', u'2008', u'Proc. Natl Acad. Sci. USA', u'105', u'18284', u'18289']"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_title,exact,list,1,0,0,0,", , , , , , , , , , , , , ",", , , , , , , , , , , , , "
f-67-00344.cermine.xml,f-67-00344.nxml,reference_title,levenshtein,list,1,0,0,0,", , , , , , , , , , , , , ",", , , , , , , , , , , , , "
f-67-00344.cermine.xml,f-67-00344.nxml,reference_year,exact,list,0,1,0,0,", , , , , , , , , , , , , ","1998, 1994, 1998, 2010, 2000, 2010, 2006, 1997, 2001, 2008, 2003, 2008, 1998, 2008"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_year,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , ","1998, 1994, 1998, 2010, 2000, 2010, 2006, 1997, 2001, 2008, 2003, 2008, 1998, 2008"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_source,exact,list,0,1,0,0,", , , , , , , , , , , , , ","J. Virol, Collaborative Computational Project, Number, Acta Cryst. D50, , Nature Rev. Mol. Cell Biol, J. Virol, Proc. Jpn Acad. Ser. B Phys. Biol. Sci, IUBMB Life, Methods Enzymol, J. Virol, Annu. Rev. Cell Dev. Biol, Cancer Sci, Nature Rev. Mol. Cell Biol, , Proc. Natl Acad. Sci. USA"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_source,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , ","J. Virol, Collaborative Computational Project, Number, Acta Cryst. D50, , Nature Rev. Mol. Cell Biol, J. Virol, Proc. Jpn Acad. Ser. B Phys. Biol. Sci, IUBMB Life, Methods Enzymol, J. Virol, Annu. Rev. Cell Dev. Biol, Cancer Sci, Nature Rev. Mol. Cell Biol, , Proc. Natl Acad. Sci. USA"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_volume,exact,list,0,1,0,0,", , , , , , , , , , , , , ","72, 4, 280, 11, 74, 86, 58, 276, 75, 24, 94, 9, 246, 105"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_volume,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , ","72, 4, 280, 11, 74, 86, 58, 276, 75, 24, 94, 9, 246, 105"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_fpage,exact,list,0,1,0,0,", , , , , , , , , , , , , ","9992, 760, 1618, 502, 1267, 621, 334, 307, 4734, 309, 655, 603, 179, 18284"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_fpage,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , ","9992, 760, 1618, 502, 1267, 621, 334, 307, 4734, 309, 655, 603, 179, 18284"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_lpage,exact,list,0,1,0,0,", , , , , , , , , , , , , ","10002, 763, 1620, 514, 1274, 629, 343, 326, 4743, 342, 667, 615, 189, 18289"
f-67-00344.cermine.xml,f-67-00344.nxml,reference_lpage,levenshtein,list,0,1,0,0,", , , , , , , , , , , , , ","10002, 763, 1620, 514, 1274, 629, 343, 326, 4743, 342, 667, 615, 189, 18289"
sobs89-975.cermine.xml,sobs89-975.nxml,title,exact,string,1,0,0,0,Camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia,Camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia
sobs89-975.cermine.xml,sobs89-975.nxml,title,levenshtein,string,1,0,0,0,Camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia,Camera trocar lifting in office gasless laparoscopic sterilization under local anesthesia
sobs89-975.cermine.xml,sobs89-975.nxml,abstract,exact,string,0,1,0,0,"We evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. Lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the Fallopian tubes. Only mild sedation was necessary. All women walked to and from the operating room. All had successful tubal ligation. The overall satisfaction rate was 97%. The mechanical lifting moment was not painful. With the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (VAS 0–10). No complications occurred except one wound infection. The costs were < ¼ of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. This approach is effective for office-based laparoscopic sterilization. Room air, two strings and a needle replace active gas insufflation and narcosis.","We evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. Lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the Fallopian tubes. Only mild sedation was necessary. All women walked to and from the operating room. All had successful tubal ligation. The overall satisfaction rate was 97%. The mechanical lifting moment was not painful. With the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (VAS 010). No complications occurred except one wound infection. The costs were £ 1/4 of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. This approach is effective for office-based laparoscopic sterilization. Room air, two strings and a needle replace active gas insufflation and narcosis."
sobs89-975.cermine.xml,sobs89-975.nxml,abstract,levenshtein,string,1,0,0,0,"We evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. Lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the Fallopian tubes. Only mild sedation was necessary. All women walked to and from the operating room. All had successful tubal ligation. The overall satisfaction rate was 97%. The mechanical lifting moment was not painful. With the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (VAS 0–10). No complications occurred except one wound infection. The costs were < ¼ of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. This approach is effective for office-based laparoscopic sterilization. Room air, two strings and a needle replace active gas insufflation and narcosis.","We evaluated 35 cases of a mechanical approach to abdominal wall lifting, used in office-based gasless laparoscopic sterilization under local anesthesia. Lifting of the abdominal wall, using the camera trocar as an anchoring device and complemented by suprapubic lifting by means of a towel clamp, led to passive intra-abdominal air filling, giving sufficient space to identify, anesthetize, coagulate and cut the Fallopian tubes. Only mild sedation was necessary. All women walked to and from the operating room. All had successful tubal ligation. The overall satisfaction rate was 97%. The mechanical lifting moment was not painful. With the exception of one woman with failed tubal anesthesia, all women had a low mean pain score of 2.6 (VAS 010). No complications occurred except one wound infection. The costs were £ 1/4 of those of traditional laparoscopic sterilization and office hysteroscopic sterilization. This approach is effective for office-based laparoscopic sterilization. Room air, two strings and a needle replace active gas insufflation and narcosis."
sobs89-975.cermine.xml,sobs89-975.nxml,keywords,exact,set,1,0,0,0,"Female sterilization, endoscopic surgery, gasless, laparoscopy, local anesthesia, office, surgical techniques","Female sterilization, endoscopic surgery, gasless, laparoscopy, local anesthesia, office, surgical techniques"
sobs89-975.cermine.xml,sobs89-975.nxml,keywords,levenshtein,set,1,0,0,0,"Female sterilization, endoscopic surgery, gasless, laparoscopy, local anesthesia, office, surgical techniques","Female sterilization, endoscopic surgery, gasless, laparoscopy, local anesthesia, office, surgical techniques"
sobs89-975.cermine.xml,sobs89-975.nxml,author_surnames,exact,set,0,0,1,0,Bergström,
sobs89-975.cermine.xml,sobs89-975.nxml,author_surnames,levenshtein,set,0,0,1,0,Bergström,
sobs89-975.cermine.xml,sobs89-975.nxml,first_author_surname,exact,string,0,0,1,0,Bergström,
sobs89-975.cermine.xml,sobs89-975.nxml,first_author_surname,levenshtein,string,0,0,1,0,Bergström,
sobs89-975.cermine.xml,sobs89-975.nxml,author_full_names,exact,set,0,1,0,0,Bo S. Bergström,BO S. BERGSTRÖM
sobs89-975.cermine.xml,sobs89-975.nxml,author_full_names,levenshtein,set,0,1,0,0,Bo S. Bergström,BO S. BERGSTRÖM
sobs89-975.cermine.xml,sobs89-975.nxml,first_author_full_name,exact,string,0,1,0,0,Bo S. Bergström,BO S. BERGSTRÖM
sobs89-975.cermine.xml,sobs89-975.nxml,first_author_full_name,levenshtein,string,0,1,0,0,Bo S. Bergström,BO S. BERGSTRÖM
sobs89-975.cermine.xml,sobs89-975.nxml,affiliation_strings,exact,set,1,0,0,0,"Department of Obstetrics & Gynecology, Nordfjord Hospital, Nordfjordeid, Norway","Department of Obstetrics & Gynecology, Nordfjord Hospital, Nordfjordeid, Norway"
sobs89-975.cermine.xml,sobs89-975.nxml,affiliation_strings,levenshtein,set,1,0,0,0,"Department of Obstetrics & Gynecology, Nordfjord Hospital, Nordfjordeid, Norway","Department of Obstetrics & Gynecology, Nordfjord Hospital, Nordfjordeid, Norway"
sobs89-975.cermine.xml,sobs89-975.nxml,affiliation_institution,exact,set,0,1,0,0,,"Department of Obstetrics & Gynecology, Nordfjord Hospital"
sobs89-975.cermine.xml,sobs89-975.nxml,affiliation_institution,levenshtein,set,0,1,0,0,,"Department of Obstetrics & Gynecology, Nordfjord Hospital"
sobs89-975.cermine.xml,sobs89-975.nxml,section_titles,exact,list,1,0,0,0,"Introduction, Material and methods, Results, Discussion","Introduction, Material and methods, Results, Discussion"
sobs89-975.cermine.xml,sobs89-975.nxml,section_titles,levenshtein,list,1,0,0,0,"Introduction, Material and methods, Results, Discussion","Introduction, Material and methods, Results, Discussion"
sobs89-975.cermine.xml,sobs89-975.nxml,tables,exact,table,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,tables,levenshtein,table,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_strings,exact,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_strings,levenshtein,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_labels,exact,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_labels,levenshtein,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_captions,exact,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_captions,levenshtein,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_label_captions,exact,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
sobs89-975.cermine.xml,sobs89-975.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'1', u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68', u'9050587']","[u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68']"
sobs89-975.cermine.xml,sobs89-975.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68', u'9050587']","[u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68']"
sobs89-975.cermine.xml,sobs89-975.nxml,first_reference_title,exact,string,1,0,0,0,Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them,Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them
sobs89-975.cermine.xml,sobs89-975.nxml,first_reference_title,levenshtein,string,1,0,0,0,Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them,Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them
sobs89-975.cermine.xml,sobs89-975.nxml,reference_fields,exact,list,0,1,0,0,"[u'1', u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68', u'9050587'], [u'2', u'Almeida', u'OD', u'Jr', u'Current state of office laparoscopic surgery', u'J Am Assoc Gynecol Laparosc', u'2000', u'7', u'545', u'46', u'11044510'], [u'3', u'Bordahl', u'PE', u'Raeder', u'JC', u'Nordentoft', u'J', u'Kirste', u'U', u'Refsdal', u'A', u'Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study', u'Obstet Gynecol', u'1993', u'81', u'137', u'41', u'8416449'], [u'4', u'Johnson', u'PL', u'Sibert', u'KS', u'Laparoscopy. Gasless vs. CO2 pneumoperitoneum', u'J Reprod Med', u'1997', u'42', u'255', u'59', u'9172113'], [u'5', u'Guido', u'RS', u'Brooks', u'K', u'McKenzie', u'R', u'Gruss', u'J', u'Krohn', u'MA', u'A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy', u'J Am Assoc Gynecol Laparosc', u'1998', u'5', u'149', u'53', u'9564062'], [u'6', u'WHO Task Force on Female Sterilization', u'Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study', u'Am J Obstet Gynecol', u'1982', u'143', u'645', u'9', u'6211987'], [u'7', u'Gomel', u'V', u'McComb', u'PF', u'Microsurgery for tubal infertility', u'J Reprod Med', u'2006', u'51', u'177', u'84', u'16674012'], [u'8', u'Palter', u'SF', u'Olive', u'DL', u'Office microlaparoscopy under local anesthesia for chronic pelvic pain', u'J Am Assoc Gynecol Laparosc', u'1996', u'3', u'359', u'64', u'9050656'], [u'9', u'Edwell', u'John RS', u'SpOG', u'A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization', u'World Laparosc Hosp', u'2008', u'http://www.laparoscopyhospital.com/A_Comparative_Study_of_Hysteroscopic_Sterilization_versus_Laparoscopic_Tubal_Sterilization.html'], [u'10', u'Yaghoobi', u'Notash A', u'Bahrpeyma', u'SH', u'Modaghegh', u'MH', u'Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy', u'Acta Med Iranica', u'2004', u'42', u'131', u'3'], [u'11', u'The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery', u'Surg Endosc', u'2002', u'7', u'1', u'121', u'1143']","[u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68'], [u'Almeida', u'OD', u'Current state of office laparoscopic surgery', u'J Am Assoc Gynecol Laparosc', u'2000', u'7', u'545', u'46'], [u'Bordahl', u'PE', u'Raeder', u'JC', u'Nordentoft', u'J', u'Kirste', u'U', u'Refsdal', u'A', u'Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study', u'Obstet Gynecol', u'1993', u'81', u'137', u'41'], [u'Johnson', u'PL', u'Sibert', u'KS', u'Gasless vs. CO2 pneumoperitoneum', u'J Reprod Med', u'1997', u'42', u'255', u'59'], [u'Guido', u'RS', u'Brooks', u'K', u'McKenzie', u'R', u'Gruss', u'J', u'Krohn', u'MA', u'A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy', u'J Am Assoc Gynecol Laparosc', u'1998', u'5', u'149', u'53'], [u'WHO', u'Task', u'Force on Female Sterilization. Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study', u'Am J Obstet Gynecol', u'1982', u'143', u'645', u'9'], [u'Gomel', u'V', u'McComb', u'PF', u'Microsurgery for tubal infertility', u'J Reprod Med', u'2006', u'51', u'177', u'84'], [u'Palter', u'SF', u'Olive', u'DL', u'Office microlaparoscopy under local anesthesia for chronic pelvic pain', u'J Am Assoc Gynecol Laparosc', u'1996', u'3', u'359', u'64'], [u'Edwell', u'John', u'RS', u'SpOG. A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization', u'World Laparosc Hosp', u'2008', u'2009'], [u'Yaghoobi Notash', u'A', u'Bahrpeyma', u'SH', u'Modaghegh', u'MH', u'Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy', u'Acta Med Iranica', u'2004', u'42', u'131', u'3'], [u'The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery', u'Surg Endosc', u'2002', u'7', u'1121', u'1143']"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_fields,levenshtein,list,0,1,0,0,"[u'1', u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68', u'9050587'], [u'2', u'Almeida', u'OD', u'Jr', u'Current state of office laparoscopic surgery', u'J Am Assoc Gynecol Laparosc', u'2000', u'7', u'545', u'46', u'11044510'], [u'3', u'Bordahl', u'PE', u'Raeder', u'JC', u'Nordentoft', u'J', u'Kirste', u'U', u'Refsdal', u'A', u'Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study', u'Obstet Gynecol', u'1993', u'81', u'137', u'41', u'8416449'], [u'4', u'Johnson', u'PL', u'Sibert', u'KS', u'Laparoscopy. Gasless vs. CO2 pneumoperitoneum', u'J Reprod Med', u'1997', u'42', u'255', u'59', u'9172113'], [u'5', u'Guido', u'RS', u'Brooks', u'K', u'McKenzie', u'R', u'Gruss', u'J', u'Krohn', u'MA', u'A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy', u'J Am Assoc Gynecol Laparosc', u'1998', u'5', u'149', u'53', u'9564062'], [u'6', u'WHO Task Force on Female Sterilization', u'Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study', u'Am J Obstet Gynecol', u'1982', u'143', u'645', u'9', u'6211987'], [u'7', u'Gomel', u'V', u'McComb', u'PF', u'Microsurgery for tubal infertility', u'J Reprod Med', u'2006', u'51', u'177', u'84', u'16674012'], [u'8', u'Palter', u'SF', u'Olive', u'DL', u'Office microlaparoscopy under local anesthesia for chronic pelvic pain', u'J Am Assoc Gynecol Laparosc', u'1996', u'3', u'359', u'64', u'9050656'], [u'9', u'Edwell', u'John RS', u'SpOG', u'A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization', u'World Laparosc Hosp', u'2008', u'http://www.laparoscopyhospital.com/A_Comparative_Study_of_Hysteroscopic_Sterilization_versus_Laparoscopic_Tubal_Sterilization.html'], [u'10', u'Yaghoobi', u'Notash A', u'Bahrpeyma', u'SH', u'Modaghegh', u'MH', u'Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy', u'Acta Med Iranica', u'2004', u'42', u'131', u'3'], [u'11', u'The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery', u'Surg Endosc', u'2002', u'7', u'1', u'121', u'1143']","[u'Penfield', u'AJ', u'Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them', u'J Am Assoc Gynecol Laparosc', u'1995', u'2', u'365', u'68'], [u'Almeida', u'OD', u'Current state of office laparoscopic surgery', u'J Am Assoc Gynecol Laparosc', u'2000', u'7', u'545', u'46'], [u'Bordahl', u'PE', u'Raeder', u'JC', u'Nordentoft', u'J', u'Kirste', u'U', u'Refsdal', u'A', u'Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study', u'Obstet Gynecol', u'1993', u'81', u'137', u'41'], [u'Johnson', u'PL', u'Sibert', u'KS', u'Gasless vs. CO2 pneumoperitoneum', u'J Reprod Med', u'1997', u'42', u'255', u'59'], [u'Guido', u'RS', u'Brooks', u'K', u'McKenzie', u'R', u'Gruss', u'J', u'Krohn', u'MA', u'A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy', u'J Am Assoc Gynecol Laparosc', u'1998', u'5', u'149', u'53'], [u'WHO', u'Task', u'Force on Female Sterilization. Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study', u'Am J Obstet Gynecol', u'1982', u'143', u'645', u'9'], [u'Gomel', u'V', u'McComb', u'PF', u'Microsurgery for tubal infertility', u'J Reprod Med', u'2006', u'51', u'177', u'84'], [u'Palter', u'SF', u'Olive', u'DL', u'Office microlaparoscopy under local anesthesia for chronic pelvic pain', u'J Am Assoc Gynecol Laparosc', u'1996', u'3', u'359', u'64'], [u'Edwell', u'John', u'RS', u'SpOG. A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization', u'World Laparosc Hosp', u'2008', u'2009'], [u'Yaghoobi Notash', u'A', u'Bahrpeyma', u'SH', u'Modaghegh', u'MH', u'Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy', u'Acta Med Iranica', u'2004', u'42', u'131', u'3'], [u'The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery', u'Surg Endosc', u'2002', u'7', u'1121', u'1143']"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_title,exact,list,0,1,0,0,"Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them, Current state of office laparoscopic surgery, Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study, Laparoscopy. Gasless vs. CO2 pneumoperitoneum, A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy, Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study, Microsurgery for tubal infertility, Office microlaparoscopy under local anesthesia for chronic pelvic pain, A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization, Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery","Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them, Current state of office laparoscopic surgery, Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study, Gasless vs. CO2 pneumoperitoneum, A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy, Force on Female Sterilization. Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study, Microsurgery for tubal infertility, Office microlaparoscopy under local anesthesia for chronic pelvic pain, SpOG. A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization, Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_title,levenshtein,list,0,1,0,0,"Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them, Current state of office laparoscopic surgery, Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study, Laparoscopy. Gasless vs. CO2 pneumoperitoneum, A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy, Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study, Microsurgery for tubal infertility, Office microlaparoscopy under local anesthesia for chronic pelvic pain, A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization, Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery","Twenty-two years of office and outpatient laparoscopy: current techniques and why I chose them, Current state of office laparoscopic surgery, Laparoscopic sterilization under local anesthesia or general anesthesia? A randomized study, Gasless vs. CO2 pneumoperitoneum, A randomized, prospective comparison of pain after gasless laparoscopy and traditional laparoscopy, Force on Female Sterilization. Minilaparotomy or laparoscopy for sterilization: a multicenter, multinational randomized study, Microsurgery for tubal infertility, Office microlaparoscopy under local anesthesia for chronic pelvic pain, SpOG. A comparative study of hysteroscopic sterilization versus laparoscopic tubal sterilization, Effectiveness of abdominal wall elevator in reducing intraabdominal pressure and CO2 volume during laparoscopic cholecystectomy, The European Association for Endoscopic Surgery clinical practice guideline on the pneumoperitoneum for laparoscopic surgery"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_year,exact,list,1,0,0,0,"1995, 2000, 1993, 1997, 1998, 1982, 2006, 1996, 2008, 2004, 2002","1995, 2000, 1993, 1997, 1998, 1982, 2006, 1996, 2008, 2004, 2002"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_year,levenshtein,list,1,0,0,0,"1995, 2000, 1993, 1997, 1998, 1982, 2006, 1996, 2008, 2004, 2002","1995, 2000, 1993, 1997, 1998, 1982, 2006, 1996, 2008, 2004, 2002"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_source,exact,list,1,0,0,0,"J Am Assoc Gynecol Laparosc, J Am Assoc Gynecol Laparosc, Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, Am J Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, World Laparosc Hosp, Acta Med Iranica, Surg Endosc","J Am Assoc Gynecol Laparosc, J Am Assoc Gynecol Laparosc, Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, Am J Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, World Laparosc Hosp, Acta Med Iranica, Surg Endosc"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_source,levenshtein,list,1,0,0,0,"J Am Assoc Gynecol Laparosc, J Am Assoc Gynecol Laparosc, Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, Am J Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, World Laparosc Hosp, Acta Med Iranica, Surg Endosc","J Am Assoc Gynecol Laparosc, J Am Assoc Gynecol Laparosc, Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, Am J Obstet Gynecol, J Reprod Med, J Am Assoc Gynecol Laparosc, World Laparosc Hosp, Acta Med Iranica, Surg Endosc"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_volume,exact,list,1,0,0,0,"2, 7, 81, 42, 5, 143, 51, 3, , 42, 7","2, 7, 81, 42, 5, 143, 51, 3, , 42, 7"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_volume,levenshtein,list,1,0,0,0,"2, 7, 81, 42, 5, 143, 51, 3, , 42, 7","2, 7, 81, 42, 5, 143, 51, 3, , 42, 7"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_fpage,exact,list,0,1,0,0,"365, 545, 137, 255, 149, 645, 177, 359, , 131, 121","365, 545, 137, 255, 149, 645, 177, 359, 2009, 131, 1121"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_fpage,levenshtein,list,0,1,0,0,"365, 545, 137, 255, 149, 645, 177, 359, , 131, 121","365, 545, 137, 255, 149, 645, 177, 359, 2009, 131, 1121"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_lpage,exact,list,1,0,0,0,"68, 46, 41, 59, 53, 9, 84, 64, , 3, 1143","68, 46, 41, 59, 53, 9, 84, 64, , 3, 1143"
sobs89-975.cermine.xml,sobs89-975.nxml,reference_lpage,levenshtein,list,1,0,0,0,"68, 46, 41, 59, 53, 9, 84, 64, , 3, 1143","68, 46, 41, 59, 53, 9, 84, 64, , 3, 1143"
sonc50-621.cermine.xml,sonc50-621.nxml,title,exact,string,1,0,0,0,Management of cutaneous metastases using electrochemotherapy,Management of cutaneous metastases using electrochemotherapy
sonc50-621.cermine.xml,sonc50-621.nxml,title,levenshtein,string,1,0,0,0,Management of cutaneous metastases using electrochemotherapy,Management of cutaneous metastases using electrochemotherapy
sonc50-621.cermine.xml,sonc50-621.nxml,abstract,exact,string,0,1,0,0,"Background. Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. Methods. This phase II study is a collaboration between two centres, one in Denmark and the other in the UK. Patients with cutaneous metastases of any histology were included. Bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. Results. Fifty-two patients were included. Complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases <3 cm and 8% and 23%, respectively, for cutaneous metastases >3 cm. Treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. Conclusions. ECT is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly.","Background. Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. Methods. This phase II study is a collaboration between two centres, one in Denmark and the other in the UK. Patients with cutaneous metastases of any histology were included. Bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. Results. Fifty-two patients were included. Complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases 3 cm and 8% and 23%, respectively, for cutaneous metastases 3 cm. Treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. Conclusions. ECT is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly."
sonc50-621.cermine.xml,sonc50-621.nxml,abstract,levenshtein,string,1,0,0,0,"Background. Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. Methods. This phase II study is a collaboration between two centres, one in Denmark and the other in the UK. Patients with cutaneous metastases of any histology were included. Bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. Results. Fifty-two patients were included. Complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases <3 cm and 8% and 23%, respectively, for cutaneous metastases >3 cm. Treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. Conclusions. ECT is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly.","Background. Cutaneous metastases may cause considerable discomfort as a consequence of ulceration, oozing, bleeding and pain. Electrochemotherapy has proven to be highly effective in the treatment of cutaneous metastases. Electrochemotherapy utilises pulses of electricity to increase the permeability of the cell membrane and thereby augment the effect of chemotherapy. For the drug bleomycin, the effect is enhanced several hundred-fold, enabling once-only treatment. The primary endpoint of this study is to evaluate the efficacy of electrochemotherapy as a palliative treatment. Methods. This phase II study is a collaboration between two centres, one in Denmark and the other in the UK. Patients with cutaneous metastases of any histology were included. Bleomycin was administered intratumourally or intravenously followed by application of electric pulses to the tumour site. Results. Fifty-two patients were included. Complete and partial response rate was 68% and 18%, respectively, for cutaneous metastases 3 cm and 8% and 23%, respectively, for cutaneous metastases 3 cm. Treatment was well-tolerated by patients, including the elderly, and no serious adverse events were observed. Conclusions. ECT is an efficient and safe treatment and clinicians should not hesitate to use it even in the elderly."
sonc50-621.cermine.xml,sonc50-621.nxml,keywords,exact,set,0,0,0,1,,
sonc50-621.cermine.xml,sonc50-621.nxml,keywords,levenshtein,set,0,0,0,1,,
sonc50-621.cermine.xml,sonc50-621.nxml,author_surnames,exact,set,0,0,1,0,"Bond, Chalmers, Gehl, Humphreys, Kessell, Matthiessen, Muir, Sainsbury, Veeramani",
sonc50-621.cermine.xml,sonc50-621.nxml,author_surnames,levenshtein,set,0,0,1,0,"Bond, Chalmers, Gehl, Humphreys, Kessell, Matthiessen, Muir, Sainsbury, Veeramani",
sonc50-621.cermine.xml,sonc50-621.nxml,first_author_surname,exact,string,0,0,1,0,Matthiessen,
sonc50-621.cermine.xml,sonc50-621.nxml,first_author_surname,levenshtein,string,0,0,1,0,Matthiessen,
sonc50-621.cermine.xml,sonc50-621.nxml,author_full_names,exact,set,0,1,0,0,"Alison Claire Humphreys, David Christopher George Sainsbury, Gareth Kessell, Jane Elisabeth Bond, Julie Gehl, Louise Wichmann Matthiessen, Richard Ling Chalmers, Sivakumar Veeramani, Tobian Muir","ALISON CLAIRE HUMPHREYS, DAVID CHRISTOPHER GEORGE SAINSBURY, GARETH KESSELL, JANE ELISABETH BOND, JULIE GEHL, LOUISE WICHMANN MATTHIESSEN, RICHARD LING CHALMERS, SIVAKUMAR VEERAMANI, TOBIAN MUIR"
sonc50-621.cermine.xml,sonc50-621.nxml,author_full_names,levenshtein,set,0,1,0,0,"Alison Claire Humphreys, David Christopher George Sainsbury, Gareth Kessell, Jane Elisabeth Bond, Julie Gehl, Louise Wichmann Matthiessen, Richard Ling Chalmers, Sivakumar Veeramani, Tobian Muir","ALISON CLAIRE HUMPHREYS, DAVID CHRISTOPHER GEORGE SAINSBURY, GARETH KESSELL, JANE ELISABETH BOND, JULIE GEHL, LOUISE WICHMANN MATTHIESSEN, RICHARD LING CHALMERS, SIVAKUMAR VEERAMANI, TOBIAN MUIR"
sonc50-621.cermine.xml,sonc50-621.nxml,first_author_full_name,exact,string,0,1,0,0,Louise Wichmann Matthiessen,LOUISE WICHMANN MATTHIESSEN
sonc50-621.cermine.xml,sonc50-621.nxml,first_author_full_name,levenshtein,string,0,1,0,0,Louise Wichmann Matthiessen,LOUISE WICHMANN MATTHIESSEN
sonc50-621.cermine.xml,sonc50-621.nxml,affiliation_strings,exact,set,0,1,0,0,"Center for Experimental Drug and Gene Electrotransfer (C*EDGE), Department of Oncology, Copenhagen University Hospital Herlev, Denmark, Department of Anaesthesia, James Cook University Hospital, Middlesbrough, UK, Department of Oncology, James Cook University Hospital, Middlesbrough, UK, Department of Reconstructive Plastic Surgery, James Cook University Hospital, Middlesbrough, UK","Center for Experimental Drug and Gene Electrotransfer (C, Department of Anaesthesia, James Cook University Hospital, Middlesbrough, UK, Department of Oncology, James Cook University Hospital, Middlesbrough, UK, Department of Reconstructive Plastic Surgery, James Cook University Hospital, Middlesbrough, UK, EDGE), Department of Oncology, Copenhagen University Hospital Herlev, Denmark"
sonc50-621.cermine.xml,sonc50-621.nxml,affiliation_strings,levenshtein,set,0,1,0,0,"Center for Experimental Drug and Gene Electrotransfer (C*EDGE), Department of Oncology, Copenhagen University Hospital Herlev, Denmark, Department of Anaesthesia, James Cook University Hospital, Middlesbrough, UK, Department of Oncology, James Cook University Hospital, Middlesbrough, UK, Department of Reconstructive Plastic Surgery, James Cook University Hospital, Middlesbrough, UK","Center for Experimental Drug and Gene Electrotransfer (C, Department of Anaesthesia, James Cook University Hospital, Middlesbrough, UK, Department of Oncology, James Cook University Hospital, Middlesbrough, UK, Department of Reconstructive Plastic Surgery, James Cook University Hospital, Middlesbrough, UK, EDGE), Department of Oncology, Copenhagen University Hospital Herlev, Denmark"
sonc50-621.cermine.xml,sonc50-621.nxml,affiliation_institution,exact,set,0,1,0,0,,"Center for Experimental Drug and Gene Electrotransfer (C, Department of Anaesthesia, James Cook University Hospital, Department of Oncology, James Cook University Hospital, Department of Reconstructive Plastic Surgery, James Cook University Hospital, EDGE), Department of Oncology, Copenhagen University Hospital Herlev"
sonc50-621.cermine.xml,sonc50-621.nxml,affiliation_institution,levenshtein,set,0,1,0,0,,"Center for Experimental Drug and Gene Electrotransfer (C, Department of Anaesthesia, James Cook University Hospital, Department of Oncology, James Cook University Hospital, Department of Reconstructive Plastic Surgery, James Cook University Hospital, EDGE), Department of Oncology, Copenhagen University Hospital Herlev"
sonc50-621.cermine.xml,sonc50-621.nxml,section_titles,exact,list,0,1,0,0,"Patients and methods, Study design, Procedure, Injection of bleomycin, Anaesthesia, Tumour response and safety assessment, Statistical consideration, Results, Patient population, Treatment, Anaesthesia, Choice of electrode, Duration of procedure, Treatment response, Safety, Discussion, Cutaneous metastases: A challenge in cancer treatment, Electrochemotherapy, Electrochemotherapy in routine use, ECT and its place in oncological practice, Conclusion","-, Patients and methods, Study design, Procedure, Injection of bleomycin, Intratumoural treatment (for small or few cutaneous, Anaesthesia, Local anaesthesia (for small or few cutaneous metastases)., General anaesthesia (for large or many cutaneous, Tumour response and safety assessment, Statistical consideration, Results, Patient population, Treatment, Anaesthesia, Choice of electrode, Duration of procedure, Treatment response, Safety, Discussion, Cutaneous metastases: A challenge in cancer treatment, Electrochemotherapy, Electrochemotherapy in routine use, ECT and its place in oncological practice, Conclusion, Acknowledgements"
sonc50-621.cermine.xml,sonc50-621.nxml,section_titles,levenshtein,list,0,1,0,0,"Patients and methods, Study design, Procedure, Injection of bleomycin, Anaesthesia, Tumour response and safety assessment, Statistical consideration, Results, Patient population, Treatment, Anaesthesia, Choice of electrode, Duration of procedure, Treatment response, Safety, Discussion, Cutaneous metastases: A challenge in cancer treatment, Electrochemotherapy, Electrochemotherapy in routine use, ECT and its place in oncological practice, Conclusion","-, Patients and methods, Study design, Procedure, Injection of bleomycin, Intratumoural treatment (for small or few cutaneous, Anaesthesia, Local anaesthesia (for small or few cutaneous metastases)., General anaesthesia (for large or many cutaneous, Tumour response and safety assessment, Statistical consideration, Results, Patient population, Treatment, Anaesthesia, Choice of electrode, Duration of procedure, Treatment response, Safety, Discussion, Cutaneous metastases: A challenge in cancer treatment, Electrochemotherapy, Electrochemotherapy in routine use, ECT and its place in oncological practice, Conclusion, Acknowledgements"
sonc50-621.cermine.xml,sonc50-621.nxml,tables,exact,table,0,0,1,0,"[[["""", ""Patients Total (N = 52)"", ""Patients (%)"", ""Patients Herlev, N = 30"", ""Patients Middlesbrough N = 22""], [""Median age in years (range)"", ""69.6 (38.9-94.7)"", """", ""72.1 (53-89.8)"", ""68.3 (38.9-94.7)""], [""Age distribution 1""], [""80 +"", ""11"", ""11%"", """", """"], [""70 +"", ""25"", ""48%"", """", """"], [""60 +"", ""44"", ""85%"", """", """"], [""50 +"", ""48"", ""92%"", """", """"], [""Sex""], [""Female"", ""35"", ""67%"", ""24"", ""13""], [""Male"", ""17"", ""33%"", ""6"", ""8""], [""ECOG2 performance status""], [""0"", ""35"", ""67%"", ""58%"", ""84%""], [""1"", ""12"", ""23%"", ""33%"", ""5%""], [""2"", ""5"", ""10%"", ""9%"", ""11%""], [""Previous Treatment""], [""Surgery"", ""42"", ""81%"", ""71%"", ""95%""], [""Radiotherapy"", ""20"", ""38%"", ""42%"", ""21%""], [""Chemotherapy"", ""21"", ""40%"", ""42%"", ""37%""], [""No previous treatment"", ""8"", ""15%"", ""21%"", ""0%""], [""Number of metastases treated pr. patient 3""], [""Median (range)"", ""3 (1-7)"", """", ""3 (1-7)"", ""4 (1-7)""], [""Diagnosis 4""], [""Malignant Melanoma"", ""21"", ""40%"", ""36%"", ""47%""], [""Breast Cancer"", ""15"", ""29%"", ""33%"", ""21%""], [""Adenocarcinoma (other than breast)"", ""5"", ""10%"", ""15%"", ""0%""], [""Basocellular Carcinoma"", ""5"", ""10%"", ""9%"", ""11%""], [""Squamous Cell Carcinoma"", ""3"", ""6%"", ""6%"", ""5%""], [""Other"", ""3"", ""5%"", ""0%"", ""16%""], [""Location of metastasis""], [""Chest"", ""79"", ""40"", ""40"", ""41""], [""Lower limbs"", ""54"", ""28"", ""22"", ""36""], [""Head and Neck"", ""30"", ""15"", ""22"", ""6""], [""Scalp"", ""21"", ""11"", ""12"", ""9""], [""Upper limbs"", ""6"", ""3"", ""4"", ""1""], [""Abdomen"", ""5"", ""3"", ""1"", ""5""], [""Back"", ""1"", ""1"", ""0"", ""1""], [""Size of metastases""], [""Median diameter in mm (range)"", ""12 (1-200)"", """", ""15 (2-200)"", ""5 (1-140)""], [""\u22643 cm"", ""138"", """", """", """"], ["">3 cm"", ""24"", """", """", """"]], [[""TREATMENT DATA"", ""All Patients (n = 51)"", ""All Patients (%)"", ""Herlev"", ""Middlesbrough""], [""Chemotherapy""], [""Bleomycin I.T"", ""21"", ""41%"", ""41%"", ""42%""], [""Bleomycin I.V."", ""30"", ""59%"", ""59%"", ""58%""], [""Anaesthesia""], [""Local"", ""23"", ""45%"", ""50%"", ""37%""], [""General"", ""28"", ""55%"", ""50%"", ""63%""], [""ECT session duration1, hours:minutes""], [""Median (range) (hh-mm)"", ""00:16 (00:05-01:27)"", """", ""00:29 (00:08-01:27)"", ""00:18 (00:05-00:35)""], [""Would agree for another session""], [""yes"", ""46"", ""90%"", ""87%"", ""90%""], [""no"", ""4"", ""8%"", ""13%"", ""5%""], [""no answer"", ""1"", ""2%"", ""0"", ""5%""], [""""], [""RESPONSE"", ""All Metastases (n = 97)2"", ""Metastases (%)"", ""Herlev"", ""Middlesbrough""], [""""], [""Response for registered metastases3""], [""CR"", ""58"", ""60%"", ""54%"", ""68%""], [""PR"", ""18"", ""19%"", ""20%"", ""17%""], [""SD"", ""11"", ""11%"", ""18%"", ""2%""], [""PD"", ""7"", ""7%"", ""4%"", ""12%""], [""Not evaluable"", ""3"", ""3%"", ""5%"", ""0%""], [""Time from treatment to CR (days)""], [""Median (range) (days"", ""47 (16-110)"", """", ""41 (16-110)"", ""63 (38-100)""], [""Size of metastases S30 mm (n = 84)""], [""CR"", ""57"", ""68%"", """", """"], [""PR"", ""15"", ""18%"", """", """"], [""SD"", ""5"", ""6%"", """", """"], [""PD"", ""5"", ""6%"", """", """"], [""Not evaluable"", ""2"", ""2%"", """", """"], [""Size of metastases >30 mm (n = 13)""], [""CR"", ""1"", ""8%"", """", """"], [""PR"", ""3"", ""23%"", """", """"], [""SD"", ""6"", ""46%"", """", """"], [""PD"", ""2"", ""15%"", """", """"], [""Not evaluable"", ""1"", ""8%"", """", """"]], [["""", ""Local anaesthesia"", ""General anaesthesia""], [""Location of metastases""], [""Chest"", ""23"", ""32%"", ""56"", ""46%""], [""Lower limbs"", ""31"", ""42%"", ""23"", ""19%""], [""Head and Neck"", ""11"", ""15%"", ""19"", ""15%""], [""Scalp"", ""4"", ""5%"", ""17"", ""14%""], [""Upper limbs"", ""3"", ""4%"", ""3"", ""2%""], [""Abdomen"", ""1"", ""1%"", ""4"", ""3%""], [""Back"", ""0"", ""0"", ""1"", ""1%""], [""Size of metastases""], [""Median (range) (mm)"", ""7.5 (1-60)"", """", ""10 (1-200)"", """"], [""Number of metastases per patient""], [""Median (range)"", ""3"", """", ""4"", """"]]]",
sonc50-621.cermine.xml,sonc50-621.nxml,tables,levenshtein,table,0,0,1,0,"[[["""", ""Patients Total (N = 52)"", ""Patients (%)"", ""Patients Herlev, N = 30"", ""Patients Middlesbrough N = 22""], [""Median age in years (range)"", ""69.6 (38.9-94.7)"", """", ""72.1 (53-89.8)"", ""68.3 (38.9-94.7)""], [""Age distribution 1""], [""80 +"", ""11"", ""11%"", """", """"], [""70 +"", ""25"", ""48%"", """", """"], [""60 +"", ""44"", ""85%"", """", """"], [""50 +"", ""48"", ""92%"", """", """"], [""Sex""], [""Female"", ""35"", ""67%"", ""24"", ""13""], [""Male"", ""17"", ""33%"", ""6"", ""8""], [""ECOG2 performance status""], [""0"", ""35"", ""67%"", ""58%"", ""84%""], [""1"", ""12"", ""23%"", ""33%"", ""5%""], [""2"", ""5"", ""10%"", ""9%"", ""11%""], [""Previous Treatment""], [""Surgery"", ""42"", ""81%"", ""71%"", ""95%""], [""Radiotherapy"", ""20"", ""38%"", ""42%"", ""21%""], [""Chemotherapy"", ""21"", ""40%"", ""42%"", ""37%""], [""No previous treatment"", ""8"", ""15%"", ""21%"", ""0%""], [""Number of metastases treated pr. patient 3""], [""Median (range)"", ""3 (1-7)"", """", ""3 (1-7)"", ""4 (1-7)""], [""Diagnosis 4""], [""Malignant Melanoma"", ""21"", ""40%"", ""36%"", ""47%""], [""Breast Cancer"", ""15"", ""29%"", ""33%"", ""21%""], [""Adenocarcinoma (other than breast)"", ""5"", ""10%"", ""15%"", ""0%""], [""Basocellular Carcinoma"", ""5"", ""10%"", ""9%"", ""11%""], [""Squamous Cell Carcinoma"", ""3"", ""6%"", ""6%"", ""5%""], [""Other"", ""3"", ""5%"", ""0%"", ""16%""], [""Location of metastasis""], [""Chest"", ""79"", ""40"", ""40"", ""41""], [""Lower limbs"", ""54"", ""28"", ""22"", ""36""], [""Head and Neck"", ""30"", ""15"", ""22"", ""6""], [""Scalp"", ""21"", ""11"", ""12"", ""9""], [""Upper limbs"", ""6"", ""3"", ""4"", ""1""], [""Abdomen"", ""5"", ""3"", ""1"", ""5""], [""Back"", ""1"", ""1"", ""0"", ""1""], [""Size of metastases""], [""Median diameter in mm (range)"", ""12 (1-200)"", """", ""15 (2-200)"", ""5 (1-140)""], [""\u22643 cm"", ""138"", """", """", """"], ["">3 cm"", ""24"", """", """", """"]], [[""TREATMENT DATA"", ""All Patients (n = 51)"", ""All Patients (%)"", ""Herlev"", ""Middlesbrough""], [""Chemotherapy""], [""Bleomycin I.T"", ""21"", ""41%"", ""41%"", ""42%""], [""Bleomycin I.V."", ""30"", ""59%"", ""59%"", ""58%""], [""Anaesthesia""], [""Local"", ""23"", ""45%"", ""50%"", ""37%""], [""General"", ""28"", ""55%"", ""50%"", ""63%""], [""ECT session duration1, hours:minutes""], [""Median (range) (hh-mm)"", ""00:16 (00:05-01:27)"", """", ""00:29 (00:08-01:27)"", ""00:18 (00:05-00:35)""], [""Would agree for another session""], [""yes"", ""46"", ""90%"", ""87%"", ""90%""], [""no"", ""4"", ""8%"", ""13%"", ""5%""], [""no answer"", ""1"", ""2%"", ""0"", ""5%""], [""""], [""RESPONSE"", ""All Metastases (n = 97)2"", ""Metastases (%)"", ""Herlev"", ""Middlesbrough""], [""""], [""Response for registered metastases3""], [""CR"", ""58"", ""60%"", ""54%"", ""68%""], [""PR"", ""18"", ""19%"", ""20%"", ""17%""], [""SD"", ""11"", ""11%"", ""18%"", ""2%""], [""PD"", ""7"", ""7%"", ""4%"", ""12%""], [""Not evaluable"", ""3"", ""3%"", ""5%"", ""0%""], [""Time from treatment to CR (days)""], [""Median (range) (days"", ""47 (16-110)"", """", ""41 (16-110)"", ""63 (38-100)""], [""Size of metastases S30 mm (n = 84)""], [""CR"", ""57"", ""68%"", """", """"], [""PR"", ""15"", ""18%"", """", """"], [""SD"", ""5"", ""6%"", """", """"], [""PD"", ""5"", ""6%"", """", """"], [""Not evaluable"", ""2"", ""2%"", """", """"], [""Size of metastases >30 mm (n = 13)""], [""CR"", ""1"", ""8%"", """", """"], [""PR"", ""3"", ""23%"", """", """"], [""SD"", ""6"", ""46%"", """", """"], [""PD"", ""2"", ""15%"", """", """"], [""Not evaluable"", ""1"", ""8%"", """", """"]], [["""", ""Local anaesthesia"", ""General anaesthesia""], [""Location of metastases""], [""Chest"", ""23"", ""32%"", ""56"", ""46%""], [""Lower limbs"", ""31"", ""42%"", ""23"", ""19%""], [""Head and Neck"", ""11"", ""15%"", ""19"", ""15%""], [""Scalp"", ""4"", ""5%"", ""17"", ""14%""], [""Upper limbs"", ""3"", ""4%"", ""3"", ""2%""], [""Abdomen"", ""1"", ""1%"", ""4"", ""3%""], [""Back"", ""0"", ""0"", ""1"", ""1%""], [""Size of metastases""], [""Median (range) (mm)"", ""7.5 (1-60)"", """", ""10 (1-200)"", """"], [""Number of metastases per patient""], [""Median (range)"", ""3"", """", ""4"", """"]]]",
sonc50-621.cermine.xml,sonc50-621.nxml,table_strings,exact,list,0,0,1,0,"Patients Total (N = 52) Patients (%) Patients Herlev, N = 30 Patients Middlesbrough N = 22 Median age in years (range) 69.6 (38.9-94.7) 72.1 (53-89.8) 68.3 (38.9-94.7) Age distribution 1  80 + 11 11%  70 + 25 48%  60 + 44 85%  50 + 48 92% Sex  Female 35 67% 24 13  Male 17 33% 6 8 ECOG2 performance status  0 35 67% 58% 84%  1 12 23% 33% 5%  2 5 10% 9% 11% Previous Treatment  Surgery 42 81% 71% 95%  Radiotherapy 20 38% 42% 21%  Chemotherapy 21 40% 42% 37%  No previous treatment 8 15% 21% 0% Number of metastases treated pr. patient 3  Median (range) 3 (1-7) 3 (1-7) 4 (1-7) Diagnosis 4  Malignant Melanoma 21 40% 36% 47%  Breast Cancer 15 29% 33% 21%  Adenocarcinoma (other than breast) 5 10% 15% 0%  Basocellular Carcinoma 5 10% 9% 11%  Squamous Cell Carcinoma 3 6% 6% 5%  Other 3 5% 0% 16% Location of metastasis  Chest 79 40 40 41  Lower limbs 54 28 22 36  Head and Neck 30 15 22 6  Scalp 21 11 12 9  Upper limbs 6 3 4 1  Abdomen 5 3 1 5  Back 1 1 0 1 Size of metastases  Median diameter in mm (range) 12 (1-200) 15 (2-200) 5 (1-140)  ≤3 cm 138  >3 cm 24, TREATMENT DATA All Patients (n = 51) All Patients (%) Herlev Middlesbrough Chemotherapy  Bleomycin I.T 21 41% 41% 42%  Bleomycin I.V. 30 59% 59% 58% Anaesthesia  Local 23 45% 50% 37%  General 28 55% 50% 63% ECT session duration1, hours:minutes  Median (range) (hh-mm) 00:16 (00:05-01:27) 00:29 (00:08-01:27) 00:18 (00:05-00:35) Would agree for another session  yes 46 90% 87% 90%  no 4 8% 13% 5%  no answer 1 2% 0 5% RESPONSE All Metastases (n = 97)2 Metastases (%) Herlev Middlesbrough Response for registered metastases3  CR 58 60% 54% 68%  PR 18 19% 20% 17%  SD 11 11% 18% 2%  PD 7 7% 4% 12%  Not evaluable 3 3% 5% 0% Time from treatment to CR (days)  Median (range) (days 47 (16-110) 41 (16-110) 63 (38-100) Size of metastases S30 mm (n = 84)  CR 57 68%  PR 15 18%  SD 5 6%  PD 5 6%  Not evaluable 2 2% Size of metastases >30 mm (n = 13)  CR 1 8%  PR 3 23%  SD 6 46%  PD 2 15%  Not evaluable 1 8%, Local anaesthesia General anaesthesia Location of metastases  Chest 23 32% 56 46%  Lower limbs 31 42% 23 19%  Head and Neck 11 15% 19 15%  Scalp 4 5% 17 14%  Upper limbs 3 4% 3 2%  Abdomen 1 1% 4 3%  Back 0 0 1 1% Size of metastases  Median (range) (mm) 7.5 (1-60) 10 (1-200) Number of metastases per patient  Median (range) 3 4",
sonc50-621.cermine.xml,sonc50-621.nxml,table_strings,levenshtein,list,0,0,1,0,"Patients Total (N = 52) Patients (%) Patients Herlev, N = 30 Patients Middlesbrough N = 22 Median age in years (range) 69.6 (38.9-94.7) 72.1 (53-89.8) 68.3 (38.9-94.7) Age distribution 1  80 + 11 11%  70 + 25 48%  60 + 44 85%  50 + 48 92% Sex  Female 35 67% 24 13  Male 17 33% 6 8 ECOG2 performance status  0 35 67% 58% 84%  1 12 23% 33% 5%  2 5 10% 9% 11% Previous Treatment  Surgery 42 81% 71% 95%  Radiotherapy 20 38% 42% 21%  Chemotherapy 21 40% 42% 37%  No previous treatment 8 15% 21% 0% Number of metastases treated pr. patient 3  Median (range) 3 (1-7) 3 (1-7) 4 (1-7) Diagnosis 4  Malignant Melanoma 21 40% 36% 47%  Breast Cancer 15 29% 33% 21%  Adenocarcinoma (other than breast) 5 10% 15% 0%  Basocellular Carcinoma 5 10% 9% 11%  Squamous Cell Carcinoma 3 6% 6% 5%  Other 3 5% 0% 16% Location of metastasis  Chest 79 40 40 41  Lower limbs 54 28 22 36  Head and Neck 30 15 22 6  Scalp 21 11 12 9  Upper limbs 6 3 4 1  Abdomen 5 3 1 5  Back 1 1 0 1 Size of metastases  Median diameter in mm (range) 12 (1-200) 15 (2-200) 5 (1-140)  ≤3 cm 138  >3 cm 24, TREATMENT DATA All Patients (n = 51) All Patients (%) Herlev Middlesbrough Chemotherapy  Bleomycin I.T 21 41% 41% 42%  Bleomycin I.V. 30 59% 59% 58% Anaesthesia  Local 23 45% 50% 37%  General 28 55% 50% 63% ECT session duration1, hours:minutes  Median (range) (hh-mm) 00:16 (00:05-01:27) 00:29 (00:08-01:27) 00:18 (00:05-00:35) Would agree for another session  yes 46 90% 87% 90%  no 4 8% 13% 5%  no answer 1 2% 0 5% RESPONSE All Metastases (n = 97)2 Metastases (%) Herlev Middlesbrough Response for registered metastases3  CR 58 60% 54% 68%  PR 18 19% 20% 17%  SD 11 11% 18% 2%  PD 7 7% 4% 12%  Not evaluable 3 3% 5% 0% Time from treatment to CR (days)  Median (range) (days 47 (16-110) 41 (16-110) 63 (38-100) Size of metastases S30 mm (n = 84)  CR 57 68%  PR 15 18%  SD 5 6%  PD 5 6%  Not evaluable 2 2% Size of metastases >30 mm (n = 13)  CR 1 8%  PR 3 23%  SD 6 46%  PD 2 15%  Not evaluable 1 8%, Local anaesthesia General anaesthesia Location of metastases  Chest 23 32% 56 46%  Lower limbs 31 42% 23 19%  Head and Neck 11 15% 19 15%  Scalp 4 5% 17 14%  Upper limbs 3 4% 3 2%  Abdomen 1 1% 4 3%  Back 0 0 1 1% Size of metastases  Median (range) (mm) 7.5 (1-60) 10 (1-200) Number of metastases per patient  Median (range) 3 4",
sonc50-621.cermine.xml,sonc50-621.nxml,table_labels,exact,list,0,0,1,0,"Table I, Table II, Table III",
sonc50-621.cermine.xml,sonc50-621.nxml,table_labels,levenshtein,list,0,0,1,0,"Table I, Table II, Table III",
sonc50-621.cermine.xml,sonc50-621.nxml,table_captions,exact,list,0,0,1,0,"Patients' characteristics at baseline., Treatment data and response., Choice of anaesthesia according to location of metastases and size.",
sonc50-621.cermine.xml,sonc50-621.nxml,table_captions,levenshtein,list,0,0,1,0,"Patients' characteristics at baseline., Treatment data and response., Choice of anaesthesia according to location of metastases and size.",
sonc50-621.cermine.xml,sonc50-621.nxml,table_label_captions,exact,list,0,0,1,0,"Table I Patients' characteristics at baseline., Table II Treatment data and response., Table III Choice of anaesthesia according to location of metastases and size.",
sonc50-621.cermine.xml,sonc50-621.nxml,table_label_captions,levenshtein,list,0,0,1,0,"Table I Patients' characteristics at baseline., Table II Treatment data and response., Table III Choice of anaesthesia according to location of metastases and size.",
sonc50-621.cermine.xml,sonc50-621.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'1', u'Schwartz', u'RA', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82', u'7622642']","[u'Schwartz', u'RA.', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82']"
sonc50-621.cermine.xml,sonc50-621.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Schwartz', u'RA', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82', u'7622642']","[u'Schwartz', u'RA.', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82']"
sonc50-621.cermine.xml,sonc50-621.nxml,first_reference_title,exact,string,1,0,0,0,Cutaneous metastatic disease,Cutaneous metastatic disease
sonc50-621.cermine.xml,sonc50-621.nxml,first_reference_title,levenshtein,string,1,0,0,0,Cutaneous metastatic disease,Cutaneous metastatic disease
sonc50-621.cermine.xml,sonc50-621.nxml,reference_fields,exact,list,0,1,0,0,"[u'1', u'Schwartz', u'RA', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82', u'7622642'], [u'2', u'Rolz-Cruz', u'G', u'Kim', u'CC', u'Tumor invasion of the skin', u'Dermatol Clin', u'2008', u'26', u'89', u'102', u'viii', u'18023773'], [u'3', u'Lookingbill', u'DP', u'Spangler', u'N', u'Helm', u'KF', u'Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients', u'J Am Acad Dermatol', u'1993', u'29', u'228', u'36', u'8335743'], [u'4', u'Heller', u'R', u'Jaroszeski', u'MJ', u'Reintgen', u'DS', u'Puleo', u'CA', u'DeConti', u'RC', u'Gilbert', u'RA', u'', u'Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin', u'Cancer', u'1998', u'83', u'148', u'57', u'9655305'], [u'5', u'Marty', u'M', u'Sersa', u'G', u'Garbay', u'JR', u'Gehl', u'J', u'Collins', u'CG', u'Snoj', u'M', u'', u'Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study', u'EJC Supplements', u'2006', u'4', u'3', u'13'], [u'6', u'Mir', u'LM', u'Glass', u'LF', u'Sersa', u'G', u'Teissie', u'J', u'Domenge', u'C', u'Miklavcic', u'D', u'', u'Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy', u'Br J Cancer', u'1998', u'77', u'2336', u'42', u'9649155'], [u'7', u'Gehl', u'J', u'Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research', u'Acta Physiol Scand', u'2003', u'177', u'437', u'47', u'12648161'], [u'8', u'Tounekti', u'O', u'Pron', u'G', u'Belehradek', u'J', u'Jr', u'Mir', u'LM', u'Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized', u'Cancer Res', u'1993', u'53', u'5462', u'9', u'7693342'], [u'9', u'Gehl', u'J', u'Skovsgaard', u'T', u'Mir', u'LM', u'Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs', u'Anticancer Drugs', u'1998', u'9', u'319', u'25', u'9635922'], [u'10', u'Orlowski', u'S', u'Belehradek', u'J', u'Jr', u'Paoletti', u'C', u'Mir', u'LM', u'Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs', u'Biochem Pharmacol', u'1988', u'37', u'4727', u'33', u'2462423'], [u'11', u'Jaroszeski', u'MJ', u'Dang', u'V', u'Pottinger', u'C', u'Hickey', u'J', u'Gilbert', u'R', u'Heller', u'R', u'Toxicity of anticancer agents mediated by electroporation in vitro', u'Anticancer Drugs', u'2000', u'11', u'201', u'8', u'10831279'], [u'12', u'Belehradek', u'M', u'Domenge', u'C', u'Luboinski', u'B', u'Orlowski', u'S', u'Belehradek', u'J', u'Jr', u'Mir', u'LM', u'Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial', u'Cancer', u'1993', u'72', u'3694', u'700', u'7504576'], [u'13', u'Campana', u'LG', u'Mocellin', u'S', u'Basso', u'M', u'Puccetti', u'O', u'De Salvo', u'GL', u'Chiarion-Sileni', u'V', u'', u""Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients"", u'Ann Surg Oncol', u'2009', u'16', u'191', u'9', u'18987914'], [u'14', u'Gothelf', u'A', u'Mir', u'LM', u'Gehl', u'J', u'Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation', u'Cancer Treat Rev', u'2003', u'29', u'371', u'87', u'12972356'], [u'15', u'Rodriguez-Cuevas', u'S', u'Barroso-Bravo', u'S', u'Manza-Estrada', u'J', u'Cristobal-Martinez', u'L', u'Gonzalez-Rodriguez', u'E', u'Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin', u'Arch Med Res', u'2001', u'32', u'273', u'6', u'11440782'], [u'16', u'Gehl', u'J', u'Geertsen', u'PF', u'Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy', u'Melanoma Res', u'2000', u'10', u'585', u'9', u'11198481'], [u'17', u'Mir', u'LM', u'Gehl', u'J', u'Sersa', u'G', u'Collins', u'CG', u'Garbay', u'JR', u'Billard', u'V', u'', u'Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes', u'EJC Supplements', u'2006', u'4', u'14', u'25'], [u'18', u'Domenge', u'C', u'Orlowski', u'S', u'Luboinski', u'B', u'De', u'BT', u'Schwaab', u'G', u'Belehradek', u'J', u'Jr', u'', u'Antitumor electrochemotherapy: New advances in the clinical protocol', u'Cancer', u'1996', u'77', u'956', u'63', u'8608490'], [u'19', u'Hall', u'SW', u'Strong', u'JE', u'Broughton', u'A', u'Frazier', u'ML', u'Benjamin', u'RS', u'Bleomycin clinical pharmacology by radioimmunoassay', u'Cancer Chemother Pharmacol', u'1982', u'9', u'22', u'5', u'6183016'], [u'20', u'Mathes', u'DD', u'Bleomycin and hyperoxia exposure in the operating room', u'Anesth Analg', u'1995', u'81', u'624', u'9', u'7544553'], [u'21', u'Therasse', u'P', u'Arbuck', u'SG', u'Eisenhauer', u'EA', u'Wanders', u'J', u'Kaplan', u'RS', u'Rubinstein', u'L', u'', u'New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada', u'J Natl Cancer Inst', u'2000', u'92', u'205', u'16', u'10655437'], [u'22', u'Mir', u'LM', u'Belehradek', u'M', u'Domenge', u'C', u'Orlowski', u'S', u'Poddevin', u'B', u'Belehradek', u'J', u'Jr', u'', u'[Electrochemotherapy, a new antitumor treatment: first clinical trial]', u'C R Acad Sci III', u'1991', u'313', u'613', u'8', u'1723647'], [u'23', u'Quaglino', u'P', u'Mortera', u'C', u'Osella-Abate', u'S', u'Barberis', u'M', u'Illengo', u'M', u'Rissone', u'M', u'', u'Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases', u'Ann Surg Oncol', u'2008', u'15', u'2215', u'22', u'18498012'], [u'24', u'Tijink', u'BM', u'De', u'BR', u'Van Dongen', u'GA', u'Leemans', u'CR', u'How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients', u'Clin Otolaryngol', u'2006', u'31', u'447', u'51', u'17014460'], [u'25', u'Larkin', u'JO', u'Collins', u'CG', u'Aarons', u'S', u'Tangney', u'M', u'Whelan', u'M', u""O'Reily"", u'S', u'', u'Electrochemotherapy: Aspects of preclinical development and early clinical experience', u'Ann Surg', u'2007', u'245', u'469', u'79', u'17435555']","[u'Schwartz', u'RA.', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82'], [u'Rolz-Cruz', u'G', u'Kim', u'CC', u'Tumor invasion of the skin', u'Dermatol Clin', u'2008', u'26', u'89', u'102'], [u'Lookingbill', u'DP', u'Spangler', u'N', u'Helm', u'KF', u'Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients', u'J Am Acad Dermatol', u'1993', u'29', u'228', u'36'], [u'Heller', u'R', u'Jaroszeski', u'MJ', u'Reintgen', u'DS', u'Puleo', u'CA', u'DeConti', u'RC', u'Gilbert', u'RA', u'Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin', u'Cancer', u'1998', u'83', u'148', u'57'], [u'Marty', u'M', u'Sersa', u'G', u'Garbay', u'JR', u'Gehl', u'J', u'Collins', u'CG', u'Snoj', u'M', u'Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study', u'EJC Supplements', u'2006', u'4', u'3', u'13'], [u'Mir', u'LM', u'Glass', u'LF', u'Sersa', u'G', u'Teissie', u'J', u'Domenge', u'C', u'Miklavcic', u'D', u'Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy', u'Br J Cancer', u'1998', u'77', u'2336', u'42'], [u'Gehl', u'J.', u'Electroporation', u': Theory and methods, perspectives for drug delivery, gene therapy and research', u'Acta Physiol Scand', u'2003', u'177', u'437', u'47'], [u'Tounekti', u'O', u'Pron', u'G', u'Belehradek', u'J', u'Jr.', u'Mir', u'LM', u'Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized', u'Cancer Res', u'1993', u'53', u'5462', u'9'], [u'Gehl', u'J', u'Skovsgaard', u'T', u'Mir', u'LM', u'Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs', u'Anticancer Drugs', u'1998', u'9', u'319', u'25'], [u'Orlowski', u'S', u'Belehradek Jr', u'J', u'Paoletti', u'C', u'Mir', u'LM', u'Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs', u'Biochem Pharmacol', u'1988', u'37', u'4727', u'33'], [u'Jaroszeski', u'MJ', u'Dang', u'V', u'Pottinger', u'C', u'Hickey', u'J', u'Gilbert', u'R', u'Heller', u'R', u'Toxicity of anticancer agents mediated by electroporation in vitro', u'Anticancer Drugs', u'2000', u'11', u'201', u'8'], [u'Belehradek', u'M', u'Domenge', u'C', u'Luboinski', u'B', u'Orlowski', u'S', u'Belehradek', u'J', u'Jr.', u'Mir', u'LM', u'Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial', u'Cancer', u'1993', u'72', u'3694', u'700'], [u'Campana', u'LG', u'Mocellin', u'S', u'Basso', u'M', u'Puccetti', u'O', u'De Salvo', u'GL', u'Chiarion-Sileni', u'V', u""Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients"", u'Ann Surg Oncol', u'2009', u'16', u'191', u'9'], [u'Gothelf', u'A', u'Mir', u'LM', u'Gehl', u'J', u'Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation', u'Cancer Treat Rev', u'2003', u'29', u'371', u'87'], [u'Rodriguez-Cuevas', u'S', u'Barroso-Bravo', u'S', u'Manza-Estrada', u'J', u'Cristobal-Martinez', u'L', u'Gonzalez-Rodriguez', u'E.', u'Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin', u'Arch Med Res', u'2001', u'32', u'273', u'6'], [u'Gehl', u'J', u'Geertsen', u'PF', u'Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy', u'Melanoma Res', u'2000', u'10', u'585', u'9'], [u'Mir', u'LM', u'Gehl', u'J', u'Sersa', u'G', u'Collins', u'CG', u'Garbay', u'JR', u'Billard', u'V', u'Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes', u'EJC Supplements', u'2006', u'4', u'14', u'25'], [u'Domenge', u'C', u'Orlowski', u'S', u'Luboinski', u'B', u'De', u'BT', u'Schwaab', u'G', u'Belehradek', u'J', u'Jr.', u'Antitumor electrochemotherapy: New advances in the clinical protocol', u'Cancer', u'1996', u'77', u'956', u'63'], [u'Hall', u'SW', u'Strong', u'JE', u'Broughton', u'A', u'Frazier', u'ML', u'Benjamin', u'RS', u'Bleomycin clinical pharmacology by radioimmunoassay', u'Cancer Chemother Pharmacol', u'1982', u'9', u'22', u'5'], [u'Mathes', u'DD', u'Bleomycin and hyperoxia exposure in the operating room', u'Anesth Analg', u'1995', u'81', u'624', u'9'], [u'Therasse', u'P', u'Arbuck', u'SG', u'Eisenhauer', u'EA', u'Wanders', u'J', u'Kaplan', u'RS', u'Rubinstein', u'L', u'New guidelines to evaluate the response to treatment in solid tumors', u'European Organization for Research and Treatment of Cancer', u'National Cancer Institute of the United States, National Cancer Institute of Canada', u'J Natl Cancer Inst', u'2000', u'92', u'205', u'16'], [u'Mir', u'LM', u'Belehradek', u'M', u'Domenge', u'C', u'Orlowski', u'S', u'Poddevin', u'B', u'Belehradek', u'J', u'Jr.', u'Electrochemotherapy, a new antitumor treatment: first clinical trial]', u'C R Acad Sci', u'III', u'1991', u'313', u'613', u'8'], [u'Quaglino', u'P', u'Mortera', u'C', u'Osella-Abate', u'S', u'Barberis', u'M', u'Illengo', u'M', u'Rissone', u'M', u'Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases', u'Ann Surg Oncol', u'2008', u'15', u'2215', u'22'], [u'Tijink', u'BM', u'De', u'BR', u'Van Dongen', u'GA', u'Leemans', u'CR', u'How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients', u'Clin Otolaryngol', u'2006', u'31', u'447', u'51'], [u'Larkin', u'JO', u'Collins', u'CG', u'Aarons', u'S', u'Tangney', u'M', u'Whelan', u'M', u""O'Reily S"", u'Electrochemotherapy: Aspects of preclinical development and early clinical experience', u'Ann Surg', u'2007', u'245', u'469', u'79']"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Schwartz', u'RA', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82', u'7622642'], [u'2', u'Rolz-Cruz', u'G', u'Kim', u'CC', u'Tumor invasion of the skin', u'Dermatol Clin', u'2008', u'26', u'89', u'102', u'viii', u'18023773'], [u'3', u'Lookingbill', u'DP', u'Spangler', u'N', u'Helm', u'KF', u'Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients', u'J Am Acad Dermatol', u'1993', u'29', u'228', u'36', u'8335743'], [u'4', u'Heller', u'R', u'Jaroszeski', u'MJ', u'Reintgen', u'DS', u'Puleo', u'CA', u'DeConti', u'RC', u'Gilbert', u'RA', u'', u'Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin', u'Cancer', u'1998', u'83', u'148', u'57', u'9655305'], [u'5', u'Marty', u'M', u'Sersa', u'G', u'Garbay', u'JR', u'Gehl', u'J', u'Collins', u'CG', u'Snoj', u'M', u'', u'Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study', u'EJC Supplements', u'2006', u'4', u'3', u'13'], [u'6', u'Mir', u'LM', u'Glass', u'LF', u'Sersa', u'G', u'Teissie', u'J', u'Domenge', u'C', u'Miklavcic', u'D', u'', u'Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy', u'Br J Cancer', u'1998', u'77', u'2336', u'42', u'9649155'], [u'7', u'Gehl', u'J', u'Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research', u'Acta Physiol Scand', u'2003', u'177', u'437', u'47', u'12648161'], [u'8', u'Tounekti', u'O', u'Pron', u'G', u'Belehradek', u'J', u'Jr', u'Mir', u'LM', u'Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized', u'Cancer Res', u'1993', u'53', u'5462', u'9', u'7693342'], [u'9', u'Gehl', u'J', u'Skovsgaard', u'T', u'Mir', u'LM', u'Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs', u'Anticancer Drugs', u'1998', u'9', u'319', u'25', u'9635922'], [u'10', u'Orlowski', u'S', u'Belehradek', u'J', u'Jr', u'Paoletti', u'C', u'Mir', u'LM', u'Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs', u'Biochem Pharmacol', u'1988', u'37', u'4727', u'33', u'2462423'], [u'11', u'Jaroszeski', u'MJ', u'Dang', u'V', u'Pottinger', u'C', u'Hickey', u'J', u'Gilbert', u'R', u'Heller', u'R', u'Toxicity of anticancer agents mediated by electroporation in vitro', u'Anticancer Drugs', u'2000', u'11', u'201', u'8', u'10831279'], [u'12', u'Belehradek', u'M', u'Domenge', u'C', u'Luboinski', u'B', u'Orlowski', u'S', u'Belehradek', u'J', u'Jr', u'Mir', u'LM', u'Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial', u'Cancer', u'1993', u'72', u'3694', u'700', u'7504576'], [u'13', u'Campana', u'LG', u'Mocellin', u'S', u'Basso', u'M', u'Puccetti', u'O', u'De Salvo', u'GL', u'Chiarion-Sileni', u'V', u'', u""Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients"", u'Ann Surg Oncol', u'2009', u'16', u'191', u'9', u'18987914'], [u'14', u'Gothelf', u'A', u'Mir', u'LM', u'Gehl', u'J', u'Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation', u'Cancer Treat Rev', u'2003', u'29', u'371', u'87', u'12972356'], [u'15', u'Rodriguez-Cuevas', u'S', u'Barroso-Bravo', u'S', u'Manza-Estrada', u'J', u'Cristobal-Martinez', u'L', u'Gonzalez-Rodriguez', u'E', u'Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin', u'Arch Med Res', u'2001', u'32', u'273', u'6', u'11440782'], [u'16', u'Gehl', u'J', u'Geertsen', u'PF', u'Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy', u'Melanoma Res', u'2000', u'10', u'585', u'9', u'11198481'], [u'17', u'Mir', u'LM', u'Gehl', u'J', u'Sersa', u'G', u'Collins', u'CG', u'Garbay', u'JR', u'Billard', u'V', u'', u'Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes', u'EJC Supplements', u'2006', u'4', u'14', u'25'], [u'18', u'Domenge', u'C', u'Orlowski', u'S', u'Luboinski', u'B', u'De', u'BT', u'Schwaab', u'G', u'Belehradek', u'J', u'Jr', u'', u'Antitumor electrochemotherapy: New advances in the clinical protocol', u'Cancer', u'1996', u'77', u'956', u'63', u'8608490'], [u'19', u'Hall', u'SW', u'Strong', u'JE', u'Broughton', u'A', u'Frazier', u'ML', u'Benjamin', u'RS', u'Bleomycin clinical pharmacology by radioimmunoassay', u'Cancer Chemother Pharmacol', u'1982', u'9', u'22', u'5', u'6183016'], [u'20', u'Mathes', u'DD', u'Bleomycin and hyperoxia exposure in the operating room', u'Anesth Analg', u'1995', u'81', u'624', u'9', u'7544553'], [u'21', u'Therasse', u'P', u'Arbuck', u'SG', u'Eisenhauer', u'EA', u'Wanders', u'J', u'Kaplan', u'RS', u'Rubinstein', u'L', u'', u'New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada', u'J Natl Cancer Inst', u'2000', u'92', u'205', u'16', u'10655437'], [u'22', u'Mir', u'LM', u'Belehradek', u'M', u'Domenge', u'C', u'Orlowski', u'S', u'Poddevin', u'B', u'Belehradek', u'J', u'Jr', u'', u'[Electrochemotherapy, a new antitumor treatment: first clinical trial]', u'C R Acad Sci III', u'1991', u'313', u'613', u'8', u'1723647'], [u'23', u'Quaglino', u'P', u'Mortera', u'C', u'Osella-Abate', u'S', u'Barberis', u'M', u'Illengo', u'M', u'Rissone', u'M', u'', u'Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases', u'Ann Surg Oncol', u'2008', u'15', u'2215', u'22', u'18498012'], [u'24', u'Tijink', u'BM', u'De', u'BR', u'Van Dongen', u'GA', u'Leemans', u'CR', u'How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients', u'Clin Otolaryngol', u'2006', u'31', u'447', u'51', u'17014460'], [u'25', u'Larkin', u'JO', u'Collins', u'CG', u'Aarons', u'S', u'Tangney', u'M', u'Whelan', u'M', u""O'Reily"", u'S', u'', u'Electrochemotherapy: Aspects of preclinical development and early clinical experience', u'Ann Surg', u'2007', u'245', u'469', u'79', u'17435555']","[u'Schwartz', u'RA.', u'Cutaneous metastatic disease', u'J Am Acad Dermatol', u'1995', u'33', u'161', u'82'], [u'Rolz-Cruz', u'G', u'Kim', u'CC', u'Tumor invasion of the skin', u'Dermatol Clin', u'2008', u'26', u'89', u'102'], [u'Lookingbill', u'DP', u'Spangler', u'N', u'Helm', u'KF', u'Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients', u'J Am Acad Dermatol', u'1993', u'29', u'228', u'36'], [u'Heller', u'R', u'Jaroszeski', u'MJ', u'Reintgen', u'DS', u'Puleo', u'CA', u'DeConti', u'RC', u'Gilbert', u'RA', u'Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin', u'Cancer', u'1998', u'83', u'148', u'57'], [u'Marty', u'M', u'Sersa', u'G', u'Garbay', u'JR', u'Gehl', u'J', u'Collins', u'CG', u'Snoj', u'M', u'Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study', u'EJC Supplements', u'2006', u'4', u'3', u'13'], [u'Mir', u'LM', u'Glass', u'LF', u'Sersa', u'G', u'Teissie', u'J', u'Domenge', u'C', u'Miklavcic', u'D', u'Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy', u'Br J Cancer', u'1998', u'77', u'2336', u'42'], [u'Gehl', u'J.', u'Electroporation', u': Theory and methods, perspectives for drug delivery, gene therapy and research', u'Acta Physiol Scand', u'2003', u'177', u'437', u'47'], [u'Tounekti', u'O', u'Pron', u'G', u'Belehradek', u'J', u'Jr.', u'Mir', u'LM', u'Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized', u'Cancer Res', u'1993', u'53', u'5462', u'9'], [u'Gehl', u'J', u'Skovsgaard', u'T', u'Mir', u'LM', u'Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs', u'Anticancer Drugs', u'1998', u'9', u'319', u'25'], [u'Orlowski', u'S', u'Belehradek Jr', u'J', u'Paoletti', u'C', u'Mir', u'LM', u'Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs', u'Biochem Pharmacol', u'1988', u'37', u'4727', u'33'], [u'Jaroszeski', u'MJ', u'Dang', u'V', u'Pottinger', u'C', u'Hickey', u'J', u'Gilbert', u'R', u'Heller', u'R', u'Toxicity of anticancer agents mediated by electroporation in vitro', u'Anticancer Drugs', u'2000', u'11', u'201', u'8'], [u'Belehradek', u'M', u'Domenge', u'C', u'Luboinski', u'B', u'Orlowski', u'S', u'Belehradek', u'J', u'Jr.', u'Mir', u'LM', u'Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial', u'Cancer', u'1993', u'72', u'3694', u'700'], [u'Campana', u'LG', u'Mocellin', u'S', u'Basso', u'M', u'Puccetti', u'O', u'De Salvo', u'GL', u'Chiarion-Sileni', u'V', u""Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients"", u'Ann Surg Oncol', u'2009', u'16', u'191', u'9'], [u'Gothelf', u'A', u'Mir', u'LM', u'Gehl', u'J', u'Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation', u'Cancer Treat Rev', u'2003', u'29', u'371', u'87'], [u'Rodriguez-Cuevas', u'S', u'Barroso-Bravo', u'S', u'Manza-Estrada', u'J', u'Cristobal-Martinez', u'L', u'Gonzalez-Rodriguez', u'E.', u'Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin', u'Arch Med Res', u'2001', u'32', u'273', u'6'], [u'Gehl', u'J', u'Geertsen', u'PF', u'Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy', u'Melanoma Res', u'2000', u'10', u'585', u'9'], [u'Mir', u'LM', u'Gehl', u'J', u'Sersa', u'G', u'Collins', u'CG', u'Garbay', u'JR', u'Billard', u'V', u'Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes', u'EJC Supplements', u'2006', u'4', u'14', u'25'], [u'Domenge', u'C', u'Orlowski', u'S', u'Luboinski', u'B', u'De', u'BT', u'Schwaab', u'G', u'Belehradek', u'J', u'Jr.', u'Antitumor electrochemotherapy: New advances in the clinical protocol', u'Cancer', u'1996', u'77', u'956', u'63'], [u'Hall', u'SW', u'Strong', u'JE', u'Broughton', u'A', u'Frazier', u'ML', u'Benjamin', u'RS', u'Bleomycin clinical pharmacology by radioimmunoassay', u'Cancer Chemother Pharmacol', u'1982', u'9', u'22', u'5'], [u'Mathes', u'DD', u'Bleomycin and hyperoxia exposure in the operating room', u'Anesth Analg', u'1995', u'81', u'624', u'9'], [u'Therasse', u'P', u'Arbuck', u'SG', u'Eisenhauer', u'EA', u'Wanders', u'J', u'Kaplan', u'RS', u'Rubinstein', u'L', u'New guidelines to evaluate the response to treatment in solid tumors', u'European Organization for Research and Treatment of Cancer', u'National Cancer Institute of the United States, National Cancer Institute of Canada', u'J Natl Cancer Inst', u'2000', u'92', u'205', u'16'], [u'Mir', u'LM', u'Belehradek', u'M', u'Domenge', u'C', u'Orlowski', u'S', u'Poddevin', u'B', u'Belehradek', u'J', u'Jr.', u'Electrochemotherapy, a new antitumor treatment: first clinical trial]', u'C R Acad Sci', u'III', u'1991', u'313', u'613', u'8'], [u'Quaglino', u'P', u'Mortera', u'C', u'Osella-Abate', u'S', u'Barberis', u'M', u'Illengo', u'M', u'Rissone', u'M', u'Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases', u'Ann Surg Oncol', u'2008', u'15', u'2215', u'22'], [u'Tijink', u'BM', u'De', u'BR', u'Van Dongen', u'GA', u'Leemans', u'CR', u'How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients', u'Clin Otolaryngol', u'2006', u'31', u'447', u'51'], [u'Larkin', u'JO', u'Collins', u'CG', u'Aarons', u'S', u'Tangney', u'M', u'Whelan', u'M', u""O'Reily S"", u'Electrochemotherapy: Aspects of preclinical development and early clinical experience', u'Ann Surg', u'2007', u'245', u'469', u'79']"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_title,exact,list,0,1,0,0,"Cutaneous metastatic disease, Tumor invasion of the skin, Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients, Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin, Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study, Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs, Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs, Toxicity of anticancer agents mediated by electroporation in vitro, Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial, Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients, Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation, Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin, Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy, Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes, Antitumor electrochemotherapy: New advances in the clinical protocol, Bleomycin clinical pharmacology by radioimmunoassay, Bleomycin and hyperoxia exposure in the operating room, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, [Electrochemotherapy, a new antitumor treatment: first clinical trial], Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases, How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients, Electrochemotherapy: Aspects of preclinical development and early clinical experience","Cutaneous metastatic disease, Tumor invasion of the skin, Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients, Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin, Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study, Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, : Theory and methods, perspectives for drug delivery, gene therapy and research, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs, Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs, Toxicity of anticancer agents mediated by electroporation in vitro, Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial, Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients, Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation, Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin, Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy, Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes, Antitumor electrochemotherapy: New advances in the clinical protocol, Bleomycin clinical pharmacology by radioimmunoassay, Bleomycin and hyperoxia exposure in the operating room, New guidelines to evaluate the response to treatment in solid tumors, National Cancer Institute of the United States, National Cancer Institute of Canada, Electrochemotherapy, a new antitumor treatment: first clinical trial], Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases, How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients, Electrochemotherapy: Aspects of preclinical development and early clinical experience"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_title,levenshtein,list,0,1,0,0,"Cutaneous metastatic disease, Tumor invasion of the skin, Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients, Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin, Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study, Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs, Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs, Toxicity of anticancer agents mediated by electroporation in vitro, Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial, Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients, Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation, Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin, Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy, Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes, Antitumor electrochemotherapy: New advances in the clinical protocol, Bleomycin clinical pharmacology by radioimmunoassay, Bleomycin and hyperoxia exposure in the operating room, New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, [Electrochemotherapy, a new antitumor treatment: first clinical trial], Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases, How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients, Electrochemotherapy: Aspects of preclinical development and early clinical experience","Cutaneous metastatic disease, Tumor invasion of the skin, Cutaneous metastases in patients with metastatic carcinoma: A retrospective study of 4020 patients, Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin, Electrochemotherapy, An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study, Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy, : Theory and methods, perspectives for drug delivery, gene therapy and research, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs, Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs, Toxicity of anticancer agents mediated by electroporation in vitro, Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial, Bleomycin-based electrochemotherapy: Clinical outcome from a single institution's experience with 52 patients, Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation, Electrochemotherapy in primary and metastatic skin tumors: Phase II trial using intralesional bleomycin, Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy, Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes, Antitumor electrochemotherapy: New advances in the clinical protocol, Bleomycin clinical pharmacology by radioimmunoassay, Bleomycin and hyperoxia exposure in the operating room, New guidelines to evaluate the response to treatment in solid tumors, National Cancer Institute of the United States, National Cancer Institute of Canada, Electrochemotherapy, a new antitumor treatment: first clinical trial], Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases, How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients, Electrochemotherapy: Aspects of preclinical development and early clinical experience"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_year,exact,list,1,0,0,0,"1995, 2008, 1993, 1998, 2006, 1998, 2003, 1993, 1998, 1988, 2000, 1993, 2009, 2003, 2001, 2000, 2006, 1996, 1982, 1995, 2000, 1991, 2008, 2006, 2007","1995, 2008, 1993, 1998, 2006, 1998, 2003, 1993, 1998, 1988, 2000, 1993, 2009, 2003, 2001, 2000, 2006, 1996, 1982, 1995, 2000, 1991, 2008, 2006, 2007"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_year,levenshtein,list,1,0,0,0,"1995, 2008, 1993, 1998, 2006, 1998, 2003, 1993, 1998, 1988, 2000, 1993, 2009, 2003, 2001, 2000, 2006, 1996, 1982, 1995, 2000, 1991, 2008, 2006, 2007","1995, 2008, 1993, 1998, 2006, 1998, 2003, 1993, 1998, 1988, 2000, 1993, 2009, 2003, 2001, 2000, 2006, 1996, 1982, 1995, 2000, 1991, 2008, 2006, 2007"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_source,exact,list,0,1,0,0,"J Am Acad Dermatol, Dermatol Clin, J Am Acad Dermatol, Cancer, EJC Supplements, Br J Cancer, Acta Physiol Scand, Cancer Res, Anticancer Drugs, Biochem Pharmacol, Anticancer Drugs, Cancer, Ann Surg Oncol, Cancer Treat Rev, Arch Med Res, Melanoma Res, EJC Supplements, Cancer, Cancer Chemother Pharmacol, Anesth Analg, J Natl Cancer Inst, C R Acad Sci III, Ann Surg Oncol, Clin Otolaryngol, Ann Surg","J Am Acad Dermatol, Dermatol Clin, J Am Acad Dermatol, Cancer, EJC Supplements, Br J Cancer, Acta Physiol Scand, Cancer Res, Anticancer Drugs, Biochem Pharmacol, Anticancer Drugs, Cancer, Ann Surg Oncol, Cancer Treat Rev, Arch Med Res, Melanoma Res, EJC Supplements, Cancer, Cancer Chemother Pharmacol, Anesth Analg, European Organization for Research and Treatment of Cancer, J Natl Cancer Inst, , Ann Surg Oncol, Clin Otolaryngol, Ann Surg"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_source,levenshtein,list,0,1,0,0,"J Am Acad Dermatol, Dermatol Clin, J Am Acad Dermatol, Cancer, EJC Supplements, Br J Cancer, Acta Physiol Scand, Cancer Res, Anticancer Drugs, Biochem Pharmacol, Anticancer Drugs, Cancer, Ann Surg Oncol, Cancer Treat Rev, Arch Med Res, Melanoma Res, EJC Supplements, Cancer, Cancer Chemother Pharmacol, Anesth Analg, J Natl Cancer Inst, C R Acad Sci III, Ann Surg Oncol, Clin Otolaryngol, Ann Surg","J Am Acad Dermatol, Dermatol Clin, J Am Acad Dermatol, Cancer, EJC Supplements, Br J Cancer, Acta Physiol Scand, Cancer Res, Anticancer Drugs, Biochem Pharmacol, Anticancer Drugs, Cancer, Ann Surg Oncol, Cancer Treat Rev, Arch Med Res, Melanoma Res, EJC Supplements, Cancer, Cancer Chemother Pharmacol, Anesth Analg, European Organization for Research and Treatment of Cancer, J Natl Cancer Inst, , Ann Surg Oncol, Clin Otolaryngol, Ann Surg"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_volume,exact,list,1,0,0,0,"33, 26, 29, 83, 4, 77, 177, 53, 9, 37, 11, 72, 16, 29, 32, 10, 4, 77, 9, 81, 92, 313, 15, 31, 245","33, 26, 29, 83, 4, 77, 177, 53, 9, 37, 11, 72, 16, 29, 32, 10, 4, 77, 9, 81, 92, 313, 15, 31, 245"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_volume,levenshtein,list,1,0,0,0,"33, 26, 29, 83, 4, 77, 177, 53, 9, 37, 11, 72, 16, 29, 32, 10, 4, 77, 9, 81, 92, 313, 15, 31, 245","33, 26, 29, 83, 4, 77, 177, 53, 9, 37, 11, 72, 16, 29, 32, 10, 4, 77, 9, 81, 92, 313, 15, 31, 245"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_fpage,exact,list,1,0,0,0,"161, 89, 228, 148, 3, 2336, 437, 5462, 319, 4727, 201, 3694, 191, 371, 273, 585, 14, 956, 22, 624, 205, 613, 2215, 447, 469","161, 89, 228, 148, 3, 2336, 437, 5462, 319, 4727, 201, 3694, 191, 371, 273, 585, 14, 956, 22, 624, 205, 613, 2215, 447, 469"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_fpage,levenshtein,list,1,0,0,0,"161, 89, 228, 148, 3, 2336, 437, 5462, 319, 4727, 201, 3694, 191, 371, 273, 585, 14, 956, 22, 624, 205, 613, 2215, 447, 469","161, 89, 228, 148, 3, 2336, 437, 5462, 319, 4727, 201, 3694, 191, 371, 273, 585, 14, 956, 22, 624, 205, 613, 2215, 447, 469"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_lpage,exact,list,1,0,0,0,"82, 102, 36, 57, 13, 42, 47, 9, 25, 33, 8, 700, 9, 87, 6, 9, 25, 63, 5, 9, 16, 8, 22, 51, 79","82, 102, 36, 57, 13, 42, 47, 9, 25, 33, 8, 700, 9, 87, 6, 9, 25, 63, 5, 9, 16, 8, 22, 51, 79"
sonc50-621.cermine.xml,sonc50-621.nxml,reference_lpage,levenshtein,list,1,0,0,0,"82, 102, 36, 57, 13, 42, 47, 9, 25, 33, 8, 700, 9, 87, 6, 9, 25, 63, 5, 9, 16, 8, 22, 51, 79","82, 102, 36, 57, 13, 42, 47, 9, 25, 33, 8, 700, 9, 87, 6, 9, 25, 63, 5, 9, 16, 8, 22, 51, 79"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,title,exact,string,0,1,0,0,Resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis—a case report,Resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis-a case report
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,title,levenshtein,string,1,0,0,0,Resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis—a case report,Resection arthroplasty for luxation of the manubrio-sternal joint in rheumatoid arthritis-a case report
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,abstract,exact,string,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,abstract,levenshtein,string,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,keywords,exact,set,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,keywords,levenshtein,set,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,author_surnames,exact,set,0,0,1,0,"Schmitz, de Waal Malefijt, van Heereveld",
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,author_surnames,levenshtein,set,0,0,1,0,"Schmitz, de Waal Malefijt, van Heereveld",
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_author_surname,exact,string,0,0,1,0,Schmitz,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_author_surname,levenshtein,string,0,0,1,0,Schmitz,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,author_full_names,exact,set,1,0,0,0,"Hedwig A E M van Heereveld, Maarten C de Waal Malefijt, Marloes W J L Schmitz","Hedwig A E M van Heereveld, Maarten C de Waal Malefijt, Marloes W J L Schmitz"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,author_full_names,levenshtein,set,1,0,0,0,"Hedwig A E M van Heereveld, Maarten C de Waal Malefijt, Marloes W J L Schmitz","Hedwig A E M van Heereveld, Maarten C de Waal Malefijt, Marloes W J L Schmitz"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_author_full_name,exact,string,1,0,0,0,Marloes W J L Schmitz,Marloes W J L Schmitz
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_author_full_name,levenshtein,string,1,0,0,0,Marloes W J L Schmitz,Marloes W J L Schmitz
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,affiliation_strings,exact,set,0,1,0,0,"Department of Orthopaedics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, the Netherlands","Departments of, Orthopaedics, Rheumatology, Radboud University Nijmegen Medical Centre, the Netherlands Submitted 09-09-25. Accepted 09-11-02"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,affiliation_strings,levenshtein,set,0,1,0,0,"Department of Orthopaedics, Department of Rheumatology, Radboud University Nijmegen Medical Centre, the Netherlands","Departments of, Orthopaedics, Rheumatology, Radboud University Nijmegen Medical Centre, the Netherlands Submitted 09-09-25. Accepted 09-11-02"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,affiliation_institution,exact,set,0,1,0,0,"Department of Orthopaedics, Department of Rheumatology, Radboud University Nijmegen Medical Centre","Departments of, Orthopaedics, Rheumatology, Radboud University Nijmegen Medical Centre"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,affiliation_institution,levenshtein,set,0,1,0,0,"Department of Orthopaedics, Department of Rheumatology, Radboud University Nijmegen Medical Centre","Departments of, Orthopaedics, Rheumatology, Radboud University Nijmegen Medical Centre"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,section_titles,exact,list,0,1,0,0,"Introduction, Discussion",-
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,section_titles,levenshtein,list,0,1,0,0,"Introduction, Discussion",-
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,tables,exact,table,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,tables,levenshtein,table,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_strings,exact,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_strings,levenshtein,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_labels,exact,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_labels,levenshtein,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_captions,exact,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_captions,levenshtein,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_label_captions,exact,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2', u'14792027']","[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2']"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2', u'14792027']","[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2']"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_reference_title,exact,string,1,0,0,0,Manubrio-sternal joint in rheumatoid arthritis,Manubrio-sternal joint in rheumatoid arthritis
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,first_reference_title,levenshtein,string,1,0,0,0,Manubrio-sternal joint in rheumatoid arthritis,Manubrio-sternal joint in rheumatoid arthritis
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_fields,exact,list,0,1,0,0,"[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2', u'14792027'], [u'Holt', u'ME', u'Rooney', u'PJ', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Rheumatol', u'1980', u'7', u'260', u'2', u'7373631'], [u'Kelly', u'MC', u'Hopkinson', u'ND', u'Zaphiropoulos', u'GC', u'Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis', u'Ann Rheum Dis', u'1986', u'45', u'345', u'8', u'3707222'], [u'Khong', u'TK', u'Rooney', u'PJ', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Reumatol', u'1982', u'9', u'712', u'5'], [u'Kormano', u'M', u'A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'47', u'59', u'5445309'], [u'Laitinen', u'H', u'Saksanen', u'S', u'Suoranta', u'H', u'Involvement of the manubrio-sternal articulation in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'40', u'6', u'5445308'], [u'Rapoport', u'RJ', u'Carrera', u'GF', u'Kozin', u'F', u'Manubrio-sternal joint subluxation in rheumatiod arthritis', u'J Reumatol', u'1979', u'6', u'1', u'74', u'7'], [u'Wiseman', u'MJ', u'Dislocation of the manubriosternal joint in rheumatoid arthritis', u'Ann Rheum Dis', u'1981', u'40', u'307', u'8', u'7247475']","[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2'], [u'Holt', u'M E', u'Rooney P J.', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Rheumatol', u'1980', u'7', u'260', u'2'], [u'Kelly', u'M C', u'Hopkinson', u'N D', u'Zaphiropoulos G C.', u'Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis', u'Ann Rheum Dis', u'1986', u'45', u'345', u'8'], [u'Khong T K', u'Rooney P J.', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Reumatol', u'1982', u'9', u'712', u'5'], [u'Kormano', u'M.', u'A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'47', u'59'], [u'Laitinen', u'H', u'Saksanen', u'S', u'Suoranta', u'H', u'Involvement of the manubrio-sternal articulation in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'40', u'6'], [u'Rapoport R J', u'Carrera', u'G F', u'Kozin F', u'Manubrio-sternal joint subluxation in rheumatiod arthritis', u'J Reumatol', u'1979', u'6:1', u'74', u'7'], [u'Wiseman M J.', u'Dislocation of the manubriosternal joint in rheumatoid arthritis', u'Ann Rheum Dis', u'1981', u'40', u'307', u'8']"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_fields,levenshtein,list,1,0,0,0,"[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2', u'14792027'], [u'Holt', u'ME', u'Rooney', u'PJ', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Rheumatol', u'1980', u'7', u'260', u'2', u'7373631'], [u'Kelly', u'MC', u'Hopkinson', u'ND', u'Zaphiropoulos', u'GC', u'Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis', u'Ann Rheum Dis', u'1986', u'45', u'345', u'8', u'3707222'], [u'Khong', u'TK', u'Rooney', u'PJ', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Reumatol', u'1982', u'9', u'712', u'5'], [u'Kormano', u'M', u'A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'47', u'59', u'5445309'], [u'Laitinen', u'H', u'Saksanen', u'S', u'Suoranta', u'H', u'Involvement of the manubrio-sternal articulation in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'40', u'6', u'5445308'], [u'Rapoport', u'RJ', u'Carrera', u'GF', u'Kozin', u'F', u'Manubrio-sternal joint subluxation in rheumatiod arthritis', u'J Reumatol', u'1979', u'6', u'1', u'74', u'7'], [u'Wiseman', u'MJ', u'Dislocation of the manubriosternal joint in rheumatoid arthritis', u'Ann Rheum Dis', u'1981', u'40', u'307', u'8', u'7247475']","[u'Bogdan', u'A', u'Clark', u'J', u'Manubrio-sternal joint in rheumatoid arthritis', u'Br Med J', u'1950', u'16', u'1361', u'2'], [u'Holt', u'M E', u'Rooney P J.', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Rheumatol', u'1980', u'7', u'260', u'2'], [u'Kelly', u'M C', u'Hopkinson', u'N D', u'Zaphiropoulos G C.', u'Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis', u'Ann Rheum Dis', u'1986', u'45', u'345', u'8'], [u'Khong T K', u'Rooney P J.', u'Manubriosternal joint subluxation in rheumatoid arthritis', u'J Reumatol', u'1982', u'9', u'712', u'5'], [u'Kormano', u'M.', u'A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'47', u'59'], [u'Laitinen', u'H', u'Saksanen', u'S', u'Suoranta', u'H', u'Involvement of the manubrio-sternal articulation in rheumatoid arthritis', u'Acta Rheumatol Scand', u'1970', u'16', u'40', u'6'], [u'Rapoport R J', u'Carrera', u'G F', u'Kozin F', u'Manubrio-sternal joint subluxation in rheumatiod arthritis', u'J Reumatol', u'1979', u'6:1', u'74', u'7'], [u'Wiseman M J.', u'Dislocation of the manubriosternal joint in rheumatoid arthritis', u'Ann Rheum Dis', u'1981', u'40', u'307', u'8']"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_title,exact,list,0,1,0,0,"Manubrio-sternal joint in rheumatoid arthritis, Manubriosternal joint subluxation in rheumatoid arthritis, Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis, Manubriosternal joint subluxation in rheumatoid arthritis, A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis, Involvement of the manubrio-sternal articulation in rheumatoid arthritis, Manubrio-sternal joint subluxation in rheumatiod arthritis, Dislocation of the manubriosternal joint in rheumatoid arthritis","Manubrio-sternal joint in rheumatoid arthritis, Manubriosternal joint subluxation in rheumatoid arthritis, Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis, Manubriosternal joint subluxation in rheumatoid arthritis, A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis, Involvement of the manubrio-sternal articulation in rheumatoid arthritis, Kozin F, Manubrio-sternal joint subluxation in rheumatiod arthritis, Dislocation of the manubriosternal joint in rheumatoid arthritis"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_title,levenshtein,list,1,0,0,0,"Manubrio-sternal joint in rheumatoid arthritis, Manubriosternal joint subluxation in rheumatoid arthritis, Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis, Manubriosternal joint subluxation in rheumatoid arthritis, A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis, Involvement of the manubrio-sternal articulation in rheumatoid arthritis, Manubrio-sternal joint subluxation in rheumatiod arthritis, Dislocation of the manubriosternal joint in rheumatoid arthritis","Manubrio-sternal joint in rheumatoid arthritis, Manubriosternal joint subluxation in rheumatoid arthritis, Manubriosternal joint dislocation in rheumatoid arthritis: the role of thoracic kyphosis, Manubriosternal joint subluxation in rheumatoid arthritis, A micrographic an histological study of the manubrio-sternal joint in rheumatoid arthritis, Involvement of the manubrio-sternal articulation in rheumatoid arthritis, Kozin F, Manubrio-sternal joint subluxation in rheumatiod arthritis, Dislocation of the manubriosternal joint in rheumatoid arthritis"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_year,exact,list,1,0,0,0,"1950, 1980, 1986, 1982, 1970, 1970, 1979, 1981","1950, 1980, 1986, 1982, 1970, 1970, 1979, 1981"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_year,levenshtein,list,1,0,0,0,"1950, 1980, 1986, 1982, 1970, 1970, 1979, 1981","1950, 1980, 1986, 1982, 1970, 1970, 1979, 1981"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_source,exact,list,1,0,0,0,"Br Med J, J Rheumatol, Ann Rheum Dis, J Reumatol, Acta Rheumatol Scand, Acta Rheumatol Scand, J Reumatol, Ann Rheum Dis","Br Med J, J Rheumatol, Ann Rheum Dis, J Reumatol, Acta Rheumatol Scand, Acta Rheumatol Scand, J Reumatol, Ann Rheum Dis"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_source,levenshtein,list,1,0,0,0,"Br Med J, J Rheumatol, Ann Rheum Dis, J Reumatol, Acta Rheumatol Scand, Acta Rheumatol Scand, J Reumatol, Ann Rheum Dis","Br Med J, J Rheumatol, Ann Rheum Dis, J Reumatol, Acta Rheumatol Scand, Acta Rheumatol Scand, J Reumatol, Ann Rheum Dis"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_volume,exact,list,0,1,0,0,"16, 7, 45, 9, 16, 16, 6, 40","16, 7, 45, 9, 16, 16, 6:1, 40"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_volume,levenshtein,list,0,1,0,0,"16, 7, 45, 9, 16, 16, 6, 40","16, 7, 45, 9, 16, 16, 6:1, 40"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_fpage,exact,list,1,0,0,0,"1361, 260, 345, 712, 47, 40, 74, 307","1361, 260, 345, 712, 47, 40, 74, 307"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_fpage,levenshtein,list,1,0,0,0,"1361, 260, 345, 712, 47, 40, 74, 307","1361, 260, 345, 712, 47, 40, 74, 307"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_lpage,exact,list,1,0,0,0,"2, 2, 8, 5, 59, 6, 7, 8","2, 2, 8, 5, 59, 6, 7, 8"
ORT-1745-3674-81-405.cermine.xml,ORT-1745-3674-81-405.nxml,reference_lpage,levenshtein,list,1,0,0,0,"2, 2, 8, 5, 59, 6, 7, 8","2, 2, 8, 5, 59, 6, 7, 8"
soto131-469.cermine.xml,soto131-469.nxml,title,exact,string,1,0,0,0,Visualization and assessment of saccular duct and endolymphatic sinus,Visualization and assessment of saccular duct and endolymphatic sinus
soto131-469.cermine.xml,soto131-469.nxml,title,levenshtein,string,1,0,0,0,Visualization and assessment of saccular duct and endolymphatic sinus,Visualization and assessment of saccular duct and endolymphatic sinus
soto131-469.cermine.xml,soto131-469.nxml,abstract,exact,string,1,0,0,0,"Conclusion: The saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. We first clinically visualized this sulciform groove using three-dimensional (3D) cone beam CT images. This strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. Objective: To assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. Methods: The sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam CT and compared with that of a cadaver. Results: We could obtain reconstructed 3D CT images of the sulciform groove of the saccular duct and endolymphatic sinus using several CT window levels.","Conclusion: The saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. We first clinically visualized this sulciform groove using three-dimensional (3D) cone beam CT images. This strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. Objective: To assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. Methods: The sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam CT and compared with that of a cadaver. Results: We could obtain reconstructed 3D CT images of the sulciform groove of the saccular duct and endolymphatic sinus using several CT window levels."
soto131-469.cermine.xml,soto131-469.nxml,abstract,levenshtein,string,1,0,0,0,"Conclusion: The saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. We first clinically visualized this sulciform groove using three-dimensional (3D) cone beam CT images. This strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. Objective: To assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. Methods: The sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam CT and compared with that of a cadaver. Results: We could obtain reconstructed 3D CT images of the sulciform groove of the saccular duct and endolymphatic sinus using several CT window levels.","Conclusion: The saccular duct and endolymphatic sinus run in the bony groove, before reaching the orifice of the vestibular aqueduct. We first clinically visualized this sulciform groove using three-dimensional (3D) cone beam CT images. This strategy can be useful to assess the condition of the saccular duct and endolymphatic sinus concerning the longitudinal flow system of endolymph. Objective: To assess the saccular duct and endolymphatic sinus in the endolymphatic system in order to advance clinical studies on inner ear dysfunction. Methods: The sulciform groove of the saccular duct and endolymphatic sinus of human subjects was analyzed by cone beam CT and compared with that of a cadaver. Results: We could obtain reconstructed 3D CT images of the sulciform groove of the saccular duct and endolymphatic sinus using several CT window levels."
soto131-469.cermine.xml,soto131-469.nxml,keywords,exact,set,1,0,0,0,"CT image, Cochlea, bony groove, endolymphatic duct, endolymphatic hydrops, longitudinal flow, rendering, saccule","CT image, Cochlea, bony groove, endolymphatic duct, endolymphatic hydrops, longitudinal flow, rendering, saccule"
soto131-469.cermine.xml,soto131-469.nxml,keywords,levenshtein,set,1,0,0,0,"CT image, Cochlea, bony groove, endolymphatic duct, endolymphatic hydrops, longitudinal flow, rendering, saccule","CT image, Cochlea, bony groove, endolymphatic duct, endolymphatic hydrops, longitudinal flow, rendering, saccule"
soto131-469.cermine.xml,soto131-469.nxml,author_surnames,exact,set,0,0,1,0,"Anniko, Imoto, Sakamoto, Sunami, Takayama, Yamane",
soto131-469.cermine.xml,soto131-469.nxml,author_surnames,levenshtein,set,0,0,1,0,"Anniko, Imoto, Sakamoto, Sunami, Takayama, Yamane",
soto131-469.cermine.xml,soto131-469.nxml,first_author_surname,exact,string,0,0,1,0,Yamane,
soto131-469.cermine.xml,soto131-469.nxml,first_author_surname,levenshtein,string,0,0,1,0,Yamane,
soto131-469.cermine.xml,soto131-469.nxml,author_full_names,exact,set,0,1,0,0,"Hideo Yamane, Hiramori Sakamoto, Kishiko Sunami, Masahiro Takayama, Matti Anniko, Toshio Imoto","HIDEO YAMANE, HIRAMORI SAKAMOTO, KISHIKO SUNAMI, MASAHIRO TAKAYAMA, MATTI ANNIKO, TOSHIO IMOTO"
soto131-469.cermine.xml,soto131-469.nxml,author_full_names,levenshtein,set,0,1,0,0,"Hideo Yamane, Hiramori Sakamoto, Kishiko Sunami, Masahiro Takayama, Matti Anniko, Toshio Imoto","HIDEO YAMANE, HIRAMORI SAKAMOTO, KISHIKO SUNAMI, MASAHIRO TAKAYAMA, MATTI ANNIKO, TOSHIO IMOTO"
soto131-469.cermine.xml,soto131-469.nxml,first_author_full_name,exact,string,0,1,0,0,Hideo Yamane,HIDEO YAMANE
soto131-469.cermine.xml,soto131-469.nxml,first_author_full_name,levenshtein,string,0,1,0,0,Hideo Yamane,HIDEO YAMANE
soto131-469.cermine.xml,soto131-469.nxml,affiliation_strings,exact,set,1,0,0,0,"Department of Otorhinolaryngology and Head & Neck Surgery, Uppsala University Hospital, Uppsala, Sweden, Department of Otorhinolaryngology, Osaka City University Graduate School of Medicine, Osaka, Japan","Department of Otorhinolaryngology and Head & Neck Surgery, Uppsala University Hospital, Uppsala, Sweden, Department of Otorhinolaryngology, Osaka City University Graduate School of Medicine, Osaka, Japan"
soto131-469.cermine.xml,soto131-469.nxml,affiliation_strings,levenshtein,set,1,0,0,0,"Department of Otorhinolaryngology and Head & Neck Surgery, Uppsala University Hospital, Uppsala, Sweden, Department of Otorhinolaryngology, Osaka City University Graduate School of Medicine, Osaka, Japan","Department of Otorhinolaryngology and Head & Neck Surgery, Uppsala University Hospital, Uppsala, Sweden, Department of Otorhinolaryngology, Osaka City University Graduate School of Medicine, Osaka, Japan"
soto131-469.cermine.xml,soto131-469.nxml,affiliation_institution,exact,set,0,1,0,0,,"Department of Otorhinolaryngology and Head & Neck Surgery, Uppsala University Hospital, Department of Otorhinolaryngology, Osaka City University Graduate School of Medicine"
soto131-469.cermine.xml,soto131-469.nxml,affiliation_institution,levenshtein,set,0,1,0,0,,"Department of Otorhinolaryngology and Head & Neck Surgery, Uppsala University Hospital, Department of Otorhinolaryngology, Osaka City University Graduate School of Medicine"
soto131-469.cermine.xml,soto131-469.nxml,section_titles,exact,list,0,1,0,0,"Introduction, Material and methods, Results, Discussion","Introduction, Material and methods, Discussion, Acknowledgment"
soto131-469.cermine.xml,soto131-469.nxml,section_titles,levenshtein,list,0,1,0,0,"Introduction, Material and methods, Results, Discussion","Introduction, Material and methods, Discussion, Acknowledgment"
soto131-469.cermine.xml,soto131-469.nxml,tables,exact,table,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,tables,levenshtein,table,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_strings,exact,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_strings,levenshtein,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_labels,exact,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_labels,levenshtein,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_captions,exact,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_captions,levenshtein,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_label_captions,exact,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
soto131-469.cermine.xml,soto131-469.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'1', u'Guild', u'SR', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81']","[u'Guild', u'SR.', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81']"
soto131-469.cermine.xml,soto131-469.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Guild', u'SR', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81']","[u'Guild', u'SR.', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81']"
soto131-469.cermine.xml,soto131-469.nxml,first_reference_title,exact,string,1,0,0,0,The circulation of the endolymph,The circulation of the endolymph
soto131-469.cermine.xml,soto131-469.nxml,first_reference_title,levenshtein,string,1,0,0,0,The circulation of the endolymph,The circulation of the endolymph
soto131-469.cermine.xml,soto131-469.nxml,reference_fields,exact,list,0,1,0,0,"[u'1', u'Guild', u'SR', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81'], [u'2', u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'3', u'Kitamura', u'K', u'Schuknecht', u'H', u'Kimura', u'R', u'Cochlear hydrops is associated with collapsed saccule and ductus reuniens', u'Ann Otol', u'1982', u'91', u'5', u'13'], [u'4', u'Stahle', u'J', u'Wilbrand', u'H', u""The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation"", u'Acta Otolaryngol', u'1974', u'78', u'36', u'48', u'4547335'], [u'5', u'Yamamoto', u'E', u'Mizukami', u'C', u'Isono', u'M', u'Ohmura', u'M', u'Hirono', u'Y', u'Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging', u'Laryngoscope', u'1991', u'101', u'480', u'3', u'2030626'], [u'6', u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Mchizuki', u'K', u'Inoue', u'Y', u'Three-dimensional images of the reuniting duct using cone beam CT', u'Acta Otolaryngol', u'2009', u'129', u'493', u'6', u'18720066'], [u'7', u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Anniko', u'M', u'Assessment of the reuniting duct by three-dimensional CT rendering', u'Acta Otolaryngol', u'2009', u'129', u'1166', u'8', u'19863305'], [u'8', u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Imoto', u'T', u'Anniko', u'M', u""Blockage of reuniting duct in Meniere's disease"", u'Acta Otolaryngol', u'2010', u'130', u'233', u'9', u'19585278'], [u'9', u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'10', u'Schuknecht', u'HF', u'R\xfcther', u'A', u'Blockage of longitudinal flow in the endolymphatic hydrops', u'Eur Arch Otorhinolaryngol', u'1991', u'248', u'209', u'17', u'1859653']","[u'Guild', u'SR.', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81'], [u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'Kitamura', u'K', u'Schuknecht', u'H', u'Kimura', u'R', u'Cochlear hydrops is associated with collapsed saccule and ductus reuniens', u'Ann Otol', u'1982', u'91', u'5', u'13'], [u'Stahle', u'J', u'Wilbrand', u'H.', u""The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation"", u'Acta Otolaryngol', u'1974', u'78', u'36', u'48'], [u'Yamamoto', u'E', u'Mizukami', u'C', u'Isono', u'M', u'Ohmura', u'M', u'Hirono', u'Y.', u'Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging', u'Laryngoscope', u'1991', u'101', u'480', u'3'], [u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Mchizuki', u'K', u'Inoue', u'Y', u'Three-dimensional images of the reuniting duct using cone beam CT', u'Acta Otolaryngol', u'2009', u'129', u'493', u'6'], [u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Anniko', u'M.', u'Assessment of the reuniting duct by threedimensional CT rendering', u'Acta Otolaryngol', u'2009', u'129', u'1166', u'8'], [u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Imoto', u'T', u'Anniko', u'M.', u""Blockage of reuniting duct in Meniere's disease"", u'Acta Otolaryngol', u'2010', u'130', u'233', u'9'], [u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'Schuknecht', u'HF', u'R\xfcther', u'A', u'Blockage of longitudinal flow in the endolymphatic hydrops', u'Eur Arch Otorhinolaryngol', u'1991', u'248', u'209', u'17']"
soto131-469.cermine.xml,soto131-469.nxml,reference_fields,levenshtein,list,1,0,0,0,"[u'1', u'Guild', u'SR', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81'], [u'2', u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'3', u'Kitamura', u'K', u'Schuknecht', u'H', u'Kimura', u'R', u'Cochlear hydrops is associated with collapsed saccule and ductus reuniens', u'Ann Otol', u'1982', u'91', u'5', u'13'], [u'4', u'Stahle', u'J', u'Wilbrand', u'H', u""The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation"", u'Acta Otolaryngol', u'1974', u'78', u'36', u'48', u'4547335'], [u'5', u'Yamamoto', u'E', u'Mizukami', u'C', u'Isono', u'M', u'Ohmura', u'M', u'Hirono', u'Y', u'Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging', u'Laryngoscope', u'1991', u'101', u'480', u'3', u'2030626'], [u'6', u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Mchizuki', u'K', u'Inoue', u'Y', u'Three-dimensional images of the reuniting duct using cone beam CT', u'Acta Otolaryngol', u'2009', u'129', u'493', u'6', u'18720066'], [u'7', u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Anniko', u'M', u'Assessment of the reuniting duct by three-dimensional CT rendering', u'Acta Otolaryngol', u'2009', u'129', u'1166', u'8', u'19863305'], [u'8', u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Imoto', u'T', u'Anniko', u'M', u""Blockage of reuniting duct in Meniere's disease"", u'Acta Otolaryngol', u'2010', u'130', u'233', u'9', u'19585278'], [u'9', u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'10', u'Schuknecht', u'HF', u'R\xfcther', u'A', u'Blockage of longitudinal flow in the endolymphatic hydrops', u'Eur Arch Otorhinolaryngol', u'1991', u'248', u'209', u'17', u'1859653']","[u'Guild', u'SR.', u'The circulation of the endolymph', u'Am J Anat', u'1927', u'39', u'57', u'81'], [u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'Kitamura', u'K', u'Schuknecht', u'H', u'Kimura', u'R', u'Cochlear hydrops is associated with collapsed saccule and ductus reuniens', u'Ann Otol', u'1982', u'91', u'5', u'13'], [u'Stahle', u'J', u'Wilbrand', u'H.', u""The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation"", u'Acta Otolaryngol', u'1974', u'78', u'36', u'48'], [u'Yamamoto', u'E', u'Mizukami', u'C', u'Isono', u'M', u'Ohmura', u'M', u'Hirono', u'Y.', u'Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging', u'Laryngoscope', u'1991', u'101', u'480', u'3'], [u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Mchizuki', u'K', u'Inoue', u'Y', u'Three-dimensional images of the reuniting duct using cone beam CT', u'Acta Otolaryngol', u'2009', u'129', u'493', u'6'], [u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Anniko', u'M.', u'Assessment of the reuniting duct by threedimensional CT rendering', u'Acta Otolaryngol', u'2009', u'129', u'1166', u'8'], [u'Yamane', u'H', u'Takayama', u'M', u'Sunami', u'K', u'Sakamoto', u'H', u'Imoto', u'T', u'Anniko', u'M.', u""Blockage of reuniting duct in Meniere's disease"", u'Acta Otolaryngol', u'2010', u'130', u'233', u'9'], [u'Kimura', u'RS', u'Schuknecht', u'HF', u'Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac', u'Pract Otorhinolaryngol', u'1965', u'27', u'343', u'54'], [u'Schuknecht', u'HF', u'R\xfcther', u'A', u'Blockage of longitudinal flow in the endolymphatic hydrops', u'Eur Arch Otorhinolaryngol', u'1991', u'248', u'209', u'17']"
soto131-469.cermine.xml,soto131-469.nxml,reference_title,exact,list,0,1,0,0,"The circulation of the endolymph, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Cochlear hydrops is associated with collapsed saccule and ductus reuniens, The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation, Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging, Three-dimensional images of the reuniting duct using cone beam CT, Assessment of the reuniting duct by three-dimensional CT rendering, Blockage of reuniting duct in Meniere's disease, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Blockage of longitudinal flow in the endolymphatic hydrops","The circulation of the endolymph, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Cochlear hydrops is associated with collapsed saccule and ductus reuniens, The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation, Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging, Three-dimensional images of the reuniting duct using cone beam CT, Assessment of the reuniting duct by threedimensional CT rendering, Blockage of reuniting duct in Meniere's disease, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Blockage of longitudinal flow in the endolymphatic hydrops"
soto131-469.cermine.xml,soto131-469.nxml,reference_title,levenshtein,list,1,0,0,0,"The circulation of the endolymph, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Cochlear hydrops is associated with collapsed saccule and ductus reuniens, The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation, Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging, Three-dimensional images of the reuniting duct using cone beam CT, Assessment of the reuniting duct by three-dimensional CT rendering, Blockage of reuniting duct in Meniere's disease, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Blockage of longitudinal flow in the endolymphatic hydrops","The circulation of the endolymph, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Cochlear hydrops is associated with collapsed saccule and ductus reuniens, The vestibular aqueduct in patients with Meniere's disease. A tomographic and clinical investigation, Observation of the external aperture of the vestibular aqueduct using three-dimensional surface reconstruction imaging, Three-dimensional images of the reuniting duct using cone beam CT, Assessment of the reuniting duct by threedimensional CT rendering, Blockage of reuniting duct in Meniere's disease, Membranous hydrops in the inner ear of the guinea pig after obliteration of the endolymphatic sac, Blockage of longitudinal flow in the endolymphatic hydrops"
soto131-469.cermine.xml,soto131-469.nxml,reference_year,exact,list,1,0,0,0,"1927, 1965, 1982, 1974, 1991, 2009, 2009, 2010, 1965, 1991","1927, 1965, 1982, 1974, 1991, 2009, 2009, 2010, 1965, 1991"
soto131-469.cermine.xml,soto131-469.nxml,reference_year,levenshtein,list,1,0,0,0,"1927, 1965, 1982, 1974, 1991, 2009, 2009, 2010, 1965, 1991","1927, 1965, 1982, 1974, 1991, 2009, 2009, 2010, 1965, 1991"
soto131-469.cermine.xml,soto131-469.nxml,reference_source,exact,list,1,0,0,0,"Am J Anat, Pract Otorhinolaryngol, Ann Otol, Acta Otolaryngol, Laryngoscope, Acta Otolaryngol, Acta Otolaryngol, Acta Otolaryngol, Pract Otorhinolaryngol, Eur Arch Otorhinolaryngol","Am J Anat, Pract Otorhinolaryngol, Ann Otol, Acta Otolaryngol, Laryngoscope, Acta Otolaryngol, Acta Otolaryngol, Acta Otolaryngol, Pract Otorhinolaryngol, Eur Arch Otorhinolaryngol"
soto131-469.cermine.xml,soto131-469.nxml,reference_source,levenshtein,list,1,0,0,0,"Am J Anat, Pract Otorhinolaryngol, Ann Otol, Acta Otolaryngol, Laryngoscope, Acta Otolaryngol, Acta Otolaryngol, Acta Otolaryngol, Pract Otorhinolaryngol, Eur Arch Otorhinolaryngol","Am J Anat, Pract Otorhinolaryngol, Ann Otol, Acta Otolaryngol, Laryngoscope, Acta Otolaryngol, Acta Otolaryngol, Acta Otolaryngol, Pract Otorhinolaryngol, Eur Arch Otorhinolaryngol"
soto131-469.cermine.xml,soto131-469.nxml,reference_volume,exact,list,1,0,0,0,"39, 27, 91, 78, 101, 129, 129, 130, 27, 248","39, 27, 91, 78, 101, 129, 129, 130, 27, 248"
soto131-469.cermine.xml,soto131-469.nxml,reference_volume,levenshtein,list,1,0,0,0,"39, 27, 91, 78, 101, 129, 129, 130, 27, 248","39, 27, 91, 78, 101, 129, 129, 130, 27, 248"
soto131-469.cermine.xml,soto131-469.nxml,reference_fpage,exact,list,1,0,0,0,"57, 343, 5, 36, 480, 493, 1166, 233, 343, 209","57, 343, 5, 36, 480, 493, 1166, 233, 343, 209"
soto131-469.cermine.xml,soto131-469.nxml,reference_fpage,levenshtein,list,1,0,0,0,"57, 343, 5, 36, 480, 493, 1166, 233, 343, 209","57, 343, 5, 36, 480, 493, 1166, 233, 343, 209"
soto131-469.cermine.xml,soto131-469.nxml,reference_lpage,exact,list,1,0,0,0,"81, 54, 13, 48, 3, 6, 8, 9, 54, 17","81, 54, 13, 48, 3, 6, 8, 9, 54, 17"
soto131-469.cermine.xml,soto131-469.nxml,reference_lpage,levenshtein,list,1,0,0,0,"81, 54, 13, 48, 3, 6, 8, 9, 54, 17","81, 54, 13, 48, 3, 6, 8, 9, 54, 17"
apa0100-0653.cermine.xml,apa0100-0653.nxml,title,exact,string,1,0,0,0,Placental programming of blood pressure in Indian children,Placental programming of blood pressure in Indian children
apa0100-0653.cermine.xml,apa0100-0653.nxml,title,levenshtein,string,1,0,0,0,Placental programming of blood pressure in Indian children,Placental programming of blood pressure in Indian children
apa0100-0653.cermine.xml,apa0100-0653.nxml,abstract,exact,string,0,1,0,0,"Aim To determine whether the size and shape of the placental surface predict blood pressure in childhood. Methods We studied blood pressure in 471 nine-year-old Indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. Results In the daughters of short mothers (<median height), systolic blood pressure (SBP) rose as placental breadth increased (β = 0.69 mmHg/cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). In the daughters of tall mothers, SBP rose as the difference between placental length and breadth increased (β = 1.40 mmHg/cm, p = 0.007), that is as the surface became more oval. Among boys, associations with placental size were only statistically significant after adjusting for current BMI and height. After adjustment, SBP rose as placental breadth, area and weight decreased (for breadth β = −0.68 mmHg/cm, p < 0.05 for all three measurements). Conclusions The size and shape of the placental surface predict childhood blood pressure. Blood pressure may be programmed by variation in the normal processes of placentation: these include implantation, expansion of the chorionic surface in mid-gestation and compensatory expansion of the chorionic surface in late gestation.","Aim: To determine whether the size and shape of the placental surface predict blood pressure in childhood. Methods: We studied blood pressure in 471 nine-year-old Indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. Results: In the daughters of short mothers (<median height), systolic blood pressure (SBP) rose as placental breadth increased (b = 0.69 mmHg ? cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). In the daughters of tall mothers, SBP rose as the difference between placental length and breadth increased (b = 1.40 mmHg ? cm, p = 0.007), that is as the surface became more oval. Among boys, associations with placental size were only statistically significant after adjusting for current BMI and height. After adjustment, SBP rose as placental breadth, area and weight decreased (for breadth b = )0.68 mmHg ? cm, p < 0.05 for all three measurements)."
apa0100-0653.cermine.xml,apa0100-0653.nxml,abstract,levenshtein,string,0,1,0,0,"Aim To determine whether the size and shape of the placental surface predict blood pressure in childhood. Methods We studied blood pressure in 471 nine-year-old Indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. Results In the daughters of short mothers (<median height), systolic blood pressure (SBP) rose as placental breadth increased (β = 0.69 mmHg/cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). In the daughters of tall mothers, SBP rose as the difference between placental length and breadth increased (β = 1.40 mmHg/cm, p = 0.007), that is as the surface became more oval. Among boys, associations with placental size were only statistically significant after adjusting for current BMI and height. After adjustment, SBP rose as placental breadth, area and weight decreased (for breadth β = −0.68 mmHg/cm, p < 0.05 for all three measurements). Conclusions The size and shape of the placental surface predict childhood blood pressure. Blood pressure may be programmed by variation in the normal processes of placentation: these include implantation, expansion of the chorionic surface in mid-gestation and compensatory expansion of the chorionic surface in late gestation.","Aim: To determine whether the size and shape of the placental surface predict blood pressure in childhood. Methods: We studied blood pressure in 471 nine-year-old Indian children whose placental length, breadth and weight were measured in a prospective birth cohort study. Results: In the daughters of short mothers (<median height), systolic blood pressure (SBP) rose as placental breadth increased (b = 0.69 mmHg ? cm, p = 0.05) and as the ratio of placental surface area to birthweight increased (p = 0.0003). In the daughters of tall mothers, SBP rose as the difference between placental length and breadth increased (b = 1.40 mmHg ? cm, p = 0.007), that is as the surface became more oval. Among boys, associations with placental size were only statistically significant after adjusting for current BMI and height. After adjustment, SBP rose as placental breadth, area and weight decreased (for breadth b = )0.68 mmHg ? cm, p < 0.05 for all three measurements)."
apa0100-0653.cermine.xml,apa0100-0653.nxml,keywords,exact,set,0,1,0,0,"Birth size, Blood pressure, Indian children, Maternal height, Placental surface","Blood pressure, Indian children, Maternal height, Placental surface, eol>Birth size"
apa0100-0653.cermine.xml,apa0100-0653.nxml,keywords,levenshtein,set,0,1,0,0,"Birth size, Blood pressure, Indian children, Maternal height, Placental surface","Blood pressure, Indian children, Maternal height, Placental surface, eol>Birth size"
apa0100-0653.cermine.xml,apa0100-0653.nxml,author_surnames,exact,set,0,0,1,0,"Barker, Fall, Hill, Karat, Krishnaveni, Veena, Winder",
apa0100-0653.cermine.xml,apa0100-0653.nxml,author_surnames,levenshtein,set,0,0,1,0,"Barker, Fall, Hill, Karat, Krishnaveni, Veena, Winder",
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_author_surname,exact,string,0,0,1,0,Winder,
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_author_surname,levenshtein,string,0,0,1,0,Winder,
apa0100-0653.cermine.xml,apa0100-0653.nxml,author_full_names,exact,set,0,1,0,0,"Caroline HD Fall, Chitra LS Karat, David JP Barker, Ghattu V Krishnaveni, Jacqueline C Hill, Nicola R Winder, Sargoor R Veena","Caroline HD Fall, Chitra LS Karat, David JP Barker, Ghattu V Krishnaveni, Jacqueline C Hill, Nicola R Winder (nw@mrc.soton.ac.uk), Sargoor R Veena"
apa0100-0653.cermine.xml,apa0100-0653.nxml,author_full_names,levenshtein,set,0,1,0,0,"Caroline HD Fall, Chitra LS Karat, David JP Barker, Ghattu V Krishnaveni, Jacqueline C Hill, Nicola R Winder, Sargoor R Veena","Caroline HD Fall, Chitra LS Karat, David JP Barker, Ghattu V Krishnaveni, Jacqueline C Hill, Nicola R Winder (nw@mrc.soton.ac.uk), Sargoor R Veena"
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_author_full_name,exact,string,0,1,0,0,Nicola R Winder,Nicola R Winder (nw@mrc.soton.ac.uk)
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_author_full_name,levenshtein,string,0,1,0,0,Nicola R Winder,Nicola R Winder (nw@mrc.soton.ac.uk)
apa0100-0653.cermine.xml,apa0100-0653.nxml,affiliation_strings,exact,set,0,1,0,0,"Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore 570021, India, MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK","1.MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK 2.Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore 570021, India"
apa0100-0653.cermine.xml,apa0100-0653.nxml,affiliation_strings,levenshtein,set,0,1,0,0,"Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore 570021, India, MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK","1.MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK 2.Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore 570021, India"
apa0100-0653.cermine.xml,apa0100-0653.nxml,affiliation_institution,exact,set,0,1,0,0,"Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton","1.MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK 2.Epidemiology Research Unit, CSI Holdsworth Memorial Hospital"
apa0100-0653.cermine.xml,apa0100-0653.nxml,affiliation_institution,levenshtein,set,0,1,0,0,"Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton","1.MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, UK 2.Epidemiology Research Unit, CSI Holdsworth Memorial Hospital"
apa0100-0653.cermine.xml,apa0100-0653.nxml,section_titles,exact,list,0,1,0,0,"Introduction, Methods, Postnatal follow-up, Analysis sample, Statistical methods, Results, Discussion, Boys, small placental surface, Girls, large placental surface, Girls, oval placental surface, Strengths and limitations of the study, Conclusion","INTRODUCTION, METHODS, Postnatal follow-up, Analysis sample, Statistical methods, RESULTS, DISCUSSION, Boys, small placental surface, Girls, large placental surface, Girls, oval placental surface, Strengths and limitations of the study, CONCLUSION, ACKNOWLEDGEMENTS"
apa0100-0653.cermine.xml,apa0100-0653.nxml,section_titles,levenshtein,list,0,1,0,0,"Introduction, Methods, Postnatal follow-up, Analysis sample, Statistical methods, Results, Discussion, Boys, small placental surface, Girls, large placental surface, Girls, oval placental surface, Strengths and limitations of the study, Conclusion","INTRODUCTION, METHODS, Postnatal follow-up, Analysis sample, Statistical methods, RESULTS, DISCUSSION, Boys, small placental surface, Girls, large placental surface, Girls, oval placental surface, Strengths and limitations of the study, CONCLUSION, ACKNOWLEDGEMENTS"
apa0100-0653.cermine.xml,apa0100-0653.nxml,tables,exact,table,0,0,1,0,"[[["""", ""n"", ""Mean/[%]"", ""(SD)"", """", """", """", """"], [""Mother""], [""Age (years)"", ""471"", ""23.5"", ""(4.0)"", """", """", """", """"], [""Height (cm) at 30 weeks gestation"", ""471"", ""154.3"", ""(5.2)"", """", """", """", """"], [""Weight (kg) at 30 weeks gestation"", ""471"", ""55.8"", ""(8.7)"", """", """", """", """"], [""Body mass index (BMI) (kg/m2) at 30 weeks gestation"", ""471"", ""23.4"", ""(3.5)"", """", """", """", """"], [""Parity""], [""0"", ""241"", ""[51.2]"", """", """", """", """", """"], [""1"", ""151"", ""[32.0]"", """", """", """", """", """"], [""2 or more"", ""79"", ""[16.8]"", """", """", """", """", """"]], [["""", ""Boys"", ""Girls"", """"], ["""", """", """", """"], ["""", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""p-value""], [""Placenta""], [""Length (cm)"", ""228"", ""19.6"", ""(2.1)"", ""243"", ""19.4"", ""(2.0)"", ""0.2""], [""Breadth (cm)"", ""228"", ""17.0"", ""(1.8)"", ""243"", ""17.0"", ""(1.8)"", ""0.995""], [""Weight (g)"", ""228"", ""410"", ""(81)"", ""243"", ""407"", ""(85)"", ""0.7""], [""Length\u2013breadth (cm)"", ""228"", ""2.6"", ""(1.8)"", ""243"", ""2.4"", ""(1.5)"", ""0.08""], [""Area (cm2)"", ""228"", ""263.5"", ""(50.1)"", ""243"", ""259.9"", ""(48.2)"", ""0.4""], [""Baby""], [""Gestational age (weeks)"", ""228"", ""39.2"", ""(1.6)"", ""243"", ""39.4"", ""(1.5)"", ""0.2""], [""Weight (g)"", ""228"", ""2898"", ""(467)"", ""243"", ""2804"", ""(387)"", ""0.02""], [""Crown-heel length (cm)"", ""228"", ""48.8"", ""(2.3)"", ""243"", ""48.2"", ""(2.1)"", ""0.004""], [""Head circumference (cm)"", ""228"", ""34.1"", ""(1.4)"", ""243"", ""33.5"", ""(1.2)"", ""<0.0001""], [""Children at 9.5 years""], [""Age (years)"", ""228"", ""9.4"", ""(0.1)"", ""243"", ""9.4"", ""(0.1)"", ""0.29""], [""Systolic B.P (mmHg)"", ""228"", ""102.0"", ""(8.3)"", ""243"", ""99.9"", ""(8.5)"", ""0.008""], [""Diastolic B.P (mmHg)"", ""228"", ""58.5"", ""(6.9)"", ""243"", ""58.0"", ""(6.6)"", ""0.3""], [""Height (cm)"", ""228"", ""131.3"", ""(5.5)"", ""243"", ""130.2"", ""(5.9)"", ""0.05""], [""Weight (kg)"", ""228"", ""25.3"", ""(4.4)"", ""243"", ""24.8"", ""(4.7)"", ""0.3""], [""BMI (kg/m2)"", ""228"", ""14.6"", ""(1.8)"", ""243"", ""14.5"", ""(1.9)"", ""0.8""]], [["""", ""Boys"", ""Girls""], ["""", """", """"], ["""", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)"", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)""], ["""", """", """", """", """"], [""Placenta"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)""], [""Breadth (cm)""], [""\u226416"", ""68"", ""102.9"", ""(8.9)"", ""68"", ""58.7"", ""(6.5)"", ""83"", ""100.6"", ""(8.4)"", ""83"", ""59.2"", ""(6.3)""], [""17"", ""53"", ""102.6"", ""(7.8)"", ""53"", ""58.9"", ""(7.7)"", ""50"", ""98.4"", ""(8.1)"", ""50"", ""56.1"", ""(7.2)""], [""18"", ""46"", ""100.3"", ""(8.5)"", ""46"", ""58.6"", ""(6.4)"", ""49"", ""98.5"", ""(9.0)"", ""49"", ""58.3"", ""(6.7)""], ["">18"", ""61"", ""101.6"", ""(8.0)"", ""61"", ""58.0"", ""(7.0)"", ""61"", ""101.4"", ""(8.5)"", ""61"", ""57.5"", ""(6.2)""], [""p for trend (unadjusted)"", ""228"", ""0.09"", """", ""228"", ""0.67"", """", ""243"", ""0.50"", """", ""243"", ""0.12"", """"], [""p for trend*"", ""228"", ""0.01"", """", ""228"", ""0.50"", """", ""243"", ""0.83"", """", ""243"", ""0.09"", """"], [""Length (cm)""], [""\u226418"", ""56"", ""101.8"", ""(8.4)"", ""56"", ""58.3"", ""(7.1)"", ""64"", ""99.1"", ""(8.2)"", ""64"", ""58.5"", ""(5.8)""], [""19.5"", ""51"", ""103.2"", ""(8.1)"", ""51"", ""59.4"", ""(5.9)"", ""68"", ""99.8"", ""(8.6)"", ""68"", ""58.7"", ""(8.0)""], [""21"", ""67"", ""101.5"", ""(8.1)"", ""67"", ""58.7"", ""(7.2)"", ""64"", ""99.7"", ""(9.1)"", ""64"", ""56.9"", ""(5.9)""], ["">21"", ""54"", ""101.6"", ""(8.9)"", ""54"", ""57.8"", ""(7.1)"", ""47"", ""101.4"", ""(8.3)"", ""47"", ""57.6"", ""(6.4)""], [""p for trend (unadjusted)"", ""228"", ""0.60"", """", ""228"", ""0.75"", """", ""243"", ""0.07"", """", ""243"", ""0.29"", """"], [""p for trend*"", ""228"", ""0.15"", """", ""228"", ""0.53"", """", ""243"", ""0.59"", """", ""243"", ""0.19"", """"], [""Weight (g)""], [""\u2264350"", ""56"", ""102.5"", ""(8.9)"", ""56"", ""58.5"", ""(7.6)"", ""58"", ""99.4"", ""(8.1)"", ""58"", ""58.6"", ""(7.4)""], [""400"", ""57"", ""101.1"", ""(7.6)"", ""57"", ""58.7"", ""(6.5)"", ""80"", ""99.6"", ""(8.5)"", ""80"", ""58.6"", ""(6.5)""], [""450"", ""58"", ""103.6"", ""(8.5)"", ""58"", ""59.4"", ""(6.6)"", ""44"", ""100.1"", ""(9.3)"", ""44"", ""57.9"", ""(5.6)""], ["">450"", ""57"", ""100.6"", ""(8.2)"", ""57"", ""57.5"", ""(6.8)"", ""61"", ""100.6"", ""(8.6)"", ""61"", ""56.6"", ""(6.6)""], [""p for trend (unadjusted)"", ""228"", ""0.15"", """", ""228"", ""0.24"", """", ""243"", ""0.80"", """", ""243"", ""0.02"", """"], [""p for trend*"", ""228"", ""0.01"", """", ""228"", ""0.12"", """", ""243"", ""0.24"", """", ""243"", ""0.01"", """"], [""Area (cm2)""], [""\u2264225"", ""50"", ""102.4"", ""(8.3)"", ""50"", ""59.2"", ""(7.5)"", ""59"", ""99.7"", ""(8.3)"", ""59"", ""58.9"", ""(5.8)""], [""260"", ""54"", ""102.8"", ""(9.0)"", ""54"", ""58.3"", ""(6.1)"", ""64"", ""99.3"", ""(8.6)"", ""64"", ""58.9"", ""(7.7)""], [""300"", ""74"", ""102.1"", ""(7.6)"", ""74"", ""58.8"", ""(7.1)"", ""67"", ""99.4"", ""(8.7)"", ""67"", ""56.5"", ""(6.3)""], ["">300"", ""50"", ""100.5"", ""(8.6)"", ""50"", ""57.7"", ""(6.8)"", ""53"", ""101.5"", ""(8.5)"", ""53"", ""57.6"", ""(6.2)""], [""p for trend (unadjusted)"", ""228"", ""0.22"", """", ""228"", ""0.70"", """", ""243"", ""0.18"", """", ""243"", ""0.14"", """"], [""p for trend*"", ""228"", ""0.03"", """", ""228"", ""0.49"", """", ""243"", ""0.86"", """", ""243"", ""0.10"", """"], [""Area/birth weight (cm2/kg)""], [""\u226480"", ""62"", ""102.9"", ""(8.9)"", ""62"", ""59.6"", ""(7.5)"", ""49"", ""99.2"", ""(8.5)"", ""49"", ""58.4"", ""(5.6)""], [""90"", ""51"", ""102.6"", ""(8.4)"", ""51"", ""57.9"", ""(7.3)"", ""50"", ""100.2"", ""(7.0)"", ""50"", ""58.3"", ""(6.5)""], [""100"", ""52"", ""101.9"", ""(7.9)"", ""52"", ""58.2"", ""(6.9)"", ""65"", ""98.2"", ""(9.3)"", ""65"", ""57.4"", ""(7.6)""], ["">100"", ""63"", ""100.6"", ""(8.0)"", ""63"", ""58.3"", ""(5.8)"", ""79"", ""101.6"", ""(8.6)"", ""79"", ""57.9"", ""(6.4)""], [""p for trend (unadjusted)"", ""228"", ""0.10"", """", ""228"", ""0.22"", """", ""243"", ""0.01"", """", ""243"", ""0.93"", """"], [""p for trend*"", ""228"", ""0.18"", """", ""228"", ""0.30"", """", ""243"", ""0.004"", """", ""243"", ""0.89"", """"]], [["""", ""Short mothers"", ""Tall mothers""], ["""", """", """"], ["""", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)"", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)""], ["""", """", """", """", """"], [""Placenta"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)""], [""Breadth (cm)""], [""\u226416"", ""49"", ""98.8"", ""(7.9)"", ""49"", ""58.7"", ""(6.5)"", ""34"", ""103.2"", ""(8.7)"", ""34"", ""60.0"", ""(5.9)""], [""17"", ""25"", ""98.1"", ""(8.4)"", ""25"", ""56.7"", ""(7.0)"", ""25"", ""98.7"", ""(7.9)"", ""25"", ""55.4"", ""(7.5)""], [""18"", ""22"", ""100.6"", ""(8.6)"", ""22"", ""59.2"", ""(7.8)"", ""27"", ""96.8"", ""(9.0)"", ""27"", ""57.4"", ""(5.6)""], ["">18"", ""32"", ""101.7"", ""(9.2)"", ""32"", ""57.8"", ""(6.2)"", ""29"", ""101.1"", ""(7.8)"", ""29"", ""57.3"", ""(6.4)""], [""p for trend (unadjusted)"", ""128"", ""0.049"", """", ""128"", ""0.91"", """", ""115"", ""0.25"", """", ""115"", ""0.03"", """"], [""p for trend*"", ""128"", ""0.11"", """", ""128"", ""0.83"", """", ""115"", ""0.09"", """", ""115"", ""0.02"", """"], [""Length (cm)""], [""\u226418"", ""39"", ""99.0"", ""(7.6)"", ""39"", ""58.5"", ""(5.9)"", ""25"", ""99.3"", ""(9.1)"", ""25"", ""58.5"", ""(5.7)""], [""19.5"", ""36"", ""99.0"", ""(9.4)"", ""36"", ""58.6"", ""(8.8)"", ""32"", ""100.8"", ""(7.6)"", ""32"", ""58.9"", ""(7.1)""], [""21"", ""27"", ""100.4"", ""(8.3)"", ""27"", ""56.0"", ""(5.2)"", ""37"", ""99.2"", ""(9.7)"", ""37"", ""57.5"", ""(6.3)""], ["">21"", ""26"", ""100.9"", ""(8.7)"", ""26"", ""59.3"", ""(5.8)"", ""21"", ""102.00"", ""(7.8)"", ""21"", ""55.4"", ""(6.5)""], [""p for trend (unadjusted)"", ""128"", ""0.17"", """", ""128"", ""0.90"", """", ""115"", ""0.24"", """", ""115"", ""0.07"", """"], [""p for trend*"", ""128"", ""0.37"", """", ""128"", ""0.58"", """", ""115"", ""0.83"", """", ""115"", ""0.02"", """"], [""Weight (g)""], [""\u2264350"", ""34"", ""100.9"", ""(9.0)"", ""34"", ""59.1"", ""(8.4)"", ""24"", ""97.3"", ""(6.2)"", ""24"", ""57.9"", ""(5.8)""], [""400"", ""51"", ""99.5"", ""(8.2)"", ""51"", ""59.1"", ""(6.1)"", ""29"", ""99.9"", ""(9.2)"", ""29"", ""57.6"", ""(7.0)""], [""450"", ""17"", ""97.0"", ""(6.8)"", ""17"", ""54.8"", ""(4.9)"", ""27"", ""102.1"", ""(10.2)"", ""27"", ""59.8"", ""(5.2)""], ["">450"", ""26"", ""100.3"", ""(9.4)"", ""26"", ""57.3"", ""(6.0)"", ""35"", ""100.9"", ""(8.2)"", ""35"", ""56.1"", ""(7.1)""], [""p for trend (unadjusted)"", ""128"", ""0.54"", """", ""128"", ""0.05"", """", ""115"", ""0.34"", """", ""115"", ""0.24"", """"], [""p for trend*"", ""128"", ""0.23"", """", ""128"", ""0.10"", """", ""115"", ""0.92"", """", ""115"", ""0.09"", """"], [""Area (cm2)""], [""\u2264225"", ""36"", ""98.6"", ""(7.5)"", ""36"", ""58.3"", ""(6.0)"", ""23"", ""101.6"", ""(9.3)"", ""23"", ""59.7"", ""(5.6)""], [""260"", ""35"", ""98.7"", ""(9.3)"", ""35"", ""58.7"", ""(8.1)"", ""29"", ""100.1"", ""(7.8)"", ""29"", ""59.2"", ""(7.3)""], [""300"", ""33"", ""99.9"", ""(8.0)"", ""33"", ""56.8"", ""(7.1)"", ""34"", ""98.8"", ""(9.4)"", ""34"", ""56.2"", ""(5.5)""], ["">300"", ""24"", ""102.4"", ""(9.1)"", ""24"", ""59.0"", ""(5.2)"", ""29"", ""100.8"", ""(8.2)"", ""29"", ""56.5"", ""(6.9)""], [""p for trend (unadjusted)"", ""128"", ""0.07"", """", ""128"", ""0.99"", """", ""115"", ""0.97"", """", ""115"", ""0.03"", """"], [""p for trend*"", ""128"", ""0.18"", """", ""128"", ""0.70"", """", ""115"", ""0.40"", """", ""115"", ""0.01"", """"], [""Area/birth weight (cm2/g)""], [""\u2264 80"", ""23"", ""97.2"", ""(6.8)"", ""23"", ""57.1"", ""(4.7)"", ""26"", ""100.9"", ""(9.6)"", ""26"", ""59.6"", ""(6.2)""], [""90"", ""26"", ""99.3"", ""(7.0)"", ""26"", ""58.4"", ""(6.5)"", ""24"", ""101.0"", ""(7.0)"", ""24"", ""58.1"", ""(6.7)""], [""100"", ""39"", ""98.9"", ""(9.4)"", ""39"", ""57.9"", ""(8.1)"", ""26"", ""97.1"", ""(9.1)"", ""26"", ""56.7"", ""(7.0)""], ["">100"", ""40"", ""102.0"", ""(9.0)"", ""40"", ""58.8"", ""(6.7)"", ""39"", ""101.2"", ""(8.4)"", ""39"", ""56.9"", ""(6.1)""], [""p for trend (unadjusted)"", ""128"", ""0.0003"", """", ""128"", ""0.06"", """", ""115"", ""0.83"", """", ""115"", ""0.07"", """"], [""p for trend*"", ""128"", ""0.0002"", """", ""128"", ""0.0499"", """", ""115"", ""0.68"", """", ""115"", ""0.08"", """"]]]",
apa0100-0653.cermine.xml,apa0100-0653.nxml,tables,levenshtein,table,0,0,1,0,"[[["""", ""n"", ""Mean/[%]"", ""(SD)"", """", """", """", """"], [""Mother""], [""Age (years)"", ""471"", ""23.5"", ""(4.0)"", """", """", """", """"], [""Height (cm) at 30 weeks gestation"", ""471"", ""154.3"", ""(5.2)"", """", """", """", """"], [""Weight (kg) at 30 weeks gestation"", ""471"", ""55.8"", ""(8.7)"", """", """", """", """"], [""Body mass index (BMI) (kg/m2) at 30 weeks gestation"", ""471"", ""23.4"", ""(3.5)"", """", """", """", """"], [""Parity""], [""0"", ""241"", ""[51.2]"", """", """", """", """", """"], [""1"", ""151"", ""[32.0]"", """", """", """", """", """"], [""2 or more"", ""79"", ""[16.8]"", """", """", """", """", """"]], [["""", ""Boys"", ""Girls"", """"], ["""", """", """", """"], ["""", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""p-value""], [""Placenta""], [""Length (cm)"", ""228"", ""19.6"", ""(2.1)"", ""243"", ""19.4"", ""(2.0)"", ""0.2""], [""Breadth (cm)"", ""228"", ""17.0"", ""(1.8)"", ""243"", ""17.0"", ""(1.8)"", ""0.995""], [""Weight (g)"", ""228"", ""410"", ""(81)"", ""243"", ""407"", ""(85)"", ""0.7""], [""Length\u2013breadth (cm)"", ""228"", ""2.6"", ""(1.8)"", ""243"", ""2.4"", ""(1.5)"", ""0.08""], [""Area (cm2)"", ""228"", ""263.5"", ""(50.1)"", ""243"", ""259.9"", ""(48.2)"", ""0.4""], [""Baby""], [""Gestational age (weeks)"", ""228"", ""39.2"", ""(1.6)"", ""243"", ""39.4"", ""(1.5)"", ""0.2""], [""Weight (g)"", ""228"", ""2898"", ""(467)"", ""243"", ""2804"", ""(387)"", ""0.02""], [""Crown-heel length (cm)"", ""228"", ""48.8"", ""(2.3)"", ""243"", ""48.2"", ""(2.1)"", ""0.004""], [""Head circumference (cm)"", ""228"", ""34.1"", ""(1.4)"", ""243"", ""33.5"", ""(1.2)"", ""<0.0001""], [""Children at 9.5 years""], [""Age (years)"", ""228"", ""9.4"", ""(0.1)"", ""243"", ""9.4"", ""(0.1)"", ""0.29""], [""Systolic B.P (mmHg)"", ""228"", ""102.0"", ""(8.3)"", ""243"", ""99.9"", ""(8.5)"", ""0.008""], [""Diastolic B.P (mmHg)"", ""228"", ""58.5"", ""(6.9)"", ""243"", ""58.0"", ""(6.6)"", ""0.3""], [""Height (cm)"", ""228"", ""131.3"", ""(5.5)"", ""243"", ""130.2"", ""(5.9)"", ""0.05""], [""Weight (kg)"", ""228"", ""25.3"", ""(4.4)"", ""243"", ""24.8"", ""(4.7)"", ""0.3""], [""BMI (kg/m2)"", ""228"", ""14.6"", ""(1.8)"", ""243"", ""14.5"", ""(1.9)"", ""0.8""]], [["""", ""Boys"", ""Girls""], ["""", """", """"], ["""", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)"", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)""], ["""", """", """", """", """"], [""Placenta"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)""], [""Breadth (cm)""], [""\u226416"", ""68"", ""102.9"", ""(8.9)"", ""68"", ""58.7"", ""(6.5)"", ""83"", ""100.6"", ""(8.4)"", ""83"", ""59.2"", ""(6.3)""], [""17"", ""53"", ""102.6"", ""(7.8)"", ""53"", ""58.9"", ""(7.7)"", ""50"", ""98.4"", ""(8.1)"", ""50"", ""56.1"", ""(7.2)""], [""18"", ""46"", ""100.3"", ""(8.5)"", ""46"", ""58.6"", ""(6.4)"", ""49"", ""98.5"", ""(9.0)"", ""49"", ""58.3"", ""(6.7)""], ["">18"", ""61"", ""101.6"", ""(8.0)"", ""61"", ""58.0"", ""(7.0)"", ""61"", ""101.4"", ""(8.5)"", ""61"", ""57.5"", ""(6.2)""], [""p for trend (unadjusted)"", ""228"", ""0.09"", """", ""228"", ""0.67"", """", ""243"", ""0.50"", """", ""243"", ""0.12"", """"], [""p for trend*"", ""228"", ""0.01"", """", ""228"", ""0.50"", """", ""243"", ""0.83"", """", ""243"", ""0.09"", """"], [""Length (cm)""], [""\u226418"", ""56"", ""101.8"", ""(8.4)"", ""56"", ""58.3"", ""(7.1)"", ""64"", ""99.1"", ""(8.2)"", ""64"", ""58.5"", ""(5.8)""], [""19.5"", ""51"", ""103.2"", ""(8.1)"", ""51"", ""59.4"", ""(5.9)"", ""68"", ""99.8"", ""(8.6)"", ""68"", ""58.7"", ""(8.0)""], [""21"", ""67"", ""101.5"", ""(8.1)"", ""67"", ""58.7"", ""(7.2)"", ""64"", ""99.7"", ""(9.1)"", ""64"", ""56.9"", ""(5.9)""], ["">21"", ""54"", ""101.6"", ""(8.9)"", ""54"", ""57.8"", ""(7.1)"", ""47"", ""101.4"", ""(8.3)"", ""47"", ""57.6"", ""(6.4)""], [""p for trend (unadjusted)"", ""228"", ""0.60"", """", ""228"", ""0.75"", """", ""243"", ""0.07"", """", ""243"", ""0.29"", """"], [""p for trend*"", ""228"", ""0.15"", """", ""228"", ""0.53"", """", ""243"", ""0.59"", """", ""243"", ""0.19"", """"], [""Weight (g)""], [""\u2264350"", ""56"", ""102.5"", ""(8.9)"", ""56"", ""58.5"", ""(7.6)"", ""58"", ""99.4"", ""(8.1)"", ""58"", ""58.6"", ""(7.4)""], [""400"", ""57"", ""101.1"", ""(7.6)"", ""57"", ""58.7"", ""(6.5)"", ""80"", ""99.6"", ""(8.5)"", ""80"", ""58.6"", ""(6.5)""], [""450"", ""58"", ""103.6"", ""(8.5)"", ""58"", ""59.4"", ""(6.6)"", ""44"", ""100.1"", ""(9.3)"", ""44"", ""57.9"", ""(5.6)""], ["">450"", ""57"", ""100.6"", ""(8.2)"", ""57"", ""57.5"", ""(6.8)"", ""61"", ""100.6"", ""(8.6)"", ""61"", ""56.6"", ""(6.6)""], [""p for trend (unadjusted)"", ""228"", ""0.15"", """", ""228"", ""0.24"", """", ""243"", ""0.80"", """", ""243"", ""0.02"", """"], [""p for trend*"", ""228"", ""0.01"", """", ""228"", ""0.12"", """", ""243"", ""0.24"", """", ""243"", ""0.01"", """"], [""Area (cm2)""], [""\u2264225"", ""50"", ""102.4"", ""(8.3)"", ""50"", ""59.2"", ""(7.5)"", ""59"", ""99.7"", ""(8.3)"", ""59"", ""58.9"", ""(5.8)""], [""260"", ""54"", ""102.8"", ""(9.0)"", ""54"", ""58.3"", ""(6.1)"", ""64"", ""99.3"", ""(8.6)"", ""64"", ""58.9"", ""(7.7)""], [""300"", ""74"", ""102.1"", ""(7.6)"", ""74"", ""58.8"", ""(7.1)"", ""67"", ""99.4"", ""(8.7)"", ""67"", ""56.5"", ""(6.3)""], ["">300"", ""50"", ""100.5"", ""(8.6)"", ""50"", ""57.7"", ""(6.8)"", ""53"", ""101.5"", ""(8.5)"", ""53"", ""57.6"", ""(6.2)""], [""p for trend (unadjusted)"", ""228"", ""0.22"", """", ""228"", ""0.70"", """", ""243"", ""0.18"", """", ""243"", ""0.14"", """"], [""p for trend*"", ""228"", ""0.03"", """", ""228"", ""0.49"", """", ""243"", ""0.86"", """", ""243"", ""0.10"", """"], [""Area/birth weight (cm2/kg)""], [""\u226480"", ""62"", ""102.9"", ""(8.9)"", ""62"", ""59.6"", ""(7.5)"", ""49"", ""99.2"", ""(8.5)"", ""49"", ""58.4"", ""(5.6)""], [""90"", ""51"", ""102.6"", ""(8.4)"", ""51"", ""57.9"", ""(7.3)"", ""50"", ""100.2"", ""(7.0)"", ""50"", ""58.3"", ""(6.5)""], [""100"", ""52"", ""101.9"", ""(7.9)"", ""52"", ""58.2"", ""(6.9)"", ""65"", ""98.2"", ""(9.3)"", ""65"", ""57.4"", ""(7.6)""], ["">100"", ""63"", ""100.6"", ""(8.0)"", ""63"", ""58.3"", ""(5.8)"", ""79"", ""101.6"", ""(8.6)"", ""79"", ""57.9"", ""(6.4)""], [""p for trend (unadjusted)"", ""228"", ""0.10"", """", ""228"", ""0.22"", """", ""243"", ""0.01"", """", ""243"", ""0.93"", """"], [""p for trend*"", ""228"", ""0.18"", """", ""228"", ""0.30"", """", ""243"", ""0.004"", """", ""243"", ""0.89"", """"]], [["""", ""Short mothers"", ""Tall mothers""], ["""", """", """"], ["""", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)"", ""Systolic blood pressure (mmHg)"", ""Diastolic blood pressure (mmHg)""], ["""", """", """", """", """"], [""Placenta"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)"", ""n"", ""Mean"", ""(SD)""], [""Breadth (cm)""], [""\u226416"", ""49"", ""98.8"", ""(7.9)"", ""49"", ""58.7"", ""(6.5)"", ""34"", ""103.2"", ""(8.7)"", ""34"", ""60.0"", ""(5.9)""], [""17"", ""25"", ""98.1"", ""(8.4)"", ""25"", ""56.7"", ""(7.0)"", ""25"", ""98.7"", ""(7.9)"", ""25"", ""55.4"", ""(7.5)""], [""18"", ""22"", ""100.6"", ""(8.6)"", ""22"", ""59.2"", ""(7.8)"", ""27"", ""96.8"", ""(9.0)"", ""27"", ""57.4"", ""(5.6)""], ["">18"", ""32"", ""101.7"", ""(9.2)"", ""32"", ""57.8"", ""(6.2)"", ""29"", ""101.1"", ""(7.8)"", ""29"", ""57.3"", ""(6.4)""], [""p for trend (unadjusted)"", ""128"", ""0.049"", """", ""128"", ""0.91"", """", ""115"", ""0.25"", """", ""115"", ""0.03"", """"], [""p for trend*"", ""128"", ""0.11"", """", ""128"", ""0.83"", """", ""115"", ""0.09"", """", ""115"", ""0.02"", """"], [""Length (cm)""], [""\u226418"", ""39"", ""99.0"", ""(7.6)"", ""39"", ""58.5"", ""(5.9)"", ""25"", ""99.3"", ""(9.1)"", ""25"", ""58.5"", ""(5.7)""], [""19.5"", ""36"", ""99.0"", ""(9.4)"", ""36"", ""58.6"", ""(8.8)"", ""32"", ""100.8"", ""(7.6)"", ""32"", ""58.9"", ""(7.1)""], [""21"", ""27"", ""100.4"", ""(8.3)"", ""27"", ""56.0"", ""(5.2)"", ""37"", ""99.2"", ""(9.7)"", ""37"", ""57.5"", ""(6.3)""], ["">21"", ""26"", ""100.9"", ""(8.7)"", ""26"", ""59.3"", ""(5.8)"", ""21"", ""102.00"", ""(7.8)"", ""21"", ""55.4"", ""(6.5)""], [""p for trend (unadjusted)"", ""128"", ""0.17"", """", ""128"", ""0.90"", """", ""115"", ""0.24"", """", ""115"", ""0.07"", """"], [""p for trend*"", ""128"", ""0.37"", """", ""128"", ""0.58"", """", ""115"", ""0.83"", """", ""115"", ""0.02"", """"], [""Weight (g)""], [""\u2264350"", ""34"", ""100.9"", ""(9.0)"", ""34"", ""59.1"", ""(8.4)"", ""24"", ""97.3"", ""(6.2)"", ""24"", ""57.9"", ""(5.8)""], [""400"", ""51"", ""99.5"", ""(8.2)"", ""51"", ""59.1"", ""(6.1)"", ""29"", ""99.9"", ""(9.2)"", ""29"", ""57.6"", ""(7.0)""], [""450"", ""17"", ""97.0"", ""(6.8)"", ""17"", ""54.8"", ""(4.9)"", ""27"", ""102.1"", ""(10.2)"", ""27"", ""59.8"", ""(5.2)""], ["">450"", ""26"", ""100.3"", ""(9.4)"", ""26"", ""57.3"", ""(6.0)"", ""35"", ""100.9"", ""(8.2)"", ""35"", ""56.1"", ""(7.1)""], [""p for trend (unadjusted)"", ""128"", ""0.54"", """", ""128"", ""0.05"", """", ""115"", ""0.34"", """", ""115"", ""0.24"", """"], [""p for trend*"", ""128"", ""0.23"", """", ""128"", ""0.10"", """", ""115"", ""0.92"", """", ""115"", ""0.09"", """"], [""Area (cm2)""], [""\u2264225"", ""36"", ""98.6"", ""(7.5)"", ""36"", ""58.3"", ""(6.0)"", ""23"", ""101.6"", ""(9.3)"", ""23"", ""59.7"", ""(5.6)""], [""260"", ""35"", ""98.7"", ""(9.3)"", ""35"", ""58.7"", ""(8.1)"", ""29"", ""100.1"", ""(7.8)"", ""29"", ""59.2"", ""(7.3)""], [""300"", ""33"", ""99.9"", ""(8.0)"", ""33"", ""56.8"", ""(7.1)"", ""34"", ""98.8"", ""(9.4)"", ""34"", ""56.2"", ""(5.5)""], ["">300"", ""24"", ""102.4"", ""(9.1)"", ""24"", ""59.0"", ""(5.2)"", ""29"", ""100.8"", ""(8.2)"", ""29"", ""56.5"", ""(6.9)""], [""p for trend (unadjusted)"", ""128"", ""0.07"", """", ""128"", ""0.99"", """", ""115"", ""0.97"", """", ""115"", ""0.03"", """"], [""p for trend*"", ""128"", ""0.18"", """", ""128"", ""0.70"", """", ""115"", ""0.40"", """", ""115"", ""0.01"", """"], [""Area/birth weight (cm2/g)""], [""\u2264 80"", ""23"", ""97.2"", ""(6.8)"", ""23"", ""57.1"", ""(4.7)"", ""26"", ""100.9"", ""(9.6)"", ""26"", ""59.6"", ""(6.2)""], [""90"", ""26"", ""99.3"", ""(7.0)"", ""26"", ""58.4"", ""(6.5)"", ""24"", ""101.0"", ""(7.0)"", ""24"", ""58.1"", ""(6.7)""], [""100"", ""39"", ""98.9"", ""(9.4)"", ""39"", ""57.9"", ""(8.1)"", ""26"", ""97.1"", ""(9.1)"", ""26"", ""56.7"", ""(7.0)""], ["">100"", ""40"", ""102.0"", ""(9.0)"", ""40"", ""58.8"", ""(6.7)"", ""39"", ""101.2"", ""(8.4)"", ""39"", ""56.9"", ""(6.1)""], [""p for trend (unadjusted)"", ""128"", ""0.0003"", """", ""128"", ""0.06"", """", ""115"", ""0.83"", """", ""115"", ""0.07"", """"], [""p for trend*"", ""128"", ""0.0002"", """", ""128"", ""0.0499"", """", ""115"", ""0.68"", """", ""115"", ""0.08"", """"]]]",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_strings,exact,list,0,0,1,0,"n Mean/[%] (SD) Mother  Age (years) 471 23.5 (4.0)  Height (cm) at 30 weeks gestation 471 154.3 (5.2)  Weight (kg) at 30 weeks gestation 471 55.8 (8.7)  Body mass index (BMI) (kg/m2) at 30 weeks gestation 471 23.4 (3.5) Parity  0 241 [51.2]  1 151 [32.0]  2 or more 79 [16.8], Boys Girls n Mean (SD) n Mean (SD) p-value Placenta  Length (cm) 228 19.6 (2.1) 243 19.4 (2.0) 0.2  Breadth (cm) 228 17.0 (1.8) 243 17.0 (1.8) 0.995  Weight (g) 228 410 (81) 243 407 (85) 0.7  Length–breadth (cm) 228 2.6 (1.8) 243 2.4 (1.5) 0.08  Area (cm2) 228 263.5 (50.1) 243 259.9 (48.2) 0.4 Baby  Gestational age (weeks) 228 39.2 (1.6) 243 39.4 (1.5) 0.2  Weight (g) 228 2898 (467) 243 2804 (387) 0.02  Crown-heel length (cm) 228 48.8 (2.3) 243 48.2 (2.1) 0.004  Head circumference (cm) 228 34.1 (1.4) 243 33.5 (1.2) <0.0001 Children at 9.5 years  Age (years) 228 9.4 (0.1) 243 9.4 (0.1) 0.29  Systolic B.P (mmHg) 228 102.0 (8.3) 243 99.9 (8.5) 0.008  Diastolic B.P (mmHg) 228 58.5 (6.9) 243 58.0 (6.6) 0.3  Height (cm) 228 131.3 (5.5) 243 130.2 (5.9) 0.05  Weight (kg) 228 25.3 (4.4) 243 24.8 (4.7) 0.3  BMI (kg/m2) 228 14.6 (1.8) 243 14.5 (1.9) 0.8, Boys Girls Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Placenta n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) Breadth (cm)  ≤16 68 102.9 (8.9) 68 58.7 (6.5) 83 100.6 (8.4) 83 59.2 (6.3)  17 53 102.6 (7.8) 53 58.9 (7.7) 50 98.4 (8.1) 50 56.1 (7.2)  18 46 100.3 (8.5) 46 58.6 (6.4) 49 98.5 (9.0) 49 58.3 (6.7)  >18 61 101.6 (8.0) 61 58.0 (7.0) 61 101.4 (8.5) 61 57.5 (6.2) p for trend (unadjusted) 228 0.09 228 0.67 243 0.50 243 0.12 p for trend* 228 0.01 228 0.50 243 0.83 243 0.09 Length (cm)  ≤18 56 101.8 (8.4) 56 58.3 (7.1) 64 99.1 (8.2) 64 58.5 (5.8)  19.5 51 103.2 (8.1) 51 59.4 (5.9) 68 99.8 (8.6) 68 58.7 (8.0)  21 67 101.5 (8.1) 67 58.7 (7.2) 64 99.7 (9.1) 64 56.9 (5.9)  >21 54 101.6 (8.9) 54 57.8 (7.1) 47 101.4 (8.3) 47 57.6 (6.4) p for trend (unadjusted) 228 0.60 228 0.75 243 0.07 243 0.29 p for trend* 228 0.15 228 0.53 243 0.59 243 0.19 Weight (g)  ≤350 56 102.5 (8.9) 56 58.5 (7.6) 58 99.4 (8.1) 58 58.6 (7.4)  400 57 101.1 (7.6) 57 58.7 (6.5) 80 99.6 (8.5) 80 58.6 (6.5)  450 58 103.6 (8.5) 58 59.4 (6.6) 44 100.1 (9.3) 44 57.9 (5.6)  >450 57 100.6 (8.2) 57 57.5 (6.8) 61 100.6 (8.6) 61 56.6 (6.6) p for trend (unadjusted) 228 0.15 228 0.24 243 0.80 243 0.02 p for trend* 228 0.01 228 0.12 243 0.24 243 0.01 Area (cm2)  ≤225 50 102.4 (8.3) 50 59.2 (7.5) 59 99.7 (8.3) 59 58.9 (5.8)  260 54 102.8 (9.0) 54 58.3 (6.1) 64 99.3 (8.6) 64 58.9 (7.7)  300 74 102.1 (7.6) 74 58.8 (7.1) 67 99.4 (8.7) 67 56.5 (6.3)  >300 50 100.5 (8.6) 50 57.7 (6.8) 53 101.5 (8.5) 53 57.6 (6.2) p for trend (unadjusted) 228 0.22 228 0.70 243 0.18 243 0.14 p for trend* 228 0.03 228 0.49 243 0.86 243 0.10 Area/birth weight (cm2/kg)  ≤80 62 102.9 (8.9) 62 59.6 (7.5) 49 99.2 (8.5) 49 58.4 (5.6)  90 51 102.6 (8.4) 51 57.9 (7.3) 50 100.2 (7.0) 50 58.3 (6.5)  100 52 101.9 (7.9) 52 58.2 (6.9) 65 98.2 (9.3) 65 57.4 (7.6)  >100 63 100.6 (8.0) 63 58.3 (5.8) 79 101.6 (8.6) 79 57.9 (6.4) p for trend (unadjusted) 228 0.10 228 0.22 243 0.01 243 0.93 p for trend* 228 0.18 228 0.30 243 0.004 243 0.89, Short mothers Tall mothers Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Placenta n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) Breadth (cm)  ≤16 49 98.8 (7.9) 49 58.7 (6.5) 34 103.2 (8.7) 34 60.0 (5.9)  17 25 98.1 (8.4) 25 56.7 (7.0) 25 98.7 (7.9) 25 55.4 (7.5)  18 22 100.6 (8.6) 22 59.2 (7.8) 27 96.8 (9.0) 27 57.4 (5.6)  >18 32 101.7 (9.2) 32 57.8 (6.2) 29 101.1 (7.8) 29 57.3 (6.4) p for trend (unadjusted) 128 0.049 128 0.91 115 0.25 115 0.03 p for trend* 128 0.11 128 0.83 115 0.09 115 0.02 Length (cm)  ≤18 39 99.0 (7.6) 39 58.5 (5.9) 25 99.3 (9.1) 25 58.5 (5.7)  19.5 36 99.0 (9.4) 36 58.6 (8.8) 32 100.8 (7.6) 32 58.9 (7.1)  21 27 100.4 (8.3) 27 56.0 (5.2) 37 99.2 (9.7) 37 57.5 (6.3)  >21 26 100.9 (8.7) 26 59.3 (5.8) 21 102.00 (7.8) 21 55.4 (6.5) p for trend (unadjusted) 128 0.17 128 0.90 115 0.24 115 0.07 p for trend* 128 0.37 128 0.58 115 0.83 115 0.02 Weight (g)  ≤350 34 100.9 (9.0) 34 59.1 (8.4) 24 97.3 (6.2) 24 57.9 (5.8)  400 51 99.5 (8.2) 51 59.1 (6.1) 29 99.9 (9.2) 29 57.6 (7.0)  450 17 97.0 (6.8) 17 54.8 (4.9) 27 102.1 (10.2) 27 59.8 (5.2)  >450 26 100.3 (9.4) 26 57.3 (6.0) 35 100.9 (8.2) 35 56.1 (7.1) p for trend (unadjusted) 128 0.54 128 0.05 115 0.34 115 0.24 p for trend* 128 0.23 128 0.10 115 0.92 115 0.09 Area (cm2)  ≤225 36 98.6 (7.5) 36 58.3 (6.0) 23 101.6 (9.3) 23 59.7 (5.6)  260 35 98.7 (9.3) 35 58.7 (8.1) 29 100.1 (7.8) 29 59.2 (7.3)  300 33 99.9 (8.0) 33 56.8 (7.1) 34 98.8 (9.4) 34 56.2 (5.5)  >300 24 102.4 (9.1) 24 59.0 (5.2) 29 100.8 (8.2) 29 56.5 (6.9) p for trend (unadjusted) 128 0.07 128 0.99 115 0.97 115 0.03 p for trend* 128 0.18 128 0.70 115 0.40 115 0.01 Area/birth weight (cm2/g)  ≤ 80 23 97.2 (6.8) 23 57.1 (4.7) 26 100.9 (9.6) 26 59.6 (6.2)  90 26 99.3 (7.0) 26 58.4 (6.5) 24 101.0 (7.0) 24 58.1 (6.7)  100 39 98.9 (9.4) 39 57.9 (8.1) 26 97.1 (9.1) 26 56.7 (7.0)  >100 40 102.0 (9.0) 40 58.8 (6.7) 39 101.2 (8.4) 39 56.9 (6.1) p for trend (unadjusted) 128 0.0003 128 0.06 115 0.83 115 0.07 p for trend* 128 0.0002 128 0.0499 115 0.68 115 0.08",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_strings,levenshtein,list,0,0,1,0,"n Mean/[%] (SD) Mother  Age (years) 471 23.5 (4.0)  Height (cm) at 30 weeks gestation 471 154.3 (5.2)  Weight (kg) at 30 weeks gestation 471 55.8 (8.7)  Body mass index (BMI) (kg/m2) at 30 weeks gestation 471 23.4 (3.5) Parity  0 241 [51.2]  1 151 [32.0]  2 or more 79 [16.8], Boys Girls n Mean (SD) n Mean (SD) p-value Placenta  Length (cm) 228 19.6 (2.1) 243 19.4 (2.0) 0.2  Breadth (cm) 228 17.0 (1.8) 243 17.0 (1.8) 0.995  Weight (g) 228 410 (81) 243 407 (85) 0.7  Length–breadth (cm) 228 2.6 (1.8) 243 2.4 (1.5) 0.08  Area (cm2) 228 263.5 (50.1) 243 259.9 (48.2) 0.4 Baby  Gestational age (weeks) 228 39.2 (1.6) 243 39.4 (1.5) 0.2  Weight (g) 228 2898 (467) 243 2804 (387) 0.02  Crown-heel length (cm) 228 48.8 (2.3) 243 48.2 (2.1) 0.004  Head circumference (cm) 228 34.1 (1.4) 243 33.5 (1.2) <0.0001 Children at 9.5 years  Age (years) 228 9.4 (0.1) 243 9.4 (0.1) 0.29  Systolic B.P (mmHg) 228 102.0 (8.3) 243 99.9 (8.5) 0.008  Diastolic B.P (mmHg) 228 58.5 (6.9) 243 58.0 (6.6) 0.3  Height (cm) 228 131.3 (5.5) 243 130.2 (5.9) 0.05  Weight (kg) 228 25.3 (4.4) 243 24.8 (4.7) 0.3  BMI (kg/m2) 228 14.6 (1.8) 243 14.5 (1.9) 0.8, Boys Girls Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Placenta n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) Breadth (cm)  ≤16 68 102.9 (8.9) 68 58.7 (6.5) 83 100.6 (8.4) 83 59.2 (6.3)  17 53 102.6 (7.8) 53 58.9 (7.7) 50 98.4 (8.1) 50 56.1 (7.2)  18 46 100.3 (8.5) 46 58.6 (6.4) 49 98.5 (9.0) 49 58.3 (6.7)  >18 61 101.6 (8.0) 61 58.0 (7.0) 61 101.4 (8.5) 61 57.5 (6.2) p for trend (unadjusted) 228 0.09 228 0.67 243 0.50 243 0.12 p for trend* 228 0.01 228 0.50 243 0.83 243 0.09 Length (cm)  ≤18 56 101.8 (8.4) 56 58.3 (7.1) 64 99.1 (8.2) 64 58.5 (5.8)  19.5 51 103.2 (8.1) 51 59.4 (5.9) 68 99.8 (8.6) 68 58.7 (8.0)  21 67 101.5 (8.1) 67 58.7 (7.2) 64 99.7 (9.1) 64 56.9 (5.9)  >21 54 101.6 (8.9) 54 57.8 (7.1) 47 101.4 (8.3) 47 57.6 (6.4) p for trend (unadjusted) 228 0.60 228 0.75 243 0.07 243 0.29 p for trend* 228 0.15 228 0.53 243 0.59 243 0.19 Weight (g)  ≤350 56 102.5 (8.9) 56 58.5 (7.6) 58 99.4 (8.1) 58 58.6 (7.4)  400 57 101.1 (7.6) 57 58.7 (6.5) 80 99.6 (8.5) 80 58.6 (6.5)  450 58 103.6 (8.5) 58 59.4 (6.6) 44 100.1 (9.3) 44 57.9 (5.6)  >450 57 100.6 (8.2) 57 57.5 (6.8) 61 100.6 (8.6) 61 56.6 (6.6) p for trend (unadjusted) 228 0.15 228 0.24 243 0.80 243 0.02 p for trend* 228 0.01 228 0.12 243 0.24 243 0.01 Area (cm2)  ≤225 50 102.4 (8.3) 50 59.2 (7.5) 59 99.7 (8.3) 59 58.9 (5.8)  260 54 102.8 (9.0) 54 58.3 (6.1) 64 99.3 (8.6) 64 58.9 (7.7)  300 74 102.1 (7.6) 74 58.8 (7.1) 67 99.4 (8.7) 67 56.5 (6.3)  >300 50 100.5 (8.6) 50 57.7 (6.8) 53 101.5 (8.5) 53 57.6 (6.2) p for trend (unadjusted) 228 0.22 228 0.70 243 0.18 243 0.14 p for trend* 228 0.03 228 0.49 243 0.86 243 0.10 Area/birth weight (cm2/kg)  ≤80 62 102.9 (8.9) 62 59.6 (7.5) 49 99.2 (8.5) 49 58.4 (5.6)  90 51 102.6 (8.4) 51 57.9 (7.3) 50 100.2 (7.0) 50 58.3 (6.5)  100 52 101.9 (7.9) 52 58.2 (6.9) 65 98.2 (9.3) 65 57.4 (7.6)  >100 63 100.6 (8.0) 63 58.3 (5.8) 79 101.6 (8.6) 79 57.9 (6.4) p for trend (unadjusted) 228 0.10 228 0.22 243 0.01 243 0.93 p for trend* 228 0.18 228 0.30 243 0.004 243 0.89, Short mothers Tall mothers Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Systolic blood pressure (mmHg) Diastolic blood pressure (mmHg) Placenta n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) Breadth (cm)  ≤16 49 98.8 (7.9) 49 58.7 (6.5) 34 103.2 (8.7) 34 60.0 (5.9)  17 25 98.1 (8.4) 25 56.7 (7.0) 25 98.7 (7.9) 25 55.4 (7.5)  18 22 100.6 (8.6) 22 59.2 (7.8) 27 96.8 (9.0) 27 57.4 (5.6)  >18 32 101.7 (9.2) 32 57.8 (6.2) 29 101.1 (7.8) 29 57.3 (6.4) p for trend (unadjusted) 128 0.049 128 0.91 115 0.25 115 0.03 p for trend* 128 0.11 128 0.83 115 0.09 115 0.02 Length (cm)  ≤18 39 99.0 (7.6) 39 58.5 (5.9) 25 99.3 (9.1) 25 58.5 (5.7)  19.5 36 99.0 (9.4) 36 58.6 (8.8) 32 100.8 (7.6) 32 58.9 (7.1)  21 27 100.4 (8.3) 27 56.0 (5.2) 37 99.2 (9.7) 37 57.5 (6.3)  >21 26 100.9 (8.7) 26 59.3 (5.8) 21 102.00 (7.8) 21 55.4 (6.5) p for trend (unadjusted) 128 0.17 128 0.90 115 0.24 115 0.07 p for trend* 128 0.37 128 0.58 115 0.83 115 0.02 Weight (g)  ≤350 34 100.9 (9.0) 34 59.1 (8.4) 24 97.3 (6.2) 24 57.9 (5.8)  400 51 99.5 (8.2) 51 59.1 (6.1) 29 99.9 (9.2) 29 57.6 (7.0)  450 17 97.0 (6.8) 17 54.8 (4.9) 27 102.1 (10.2) 27 59.8 (5.2)  >450 26 100.3 (9.4) 26 57.3 (6.0) 35 100.9 (8.2) 35 56.1 (7.1) p for trend (unadjusted) 128 0.54 128 0.05 115 0.34 115 0.24 p for trend* 128 0.23 128 0.10 115 0.92 115 0.09 Area (cm2)  ≤225 36 98.6 (7.5) 36 58.3 (6.0) 23 101.6 (9.3) 23 59.7 (5.6)  260 35 98.7 (9.3) 35 58.7 (8.1) 29 100.1 (7.8) 29 59.2 (7.3)  300 33 99.9 (8.0) 33 56.8 (7.1) 34 98.8 (9.4) 34 56.2 (5.5)  >300 24 102.4 (9.1) 24 59.0 (5.2) 29 100.8 (8.2) 29 56.5 (6.9) p for trend (unadjusted) 128 0.07 128 0.99 115 0.97 115 0.03 p for trend* 128 0.18 128 0.70 115 0.40 115 0.01 Area/birth weight (cm2/g)  ≤ 80 23 97.2 (6.8) 23 57.1 (4.7) 26 100.9 (9.6) 26 59.6 (6.2)  90 26 99.3 (7.0) 26 58.4 (6.5) 24 101.0 (7.0) 24 58.1 (6.7)  100 39 98.9 (9.4) 39 57.9 (8.1) 26 97.1 (9.1) 26 56.7 (7.0)  >100 40 102.0 (9.0) 40 58.8 (6.7) 39 101.2 (8.4) 39 56.9 (6.1) p for trend (unadjusted) 128 0.0003 128 0.06 115 0.83 115 0.07 p for trend* 128 0.0002 128 0.0499 115 0.68 115 0.08",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_labels,exact,list,0,0,1,0,"Table 1, Table 2, Table 3",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_labels,levenshtein,list,0,0,1,0,"Table 1, Table 2, Table 3",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_captions,exact,list,0,0,1,0,"Characteristics of the mothers, placentas, babies and children in the Mysore Parthenon cohort, Blood pressure at 9.5 years among boys and girls according to placental size, Blood pressure at 9.5 years among girls according to mother’s height and placental size",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_captions,levenshtein,list,0,0,1,0,"Characteristics of the mothers, placentas, babies and children in the Mysore Parthenon cohort, Blood pressure at 9.5 years among boys and girls according to placental size, Blood pressure at 9.5 years among girls according to mother’s height and placental size",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_label_captions,exact,list,0,0,1,0,"Table 1 Characteristics of the mothers, placentas, babies and children in the Mysore Parthenon cohort, Table 2 Blood pressure at 9.5 years among boys and girls according to placental size, Table 3 Blood pressure at 9.5 years among girls according to mother’s height and placental size",
apa0100-0653.cermine.xml,apa0100-0653.nxml,table_label_captions,levenshtein,list,0,0,1,0,"Table 1 Characteristics of the mothers, placentas, babies and children in the Mysore Parthenon cohort, Table 2 Blood pressure at 9.5 years among boys and girls according to placental size, Table 3 Blood pressure at 9.5 years among girls according to mother’s height and placental size",
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'1', u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'', u'in utero', u'Br Med J', u'1993', u'306', u'24', u'7', u'8435572']","[u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'Initiation of hypertension in utero and its amplification throughout life', u'Br Med J', u'1993', u'306', u'24', u'7']"
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_reference_fields,levenshtein,list,0,1,0,0,"[u'1', u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'', u'in utero', u'Br Med J', u'1993', u'306', u'24', u'7', u'8435572']","[u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'Initiation of hypertension in utero and its amplification throughout life', u'Br Med J', u'1993', u'306', u'24', u'7']"
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_reference_title,exact,string,1,0,0,0,Initiation of hypertension in utero and its amplification throughout life,Initiation of hypertension in utero and its amplification throughout life
apa0100-0653.cermine.xml,apa0100-0653.nxml,first_reference_title,levenshtein,string,1,0,0,0,Initiation of hypertension in utero and its amplification throughout life,Initiation of hypertension in utero and its amplification throughout life
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_fields,exact,list,0,1,0,0,"[u'1', u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'', u'in utero', u'Br Med J', u'1993', u'306', u'24', u'7', u'8435572'], [u'2', u'Adair', u'L', u'Dahly', u'D', u'Developmental determinants of blood pressure in adults', u'Annu Rev Nutr', u'2005', u'25', u'407', u'34', u'16011473'], [u'3', u'Eriksson', u'JG', u'Forsen', u'TJ', u'Kajantie', u'E', u'Osmond', u'C', u'Barker', u'DJP', u'Childhood growth and hypertension in later life', u'Hypertension', u'2007', u'49', u'1415', u'21', u'17452506'], [u'4', u'Barker', u'DJP', u'Fetal origins of coronary heart disease', u'Br Med J', u'1995', u'311', u'171', u'4', u'7613432'], [u'5', u'Barker', u'DJP', u'Mothers, babies and disease in later life', u'1998', u'2nd edn', u'Churchill Livingstone', u'Edinburgh'], [u'6', u'Harding', u'JE', u'The nutritional basis of the fetal origins of adult disease', u'Int J Epidemiol', u'2001', u'30', u'15', u'23', u'11171842'], [u'7', u'Jackson', u'AA', u'All that glitters. Br Nutr Foundation Annual Lecture', u'Nutr Bull', u'2000', u'25', u'11', u'24'], [u'8', u'Tanner', u'JM', u'Fetus into man', u'1989', u'2nd edn', u'Castlemead', u'Ware'], [u'9', u'Duggleby', u'SL', u'Jackson', u'AA', u'Relationship of maternal protein turnover and lean body mass during pregnancy and birth length', u'Clin Sci', u'2001', u'101', u'65', u'72', u'11410116'], [u'10', u'Sibley', u'CP', u'Boyd', u'RDH', u'Polin', u'RA', u'Fox', u'WW', u'Mechanisms of transfer across the human placenta', u'Fetal and neonatal physiology', u'1992', u'Saunders', u'Philadelphia', u'62', u'74'], [u'11', u'Barker', u'DJP', u'Thornburg', u'KL', u'Osmond', u'C', u'Kajantie', u'E', u'Eriksson', u'JG', u'The surface area of the placenta and hypertension in the offspring in later life', u'Int J Dev Biol', u'2010', u'54', u'525', u'30', u'19876839'], [u'12', u'Barker', u'DJP', u'Bull', u'AR', u'Osmond', u'C', u'Simmonds', u'SJ', u'Fetal and placental size and risk of hypertension in adult life', u'Br Med J', u'1990', u'301', u'259', u'62', u'2390618'], [u'13', u'Campbell', u'DM', u'Hall', u'MH', u'Barker', u'DJ', u'Cross', u'J', u'Shiell', u'AW', u'Godfrey', u'KM', u'Diet in pregnancy and the offspring\u2019s blood pressure 40 years later', u'Br J Obstet Gynaecol', u'1996', u'103', u'273', u'80', u'8630314'], [u'14', u'Eriksson', u'J', u'Forsen', u'T', u'Tuomilehto', u'J', u'Osmond', u'C', u'Barker', u'D', u'Fetal and childhood growth and hypertension in adult life', u'Hypertension', u'2000', u'36', u'790', u'4', u'11082144'], [u'15', u'Moore', u'VM', u'Miller', u'AG', u'Boulton', u'TJ', u'Cockington', u'RA', u'Craug', u'IH', u'Magarey', u'AM', u'', u'Placental weight, birth measurements, and blood pressure at age 8 years', u'Arch Dis Child', u'1996', u'74', u'538', u'41', u'8758133'], [u'16', u'Taylor', u'SJC', u'Whincup', u'PH', u'Cook', u'DG', u'Papacosta', u'O', u'Walker', u'M', u'Size at birth and blood pressure; cross sectional study in 8\u201311 year old children', u'Br Med J', u'1997', u'314', u'475', u'80', u'9056797'], [u'17', u'Whincup', u'P', u'Cook', u'D', u'Papacosta', u'O', u'Walker', u'M', u'Birth weight and blood pressure: cross sectional and longitudinal relations in childhood', u'Br Med J', u'1995', u'311', u'773', u'6', u'7580437'], [u'18', u'Hill', u'JC', u'Krishnaveni', u'GV', u'Annamma', u'I', u'Leary', u'SD', u'Fall', u'CHD', u'Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry', u'Acta Obstet Gynecol Scand', u'2005', u'84', u'159', u'65', u'15683377'], [u'19', u'Eriksson', u'JG', u'Kajantie', u'E', u'Osmond', u'C', u'Thornburg', u'K', u'Barker', u'DJP', u'Boys live dangerously in the womb', u'Am J Hum Biol', u'2010', u'22', u'330', u'5', u'19844898'], [u'20', u'Krishnaveni', u'GV', u'Veena', u'SR', u'Hill', u'JC', u'Kehoe', u'S', u'Karat', u'SC', u'Fall', u'CHD', u'Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children', u'Diabetes Care', u'2010', u'33', u'402', u'4', u'19918007'], [u'21', u'National High Blood Pressure Educational Program Working Group on High Blood Pressure and Adolescents', u'The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents', u'Pediatrics', u'2004', u'114', u'555', u'76', u'15286277'], [u'22', u'Jansson', u'T', u'Powell', u'TL', u'Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches', u'Clin Sci', u'2007', u'113', u'1', u'13', u'17536998'], [u'23', u'Pedersen', u'JF', u'Ultrasound evidence of sexual differences in fetal size in first trimester', u'Br Med J', u'1980', u'281', u'1253', u'7427655'], [u'24', u'Di Renzo', u'GC', u'Rosati', u'A', u'Sarti', u'RD', u'Cruciani', u'L', u'Cutuli', u'AM', u'Does fetal sex affect pregnancy outcome?', u'Gend Med', u'2007', u'4', u'19', u'30', u'17584623'], [u'25', u'Barker', u'DJP', u'Kajantie', u'E', u'Eriksson', u'JG', u'Alwasel', u'SH', u'Fall', u'CHD', u'Roseboom', u'TJ', u'', u'Burton', u'GJ', u'Barker', u'DJP', u'Moffett', u'A', u'Thornburg', u'K', u'The maternal and placental origins of chronic disease', u'The placenta and human developmental programming', u'2010', u'Cambridge University Press', u'Cambridge', u'5', u'16'], [u'26', u'Kajantie', u'E', u'Thornburg', u'K', u'Eriksson', u'JG', u'Osmond', u'C', u'Barker', u'DJP', u'In preeclampsia, the placenta grows slowly along its minor axis', u'Int J Dev Biol', u'2010', u'54', u'469', u'73', u'19876819'], [u'27', u'Martyn', u'CN', u'Barker', u'DJP', u'Osmond', u'C', u'Mothers pelvic size, fetal growth and death from stroke in men', u'Lancet', u'1996', u'348', u'1264', u'8', u'8909378'], [u'28', u'McCrabb', u'GJ', u'Egan', u'AR', u'Hosking', u'BJ', u'Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth', u'J Agric Sci', u'1992', u'118', u'127', u'32']","[u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'Initiation of hypertension in utero and its amplification throughout life', u'Br Med J', u'1993', u'306', u'24', u'7'], [u'Adair', u'L', u'Dahly', u'D.', u'Developmental determinants of blood pressure in adults', u'Annu Rev Nutr', u'2005', u'25', u'407', u'34'], [u'Eriksson', u'JG', u'Forsen', u'TJ', u'Kajantie', u'E', u'Osmond', u'C', u'Barker', u'DJP', u'Childhood growth and hypertension in later life', u'Hypertension', u'2007', u'49', u'1415', u'21'], [u'Barker', u'DJP', u'Fetal origins of coronary heart disease', u'Br Med J', u'1995', u'311', u'171', u'4'], [u'Barker', u'DJP', u'Mothers, babies and disease in later life, 2nd edn', u'1998'], [u'Harding', u'JE', u'The nutritional basis of the fetal origins of adult disease', u'Int J Epidemiol', u'2001', u'30', u'15', u'23'], [u'Jackson', u'AA', u'All that glitters', u'Br Nutr Foundation Annual Lecture. Nutr Bull', u'2000', u'25', u'11', u'24'], [u'Tanner', u'JM', u'Fetus into man, 2nd edn', u'1989'], [u'Duggleby', u'SL', u'Jackson', u'AA', u'Relationship of maternal protein turnover and lean body mass during pregnancy and birth length', u'Clin Sci', u'2001', u'101', u'65', u'72'], [u'Sibley', u'CP', u'Boyd', u'RDH', u'Mechanisms of transfer across the human placenta', u'In: Polin RA', u'Fetal and neonatal physiology. Saunders', u'1992', u'62', u'74'], [u'Barker', u'DJP', u'Thornburg', u'KL', u'Osmond', u'C', u'Kajantie', u'E', u'Eriksson', u'JG', u'The surface area of the placenta and hypertension in the offspring in later life', u'Int J Dev Biol', u'2010', u'54', u'525', u'30'], [u'Barker', u'DJP', u'Bull', u'AR', u'Osmond', u'C', u'Simmonds', u'SJ', u'Fetal and placental size and risk of hypertension in adult life', u'Br Med J', u'1990', u'301', u'259', u'62'], [u'Campbell', u'DM', u'Hall', u'MH', u'Barker', u'DJ', u'Cross', u'J', u'Shiell', u'AW', u'Godfrey', u'KM', u""Diet in pregnancy and the offspring's blood pressure 40 years later"", u'Br J Obstet Gynaecol', u'1996', u'103', u'273', u'80'], [u'Eriksson', u'J', u'Forsen', u'T', u'Tuomilehto', u'J', u'Osmond', u'C', u'Barker D', u'Fetal and childhood growth and hypertension in adult life', u'Hypertension', u'2000', u'36', u'790', u'4'], [u'Moore', u'VM', u'Miller', u'AG', u'Boulton', u'TJ', u'Cockington', u'RA', u'Craug', u'IH', u'Magarey', u'AM', u'Placental weight, birth measurements, and blood pressure at age 8 years', u'Arch Dis Child', u'1996', u'74', u'538', u'41'], [u'Taylor', u'SJC', u'Whincup', u'PH', u'Cook', u'DG', u'Papacosta', u'O', u'Walker', u'M.', u'Size at birth and blood pressure; cross sectional study in 8- 11 year old children', u'Br Med J', u'1997', u'314', u'475', u'80'], [u'Whincup', u'P', u'Cook', u'D', u'Papacosta', u'O', u'Walker', u'M.', u'Birth weight and blood pressure: cross sectional and longitudinal relations in childhood', u'Br Med J', u'1995', u'311', u'773', u'6'], [u'Hill', u'JC', u'Krishnaveni', u'GV', u'Annamma', u'I', u'Leary', u'SD', u'Fall', u'CHD', u'Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry', u'Acta Obstet Gynecol Scand', u'2005', u'84', u'159', u'65'], [u'Eriksson', u'JG', u'Kajantie', u'E', u'Osmond', u'C', u'Thornburg', u'K', u'Barker', u'DJP', u'Boys live dangerously in the womb', u'Am J Hum Biol', u'2010', u'22', u'330', u'5'], [u'Krishnaveni', u'GV', u'Veena', u'SR', u'Hill', u'JC', u'Kehoe', u'S', u'Karat', u'SC', u'Fall', u'CHD', u'Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children', u'Diabetes Care', u'2010', u'33', u'402', u'4'], [u'National High Blood Pressure Educational Program Working', u'Group on High Blood Pressure and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents', u'Pediatrics', u'2004', u'114', u'555', u'76'], [u'Jansson', u'T', u'Powell', u'TL', u'Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches', u'Clin Sci', u'2007', u'113', u'1', u'13'], [u'Pedersen', u'JF', u'Ultrasound evidence of sexual differences in fetal size in first trimester', u'Br Med J', u'1980', u'281', u'1253'], [u'Di Renzo', u'GC', u'Rosati', u'A', u'Sarti', u'RD', u'Cruciani', u'L', u'Cutuli', u'AM', u'Does fetal sex affect pregnancy outcome?', u'Gend Med', u'2007', u'4', u'19', u'30'], [u'Barker', u'DJP', u'Kajantie', u'E', u'Eriksson', u'JG', u'Alwasel', u'SH', u'Fall', u'CHD', u'Roseboom', u'TJ', u'The maternal and placental origins of chronic disease', u'Burton', u'GJ', u'Barker', u'DJP', u'Moffett', u'A', u'Thornburg', u'K', u'The placenta and human developmental programming', u'2010', u'5', u'16'], [u'Kajantie', u'E', u'Thornburg', u'K', u'Eriksson', u'JG', u'Osmond', u'C', u'Barker DJP', u'In preeclampsia, the placenta grows slowly along its minor axis', u'Int J Dev Biol', u'2010', u'54', u'469', u'73'], [u'Martyn', u'CN', u'Barker', u'DJP', u'Osmond', u'C', u'Mothers pelvic size, fetal growth and death from stroke in men', u'Lancet', u'1996', u'348', u'1264', u'8'], [u'McCrabb', u'GJ', u'Egan', u'AR', u'Hosking', u'BJ', u'Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth', u'J Agric Sci', u'1992', u'118', u'127', u'32']"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_fields,levenshtein,list,0,1,0,0,"[u'1', u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'', u'in utero', u'Br Med J', u'1993', u'306', u'24', u'7', u'8435572'], [u'2', u'Adair', u'L', u'Dahly', u'D', u'Developmental determinants of blood pressure in adults', u'Annu Rev Nutr', u'2005', u'25', u'407', u'34', u'16011473'], [u'3', u'Eriksson', u'JG', u'Forsen', u'TJ', u'Kajantie', u'E', u'Osmond', u'C', u'Barker', u'DJP', u'Childhood growth and hypertension in later life', u'Hypertension', u'2007', u'49', u'1415', u'21', u'17452506'], [u'4', u'Barker', u'DJP', u'Fetal origins of coronary heart disease', u'Br Med J', u'1995', u'311', u'171', u'4', u'7613432'], [u'5', u'Barker', u'DJP', u'Mothers, babies and disease in later life', u'1998', u'2nd edn', u'Churchill Livingstone', u'Edinburgh'], [u'6', u'Harding', u'JE', u'The nutritional basis of the fetal origins of adult disease', u'Int J Epidemiol', u'2001', u'30', u'15', u'23', u'11171842'], [u'7', u'Jackson', u'AA', u'All that glitters. Br Nutr Foundation Annual Lecture', u'Nutr Bull', u'2000', u'25', u'11', u'24'], [u'8', u'Tanner', u'JM', u'Fetus into man', u'1989', u'2nd edn', u'Castlemead', u'Ware'], [u'9', u'Duggleby', u'SL', u'Jackson', u'AA', u'Relationship of maternal protein turnover and lean body mass during pregnancy and birth length', u'Clin Sci', u'2001', u'101', u'65', u'72', u'11410116'], [u'10', u'Sibley', u'CP', u'Boyd', u'RDH', u'Polin', u'RA', u'Fox', u'WW', u'Mechanisms of transfer across the human placenta', u'Fetal and neonatal physiology', u'1992', u'Saunders', u'Philadelphia', u'62', u'74'], [u'11', u'Barker', u'DJP', u'Thornburg', u'KL', u'Osmond', u'C', u'Kajantie', u'E', u'Eriksson', u'JG', u'The surface area of the placenta and hypertension in the offspring in later life', u'Int J Dev Biol', u'2010', u'54', u'525', u'30', u'19876839'], [u'12', u'Barker', u'DJP', u'Bull', u'AR', u'Osmond', u'C', u'Simmonds', u'SJ', u'Fetal and placental size and risk of hypertension in adult life', u'Br Med J', u'1990', u'301', u'259', u'62', u'2390618'], [u'13', u'Campbell', u'DM', u'Hall', u'MH', u'Barker', u'DJ', u'Cross', u'J', u'Shiell', u'AW', u'Godfrey', u'KM', u'Diet in pregnancy and the offspring\u2019s blood pressure 40 years later', u'Br J Obstet Gynaecol', u'1996', u'103', u'273', u'80', u'8630314'], [u'14', u'Eriksson', u'J', u'Forsen', u'T', u'Tuomilehto', u'J', u'Osmond', u'C', u'Barker', u'D', u'Fetal and childhood growth and hypertension in adult life', u'Hypertension', u'2000', u'36', u'790', u'4', u'11082144'], [u'15', u'Moore', u'VM', u'Miller', u'AG', u'Boulton', u'TJ', u'Cockington', u'RA', u'Craug', u'IH', u'Magarey', u'AM', u'', u'Placental weight, birth measurements, and blood pressure at age 8 years', u'Arch Dis Child', u'1996', u'74', u'538', u'41', u'8758133'], [u'16', u'Taylor', u'SJC', u'Whincup', u'PH', u'Cook', u'DG', u'Papacosta', u'O', u'Walker', u'M', u'Size at birth and blood pressure; cross sectional study in 8\u201311 year old children', u'Br Med J', u'1997', u'314', u'475', u'80', u'9056797'], [u'17', u'Whincup', u'P', u'Cook', u'D', u'Papacosta', u'O', u'Walker', u'M', u'Birth weight and blood pressure: cross sectional and longitudinal relations in childhood', u'Br Med J', u'1995', u'311', u'773', u'6', u'7580437'], [u'18', u'Hill', u'JC', u'Krishnaveni', u'GV', u'Annamma', u'I', u'Leary', u'SD', u'Fall', u'CHD', u'Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry', u'Acta Obstet Gynecol Scand', u'2005', u'84', u'159', u'65', u'15683377'], [u'19', u'Eriksson', u'JG', u'Kajantie', u'E', u'Osmond', u'C', u'Thornburg', u'K', u'Barker', u'DJP', u'Boys live dangerously in the womb', u'Am J Hum Biol', u'2010', u'22', u'330', u'5', u'19844898'], [u'20', u'Krishnaveni', u'GV', u'Veena', u'SR', u'Hill', u'JC', u'Kehoe', u'S', u'Karat', u'SC', u'Fall', u'CHD', u'Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children', u'Diabetes Care', u'2010', u'33', u'402', u'4', u'19918007'], [u'21', u'National High Blood Pressure Educational Program Working Group on High Blood Pressure and Adolescents', u'The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents', u'Pediatrics', u'2004', u'114', u'555', u'76', u'15286277'], [u'22', u'Jansson', u'T', u'Powell', u'TL', u'Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches', u'Clin Sci', u'2007', u'113', u'1', u'13', u'17536998'], [u'23', u'Pedersen', u'JF', u'Ultrasound evidence of sexual differences in fetal size in first trimester', u'Br Med J', u'1980', u'281', u'1253', u'7427655'], [u'24', u'Di Renzo', u'GC', u'Rosati', u'A', u'Sarti', u'RD', u'Cruciani', u'L', u'Cutuli', u'AM', u'Does fetal sex affect pregnancy outcome?', u'Gend Med', u'2007', u'4', u'19', u'30', u'17584623'], [u'25', u'Barker', u'DJP', u'Kajantie', u'E', u'Eriksson', u'JG', u'Alwasel', u'SH', u'Fall', u'CHD', u'Roseboom', u'TJ', u'', u'Burton', u'GJ', u'Barker', u'DJP', u'Moffett', u'A', u'Thornburg', u'K', u'The maternal and placental origins of chronic disease', u'The placenta and human developmental programming', u'2010', u'Cambridge University Press', u'Cambridge', u'5', u'16'], [u'26', u'Kajantie', u'E', u'Thornburg', u'K', u'Eriksson', u'JG', u'Osmond', u'C', u'Barker', u'DJP', u'In preeclampsia, the placenta grows slowly along its minor axis', u'Int J Dev Biol', u'2010', u'54', u'469', u'73', u'19876819'], [u'27', u'Martyn', u'CN', u'Barker', u'DJP', u'Osmond', u'C', u'Mothers pelvic size, fetal growth and death from stroke in men', u'Lancet', u'1996', u'348', u'1264', u'8', u'8909378'], [u'28', u'McCrabb', u'GJ', u'Egan', u'AR', u'Hosking', u'BJ', u'Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth', u'J Agric Sci', u'1992', u'118', u'127', u'32']","[u'Law', u'CM', u'de', u'SM', u'Osmond', u'C', u'Fayers', u'PM', u'Barker', u'DJ', u'Cruddas', u'AM', u'Initiation of hypertension in utero and its amplification throughout life', u'Br Med J', u'1993', u'306', u'24', u'7'], [u'Adair', u'L', u'Dahly', u'D.', u'Developmental determinants of blood pressure in adults', u'Annu Rev Nutr', u'2005', u'25', u'407', u'34'], [u'Eriksson', u'JG', u'Forsen', u'TJ', u'Kajantie', u'E', u'Osmond', u'C', u'Barker', u'DJP', u'Childhood growth and hypertension in later life', u'Hypertension', u'2007', u'49', u'1415', u'21'], [u'Barker', u'DJP', u'Fetal origins of coronary heart disease', u'Br Med J', u'1995', u'311', u'171', u'4'], [u'Barker', u'DJP', u'Mothers, babies and disease in later life, 2nd edn', u'1998'], [u'Harding', u'JE', u'The nutritional basis of the fetal origins of adult disease', u'Int J Epidemiol', u'2001', u'30', u'15', u'23'], [u'Jackson', u'AA', u'All that glitters', u'Br Nutr Foundation Annual Lecture. Nutr Bull', u'2000', u'25', u'11', u'24'], [u'Tanner', u'JM', u'Fetus into man, 2nd edn', u'1989'], [u'Duggleby', u'SL', u'Jackson', u'AA', u'Relationship of maternal protein turnover and lean body mass during pregnancy and birth length', u'Clin Sci', u'2001', u'101', u'65', u'72'], [u'Sibley', u'CP', u'Boyd', u'RDH', u'Mechanisms of transfer across the human placenta', u'In: Polin RA', u'Fetal and neonatal physiology. Saunders', u'1992', u'62', u'74'], [u'Barker', u'DJP', u'Thornburg', u'KL', u'Osmond', u'C', u'Kajantie', u'E', u'Eriksson', u'JG', u'The surface area of the placenta and hypertension in the offspring in later life', u'Int J Dev Biol', u'2010', u'54', u'525', u'30'], [u'Barker', u'DJP', u'Bull', u'AR', u'Osmond', u'C', u'Simmonds', u'SJ', u'Fetal and placental size and risk of hypertension in adult life', u'Br Med J', u'1990', u'301', u'259', u'62'], [u'Campbell', u'DM', u'Hall', u'MH', u'Barker', u'DJ', u'Cross', u'J', u'Shiell', u'AW', u'Godfrey', u'KM', u""Diet in pregnancy and the offspring's blood pressure 40 years later"", u'Br J Obstet Gynaecol', u'1996', u'103', u'273', u'80'], [u'Eriksson', u'J', u'Forsen', u'T', u'Tuomilehto', u'J', u'Osmond', u'C', u'Barker D', u'Fetal and childhood growth and hypertension in adult life', u'Hypertension', u'2000', u'36', u'790', u'4'], [u'Moore', u'VM', u'Miller', u'AG', u'Boulton', u'TJ', u'Cockington', u'RA', u'Craug', u'IH', u'Magarey', u'AM', u'Placental weight, birth measurements, and blood pressure at age 8 years', u'Arch Dis Child', u'1996', u'74', u'538', u'41'], [u'Taylor', u'SJC', u'Whincup', u'PH', u'Cook', u'DG', u'Papacosta', u'O', u'Walker', u'M.', u'Size at birth and blood pressure; cross sectional study in 8- 11 year old children', u'Br Med J', u'1997', u'314', u'475', u'80'], [u'Whincup', u'P', u'Cook', u'D', u'Papacosta', u'O', u'Walker', u'M.', u'Birth weight and blood pressure: cross sectional and longitudinal relations in childhood', u'Br Med J', u'1995', u'311', u'773', u'6'], [u'Hill', u'JC', u'Krishnaveni', u'GV', u'Annamma', u'I', u'Leary', u'SD', u'Fall', u'CHD', u'Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry', u'Acta Obstet Gynecol Scand', u'2005', u'84', u'159', u'65'], [u'Eriksson', u'JG', u'Kajantie', u'E', u'Osmond', u'C', u'Thornburg', u'K', u'Barker', u'DJP', u'Boys live dangerously in the womb', u'Am J Hum Biol', u'2010', u'22', u'330', u'5'], [u'Krishnaveni', u'GV', u'Veena', u'SR', u'Hill', u'JC', u'Kehoe', u'S', u'Karat', u'SC', u'Fall', u'CHD', u'Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children', u'Diabetes Care', u'2010', u'33', u'402', u'4'], [u'National High Blood Pressure Educational Program Working', u'Group on High Blood Pressure and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents', u'Pediatrics', u'2004', u'114', u'555', u'76'], [u'Jansson', u'T', u'Powell', u'TL', u'Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches', u'Clin Sci', u'2007', u'113', u'1', u'13'], [u'Pedersen', u'JF', u'Ultrasound evidence of sexual differences in fetal size in first trimester', u'Br Med J', u'1980', u'281', u'1253'], [u'Di Renzo', u'GC', u'Rosati', u'A', u'Sarti', u'RD', u'Cruciani', u'L', u'Cutuli', u'AM', u'Does fetal sex affect pregnancy outcome?', u'Gend Med', u'2007', u'4', u'19', u'30'], [u'Barker', u'DJP', u'Kajantie', u'E', u'Eriksson', u'JG', u'Alwasel', u'SH', u'Fall', u'CHD', u'Roseboom', u'TJ', u'The maternal and placental origins of chronic disease', u'Burton', u'GJ', u'Barker', u'DJP', u'Moffett', u'A', u'Thornburg', u'K', u'The placenta and human developmental programming', u'2010', u'5', u'16'], [u'Kajantie', u'E', u'Thornburg', u'K', u'Eriksson', u'JG', u'Osmond', u'C', u'Barker DJP', u'In preeclampsia, the placenta grows slowly along its minor axis', u'Int J Dev Biol', u'2010', u'54', u'469', u'73'], [u'Martyn', u'CN', u'Barker', u'DJP', u'Osmond', u'C', u'Mothers pelvic size, fetal growth and death from stroke in men', u'Lancet', u'1996', u'348', u'1264', u'8'], [u'McCrabb', u'GJ', u'Egan', u'AR', u'Hosking', u'BJ', u'Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth', u'J Agric Sci', u'1992', u'118', u'127', u'32']"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_title,exact,list,0,1,0,0,"Initiation of hypertension in utero and its amplification throughout life, Developmental determinants of blood pressure in adults, Childhood growth and hypertension in later life, Fetal origins of coronary heart disease, , The nutritional basis of the fetal origins of adult disease, All that glitters. Br Nutr Foundation Annual Lecture, , Relationship of maternal protein turnover and lean body mass during pregnancy and birth length, Mechanisms of transfer across the human placenta, The surface area of the placenta and hypertension in the offspring in later life, Fetal and placental size and risk of hypertension in adult life, Diet in pregnancy and the offspring’s blood pressure 40 years later, Fetal and childhood growth and hypertension in adult life, Placental weight, birth measurements, and blood pressure at age 8 years, Size at birth and blood pressure; cross sectional study in 8–11 year old children, Birth weight and blood pressure: cross sectional and longitudinal relations in childhood, Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry, Boys live dangerously in the womb, Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children, The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents, Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches, Ultrasound evidence of sexual differences in fetal size in first trimester, Does fetal sex affect pregnancy outcome?, The maternal and placental origins of chronic disease, In preeclampsia, the placenta grows slowly along its minor axis, Mothers pelvic size, fetal growth and death from stroke in men, Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth","Initiation of hypertension in utero and its amplification throughout life, Developmental determinants of blood pressure in adults, Childhood growth and hypertension in later life, Fetal origins of coronary heart disease, Mothers, babies and disease in later life, 2nd edn, The nutritional basis of the fetal origins of adult disease, All that glitters, Fetus into man, 2nd edn, Relationship of maternal protein turnover and lean body mass during pregnancy and birth length, Mechanisms of transfer across the human placenta, The surface area of the placenta and hypertension in the offspring in later life, Fetal and placental size and risk of hypertension in adult life, Diet in pregnancy and the offspring's blood pressure 40 years later, Fetal and childhood growth and hypertension in adult life, Placental weight, birth measurements, and blood pressure at age 8 years, Size at birth and blood pressure; cross sectional study in 8- 11 year old children, Birth weight and blood pressure: cross sectional and longitudinal relations in childhood, Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry, Boys live dangerously in the womb, Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children, Group on High Blood Pressure and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents, Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches, Ultrasound evidence of sexual differences in fetal size in first trimester, Does fetal sex affect pregnancy outcome?, The maternal and placental origins of chronic disease, The placenta and human developmental programming, Barker DJP, In preeclampsia, the placenta grows slowly along its minor axis, Mothers pelvic size, fetal growth and death from stroke in men, Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_title,levenshtein,list,0,1,0,0,"Initiation of hypertension in utero and its amplification throughout life, Developmental determinants of blood pressure in adults, Childhood growth and hypertension in later life, Fetal origins of coronary heart disease, , The nutritional basis of the fetal origins of adult disease, All that glitters. Br Nutr Foundation Annual Lecture, , Relationship of maternal protein turnover and lean body mass during pregnancy and birth length, Mechanisms of transfer across the human placenta, The surface area of the placenta and hypertension in the offspring in later life, Fetal and placental size and risk of hypertension in adult life, Diet in pregnancy and the offspring’s blood pressure 40 years later, Fetal and childhood growth and hypertension in adult life, Placental weight, birth measurements, and blood pressure at age 8 years, Size at birth and blood pressure; cross sectional study in 8–11 year old children, Birth weight and blood pressure: cross sectional and longitudinal relations in childhood, Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry, Boys live dangerously in the womb, Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children, The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents, Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches, Ultrasound evidence of sexual differences in fetal size in first trimester, Does fetal sex affect pregnancy outcome?, The maternal and placental origins of chronic disease, In preeclampsia, the placenta grows slowly along its minor axis, Mothers pelvic size, fetal growth and death from stroke in men, Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth","Initiation of hypertension in utero and its amplification throughout life, Developmental determinants of blood pressure in adults, Childhood growth and hypertension in later life, Fetal origins of coronary heart disease, Mothers, babies and disease in later life, 2nd edn, The nutritional basis of the fetal origins of adult disease, All that glitters, Fetus into man, 2nd edn, Relationship of maternal protein turnover and lean body mass during pregnancy and birth length, Mechanisms of transfer across the human placenta, The surface area of the placenta and hypertension in the offspring in later life, Fetal and placental size and risk of hypertension in adult life, Diet in pregnancy and the offspring's blood pressure 40 years later, Fetal and childhood growth and hypertension in adult life, Placental weight, birth measurements, and blood pressure at age 8 years, Size at birth and blood pressure; cross sectional study in 8- 11 year old children, Birth weight and blood pressure: cross sectional and longitudinal relations in childhood, Glucose tolerance in pregnancy in South India: relationships to neonatal anthropometry, Boys live dangerously in the womb, Intrauterine exposure to maternal diabetes is associated with higher adiposity and insulin resistance and clustering of cardiovascular risk markers in Indian children, Group on High Blood Pressure and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents, Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches, Ultrasound evidence of sexual differences in fetal size in first trimester, Does fetal sex affect pregnancy outcome?, The maternal and placental origins of chronic disease, The placenta and human developmental programming, Barker DJP, In preeclampsia, the placenta grows slowly along its minor axis, Mothers pelvic size, fetal growth and death from stroke in men, Maternal undernutrition during mid-pregnancy in sheep; variable effects on placental growth"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_year,exact,list,1,0,0,0,"1993, 2005, 2007, 1995, 1998, 2001, 2000, 1989, 2001, 1992, 2010, 1990, 1996, 2000, 1996, 1997, 1995, 2005, 2010, 2010, 2004, 2007, 1980, 2007, 2010, 2010, 1996, 1992","1993, 2005, 2007, 1995, 1998, 2001, 2000, 1989, 2001, 1992, 2010, 1990, 1996, 2000, 1996, 1997, 1995, 2005, 2010, 2010, 2004, 2007, 1980, 2007, 2010, 2010, 1996, 1992"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_year,levenshtein,list,1,0,0,0,"1993, 2005, 2007, 1995, 1998, 2001, 2000, 1989, 2001, 1992, 2010, 1990, 1996, 2000, 1996, 1997, 1995, 2005, 2010, 2010, 2004, 2007, 1980, 2007, 2010, 2010, 1996, 1992","1993, 2005, 2007, 1995, 1998, 2001, 2000, 1989, 2001, 1992, 2010, 1990, 1996, 2000, 1996, 1997, 1995, 2005, 2010, 2010, 2004, 2007, 1980, 2007, 2010, 2010, 1996, 1992"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_source,exact,list,0,1,0,0,"Br Med J, Annu Rev Nutr, Hypertension, Br Med J, Mothers, babies and disease in later life, Int J Epidemiol, Nutr Bull, Fetus into man, Clin Sci, Fetal and neonatal physiology, Int J Dev Biol, Br Med J, Br J Obstet Gynaecol, Hypertension, Arch Dis Child, Br Med J, Br Med J, Acta Obstet Gynecol Scand, Am J Hum Biol, Diabetes Care, Pediatrics, Clin Sci, Br Med J, Gend Med, The placenta and human developmental programming, Int J Dev Biol, Lancet, J Agric Sci","Br Med J, Annu Rev Nutr, Hypertension, Br Med J, , Int J Epidemiol, Br Nutr Foundation Annual Lecture. Nutr Bull, , Clin Sci, In: Polin RA, Fetal and neonatal physiology. Saunders, Int J Dev Biol, Br Med J, Br J Obstet Gynaecol, Hypertension, Arch Dis Child, Br Med J, Br Med J, Acta Obstet Gynecol Scand, Am J Hum Biol, Diabetes Care, Pediatrics, Clin Sci, Br Med J, Gend Med, , Int J Dev Biol, Lancet, J Agric Sci"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_source,levenshtein,list,0,1,0,0,"Br Med J, Annu Rev Nutr, Hypertension, Br Med J, Mothers, babies and disease in later life, Int J Epidemiol, Nutr Bull, Fetus into man, Clin Sci, Fetal and neonatal physiology, Int J Dev Biol, Br Med J, Br J Obstet Gynaecol, Hypertension, Arch Dis Child, Br Med J, Br Med J, Acta Obstet Gynecol Scand, Am J Hum Biol, Diabetes Care, Pediatrics, Clin Sci, Br Med J, Gend Med, The placenta and human developmental programming, Int J Dev Biol, Lancet, J Agric Sci","Br Med J, Annu Rev Nutr, Hypertension, Br Med J, , Int J Epidemiol, Br Nutr Foundation Annual Lecture. Nutr Bull, , Clin Sci, In: Polin RA, Fetal and neonatal physiology. Saunders, Int J Dev Biol, Br Med J, Br J Obstet Gynaecol, Hypertension, Arch Dis Child, Br Med J, Br Med J, Acta Obstet Gynecol Scand, Am J Hum Biol, Diabetes Care, Pediatrics, Clin Sci, Br Med J, Gend Med, , Int J Dev Biol, Lancet, J Agric Sci"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_volume,exact,list,1,0,0,0,"306, 25, 49, 311, , 30, 25, , 101, , 54, 301, 103, 36, 74, 314, 311, 84, 22, 33, 114, 113, 281, 4, , 54, 348, 118","306, 25, 49, 311, , 30, 25, , 101, , 54, 301, 103, 36, 74, 314, 311, 84, 22, 33, 114, 113, 281, 4, , 54, 348, 118"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_volume,levenshtein,list,1,0,0,0,"306, 25, 49, 311, , 30, 25, , 101, , 54, 301, 103, 36, 74, 314, 311, 84, 22, 33, 114, 113, 281, 4, , 54, 348, 118","306, 25, 49, 311, , 30, 25, , 101, , 54, 301, 103, 36, 74, 314, 311, 84, 22, 33, 114, 113, 281, 4, , 54, 348, 118"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_fpage,exact,list,1,0,0,0,"24, 407, 1415, 171, , 15, 11, , 65, 62, 525, 259, 273, 790, 538, 475, 773, 159, 330, 402, 555, 1, 1253, 19, 5, 469, 1264, 127","24, 407, 1415, 171, , 15, 11, , 65, 62, 525, 259, 273, 790, 538, 475, 773, 159, 330, 402, 555, 1, 1253, 19, 5, 469, 1264, 127"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_fpage,levenshtein,list,1,0,0,0,"24, 407, 1415, 171, , 15, 11, , 65, 62, 525, 259, 273, 790, 538, 475, 773, 159, 330, 402, 555, 1, 1253, 19, 5, 469, 1264, 127","24, 407, 1415, 171, , 15, 11, , 65, 62, 525, 259, 273, 790, 538, 475, 773, 159, 330, 402, 555, 1, 1253, 19, 5, 469, 1264, 127"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_lpage,exact,list,1,0,0,0,"7, 34, 21, 4, , 23, 24, , 72, 74, 30, 62, 80, 4, 41, 80, 6, 65, 5, 4, 76, 13, , 30, 16, 73, 8, 32","7, 34, 21, 4, , 23, 24, , 72, 74, 30, 62, 80, 4, 41, 80, 6, 65, 5, 4, 76, 13, , 30, 16, 73, 8, 32"
apa0100-0653.cermine.xml,apa0100-0653.nxml,reference_lpage,levenshtein,list,1,0,0,0,"7, 34, 21, 4, , 23, 24, , 72, 74, 30, 62, 80, 4, 41, 80, 6, 65, 5, 4, 76, 13, , 30, 16, 73, 8, 32","7, 34, 21, 4, , 23, 24, , 72, 74, 30, 62, 80, 4, 41, 80, 6, 65, 5, 4, 76, 13, , 30, 16, 73, 8, 32"
apha0202-0379.cermine.xml,apha0202-0379.nxml,title,exact,string,1,0,0,0,On the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis,On the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis
apha0202-0379.cermine.xml,apha0202-0379.nxml,title,levenshtein,string,1,0,0,0,On the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis,On the function of the mammalian renal papilla and the peristalsis of the surrounding pelvis
apha0202-0379.cermine.xml,apha0202-0379.nxml,abstract,exact,string,1,0,0,0,"This is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. It had been observed that animals with a need to produce a concentrated urine have a long renal papilla. I saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. This model led me to overlook contrary evidence. For example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. In addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. The urine concentration falls if the peristalsis is stopped. I was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. We are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. It is hoped that other researchers will tackle this interesting problem.","This is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. It had been observed that animals with a need to produce a concentrated urine have a long renal papilla. I saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. This model led me to overlook contrary evidence. For example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. In addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. The urine concentration falls if the peristalsis is stopped. I was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. We are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. It is hoped that other researchers will tackle this interesting problem."
apha0202-0379.cermine.xml,apha0202-0379.nxml,abstract,levenshtein,string,1,0,0,0,"This is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. It had been observed that animals with a need to produce a concentrated urine have a long renal papilla. I saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. This model led me to overlook contrary evidence. For example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. In addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. The urine concentration falls if the peristalsis is stopped. I was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. We are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. It is hoped that other researchers will tackle this interesting problem.","This is an informal personal review of the development over time of my ideas about the concentrating mechanism of the mammalian renal papilla. It had been observed that animals with a need to produce a concentrated urine have a long renal papilla. I saw the function of the long papilla in desert rodents as an elongation of the counter-current concentrating mechanism of the inner medulla. This model led me to overlook contrary evidence. For example, in many experiments, the final urine has a higher osmolality than that of the tissue at the tip of the papilla. In addition, we had observations of the peristalsis of the renal pelvis surrounding the papilla. The urine concentration falls if the peristalsis is stopped. I was wrong; together, these lines of evidence show that the renal papilla is not just an elongation of the inner medulla. We are left without a full explanation of the concentrating mechanism of the mammalian renal papilla. It is hoped that other researchers will tackle this interesting problem."
apha0202-0379.cermine.xml,apha0202-0379.nxml,keywords,exact,set,0,0,1,0,"concentrating mechanism, kidney, peristalsis, renal papilla, renal pelvis, water removal",
apha0202-0379.cermine.xml,apha0202-0379.nxml,keywords,levenshtein,set,0,0,1,0,"concentrating mechanism, kidney, peristalsis, renal papilla, renal pelvis, water removal",
apha0202-0379.cermine.xml,apha0202-0379.nxml,author_surnames,exact,set,0,0,1,0,Schmidt-Nielsen,
apha0202-0379.cermine.xml,apha0202-0379.nxml,author_surnames,levenshtein,set,0,0,1,0,Schmidt-Nielsen,
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_author_surname,exact,string,0,0,1,0,Schmidt-Nielsen,
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_author_surname,levenshtein,string,0,0,1,0,Schmidt-Nielsen,
apha0202-0379.cermine.xml,apha0202-0379.nxml,author_full_names,exact,set,1,0,0,0,"Bent Schmidt-Nielsen, Bodil Schmidt-Nielsen","Bent Schmidt-Nielsen, Bodil Schmidt-Nielsen"
apha0202-0379.cermine.xml,apha0202-0379.nxml,author_full_names,levenshtein,set,1,0,0,0,"Bent Schmidt-Nielsen, Bodil Schmidt-Nielsen","Bent Schmidt-Nielsen, Bodil Schmidt-Nielsen"
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_author_full_name,exact,string,1,0,0,0,Bodil Schmidt-Nielsen,Bodil Schmidt-Nielsen
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_author_full_name,levenshtein,string,1,0,0,0,Bodil Schmidt-Nielsen,Bodil Schmidt-Nielsen
apha0202-0379.cermine.xml,apha0202-0379.nxml,affiliation_strings,exact,set,1,0,0,0,"Department of Physiology, University of Florida, Gainesville, FL, USA, Lexington, MA, USA","Department of Physiology, University of Florida, Gainesville, FL, USA, Lexington, MA, USA"
apha0202-0379.cermine.xml,apha0202-0379.nxml,affiliation_strings,levenshtein,set,1,0,0,0,"Department of Physiology, University of Florida, Gainesville, FL, USA, Lexington, MA, USA","Department of Physiology, University of Florida, Gainesville, FL, USA, Lexington, MA, USA"
apha0202-0379.cermine.xml,apha0202-0379.nxml,affiliation_institution,exact,set,1,0,0,0,"Department of Physiology, University of Florida, Lexington","Department of Physiology, University of Florida, Lexington"
apha0202-0379.cermine.xml,apha0202-0379.nxml,affiliation_institution,levenshtein,set,1,0,0,0,"Department of Physiology, University of Florida, Lexington","Department of Physiology, University of Florida, Lexington"
apha0202-0379.cermine.xml,apha0202-0379.nxml,section_titles,exact,list,0,1,0,0,"The peristaltic mechanism, Hypothesis on how the renal pelvic peristaltic pumping of the papilla might contribute to the concentrating mechanism, Conclusion","-, The peristaltic mechanism, Conclusion, Supporting Information, Conflicts of interest"
apha0202-0379.cermine.xml,apha0202-0379.nxml,section_titles,levenshtein,list,0,1,0,0,"The peristaltic mechanism, Hypothesis on how the renal pelvic peristaltic pumping of the papilla might contribute to the concentrating mechanism, Conclusion","-, The peristaltic mechanism, Conclusion, Supporting Information, Conflicts of interest"
apha0202-0379.cermine.xml,apha0202-0379.nxml,tables,exact,table,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,tables,levenshtein,table,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_strings,exact,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_strings,levenshtein,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_labels,exact,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_labels,levenshtein,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_captions,exact,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_captions,levenshtein,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_label_captions,exact,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,table_label_captions,levenshtein,list,0,0,0,1,,
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_reference_fields,exact,list,0,1,0,0,"[u'Dantzler', u'WH', u'Unpublished remarks', u'The William H. Dantzler Symposium', u'2006', u'Tucson, AZ', u'April 6\u20137']","[u'Dantzler', u'W.H.', u'2006', u'Unpublished remarks', u'The William H. Dantzler Symposium. Tucson, AZ, April 6-7.']"
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_reference_fields,levenshtein,list,1,0,0,0,"[u'Dantzler', u'WH', u'Unpublished remarks', u'The William H. Dantzler Symposium', u'2006', u'Tucson, AZ', u'April 6\u20137']","[u'Dantzler', u'W.H.', u'2006', u'Unpublished remarks', u'The William H. Dantzler Symposium. Tucson, AZ, April 6-7.']"
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_reference_title,exact,string,1,0,0,0,Unpublished remarks,Unpublished remarks
apha0202-0379.cermine.xml,apha0202-0379.nxml,first_reference_title,levenshtein,string,1,0,0,0,Unpublished remarks,Unpublished remarks
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_fields,exact,list,0,1,0,0,"[u'Dantzler', u'WH', u'Unpublished remarks', u'The William H. Dantzler Symposium', u'2006', u'Tucson, AZ', u'April 6\u20137'], [u'Knepper', u'MA', u'Saidel', u'GM', u'Hascall', u'VC', u'Dwyer', u'T', u'Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer', u'Am J Physiol Renal Physiol', u'2003', u'284', u'F433', u'F446', u'12556362'], [u'Nielsen', u'S', u'Fr\xf8kiaer', u'J', u'Marples', u'D', u'Kwon', u'T-H', u'Agre', u'P', u'Knepper', u'MA', u'Aquaporins in the kidney: from molecules to medicine', u'Physiol Rev', u'2002', u'82', u'205', u'244', u'11773613'], [u'Pruitt', u'MEC', u'Knepper', u'MA', u'Graves', u'B', u'Schmidt-Nielsen', u'B', u'Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster', u'Am J Physiol Renal Physiol', u'2006', u'290', u'F892', u'F896', u'16234309'], [u'Schmidt-Nielsen', u'B', u'The renal pelvis', u'Kidney Int', u'1987', u'31', u'621', u'628', u'3550232'], [u'Schmidt-Nielsen', u'B', u'August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures', u'Am J Physiol Regul Integr Comp Physiol', u'1995', u'268', u'R1087', u'R1100'], [u'Schmidt-Nielsen', u'B', u'Graves', u'B', u'Changes in fluid compartments in hamster renal papilla due to peristalsis in the pelvic wall', u'Kidney Int', u'1982', u'22', u'613', u'625', u'International Society of Nephrology', u'6891728'], [u'Sperber', u'I', u'Studies on the mammalian kidney', u'Zoologiska Bidrag Fr\xe5n Uppsala', u'1944', u'22', u'249', u'431'], [u'Truniger', u'B', u'Schmidt-Nielsen', u'B', u'Intrarenal distribution of urea and related compounds: effects of nitrogen intake', u'Am J Physiol', u'1964', u'207', u'971', u'978', u'14237471'], [u'Zell', u'SR', u'Relationship of the Measured Osmolality in the Mammalian Renal Papilla to the Formation of a Concentrated Urine During Antidiuresis', u'1973', u'Cleveland, OH, USA', u'Case Western Reserve University', u'PhD Thesis']","[u'Dantzler', u'W.H.', u'2006', u'Unpublished remarks', u'The William H. Dantzler Symposium. Tucson, AZ, April 6-7.'], [u'Knepper', u'M.A.', u'Saidel', u'G.M.', u'Hascall', u'V.C.', u'Dwyer', u'T.', u'2003', u'Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer', u'Am J Physiol Renal Physiol', u'284', u'F433', u'F446'], [u'Nielsen', u'S.', u'Fr\xf8kiaer', u'J.', u'Marples', u'D.', u'Kwon', u'Agre', u'P.', u'Knepper', u'M.A.', u'2002', u'Aquaporins in the kidney: from molecules to medicine', u'Physiol Rev', u'82', u'205', u'244'], [u'Pruitt', u'M.E.C.', u'Knepper', u'M.A.', u'Graves', u'B.', u'Schmidt-Nielsen', u'B.', u'2006', u'Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster', u'Am J Physiol Renal Physiol', u'290', u'F892', u'F896'], [u'Schmidt-Nielsen', u'B.', u'1987', u'The renal pelvis', u'Kidney Int', u'31', u'621', u'628'], [u'Schmidt-Nielsen', u'B.', u'1995', u'August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures', u'Am J Physiol Regul Integr Comp Physiol', u'268', u'R1087', u'R1100'], [u'Schmidt-Nielsen', u'B.', u'Graves', u'B.', u'1982', u'Changes in fluid compartments in hamster renal papilla due to peristalsis in']"
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_fields,levenshtein,list,0,1,0,0,"[u'Dantzler', u'WH', u'Unpublished remarks', u'The William H. Dantzler Symposium', u'2006', u'Tucson, AZ', u'April 6\u20137'], [u'Knepper', u'MA', u'Saidel', u'GM', u'Hascall', u'VC', u'Dwyer', u'T', u'Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer', u'Am J Physiol Renal Physiol', u'2003', u'284', u'F433', u'F446', u'12556362'], [u'Nielsen', u'S', u'Fr\xf8kiaer', u'J', u'Marples', u'D', u'Kwon', u'T-H', u'Agre', u'P', u'Knepper', u'MA', u'Aquaporins in the kidney: from molecules to medicine', u'Physiol Rev', u'2002', u'82', u'205', u'244', u'11773613'], [u'Pruitt', u'MEC', u'Knepper', u'MA', u'Graves', u'B', u'Schmidt-Nielsen', u'B', u'Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster', u'Am J Physiol Renal Physiol', u'2006', u'290', u'F892', u'F896', u'16234309'], [u'Schmidt-Nielsen', u'B', u'The renal pelvis', u'Kidney Int', u'1987', u'31', u'621', u'628', u'3550232'], [u'Schmidt-Nielsen', u'B', u'August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures', u'Am J Physiol Regul Integr Comp Physiol', u'1995', u'268', u'R1087', u'R1100'], [u'Schmidt-Nielsen', u'B', u'Graves', u'B', u'Changes in fluid compartments in hamster renal papilla due to peristalsis in the pelvic wall', u'Kidney Int', u'1982', u'22', u'613', u'625', u'International Society of Nephrology', u'6891728'], [u'Sperber', u'I', u'Studies on the mammalian kidney', u'Zoologiska Bidrag Fr\xe5n Uppsala', u'1944', u'22', u'249', u'431'], [u'Truniger', u'B', u'Schmidt-Nielsen', u'B', u'Intrarenal distribution of urea and related compounds: effects of nitrogen intake', u'Am J Physiol', u'1964', u'207', u'971', u'978', u'14237471'], [u'Zell', u'SR', u'Relationship of the Measured Osmolality in the Mammalian Renal Papilla to the Formation of a Concentrated Urine During Antidiuresis', u'1973', u'Cleveland, OH, USA', u'Case Western Reserve University', u'PhD Thesis']","[u'Dantzler', u'W.H.', u'2006', u'Unpublished remarks', u'The William H. Dantzler Symposium. Tucson, AZ, April 6-7.'], [u'Knepper', u'M.A.', u'Saidel', u'G.M.', u'Hascall', u'V.C.', u'Dwyer', u'T.', u'2003', u'Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer', u'Am J Physiol Renal Physiol', u'284', u'F433', u'F446'], [u'Nielsen', u'S.', u'Fr\xf8kiaer', u'J.', u'Marples', u'D.', u'Kwon', u'Agre', u'P.', u'Knepper', u'M.A.', u'2002', u'Aquaporins in the kidney: from molecules to medicine', u'Physiol Rev', u'82', u'205', u'244'], [u'Pruitt', u'M.E.C.', u'Knepper', u'M.A.', u'Graves', u'B.', u'Schmidt-Nielsen', u'B.', u'2006', u'Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster', u'Am J Physiol Renal Physiol', u'290', u'F892', u'F896'], [u'Schmidt-Nielsen', u'B.', u'1987', u'The renal pelvis', u'Kidney Int', u'31', u'621', u'628'], [u'Schmidt-Nielsen', u'B.', u'1995', u'August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures', u'Am J Physiol Regul Integr Comp Physiol', u'268', u'R1087', u'R1100'], [u'Schmidt-Nielsen', u'B.', u'Graves', u'B.', u'1982', u'Changes in fluid compartments in hamster renal papilla due to peristalsis in']"
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_title,exact,list,0,1,0,0,"Unpublished remarks, Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer, Aquaporins in the kidney: from molecules to medicine, Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster, The renal pelvis, August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures, Changes in fluid compartments in hamster renal papilla due to peristalsis in the pelvic wall, Studies on the mammalian kidney, Intrarenal distribution of urea and related compounds: effects of nitrogen intake, ","Unpublished remarks, Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer, Aquaporins in the kidney: from molecules to medicine, Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster, The renal pelvis, August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures, Changes in fluid compartments in hamster renal papilla due to peristalsis in"
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_title,levenshtein,list,0,1,0,0,"Unpublished remarks, Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer, Aquaporins in the kidney: from molecules to medicine, Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster, The renal pelvis, August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures, Changes in fluid compartments in hamster renal papilla due to peristalsis in the pelvic wall, Studies on the mammalian kidney, Intrarenal distribution of urea and related compounds: effects of nitrogen intake, ","Unpublished remarks, Concentration of solutes in the renal inner medulla: interstitial hyaluronan as a mechano-osmotic transducer, Aquaporins in the kidney: from molecules to medicine, Effect of peristaltic contractions of the renal pelvic wall on solute concentrations of the renal inner medulla in the hamster, The renal pelvis, August Krogh Lecture. The renal concentrating mechanism in insects and mammals: a new hypothesis involving hydrostatic pressures, Changes in fluid compartments in hamster renal papilla due to peristalsis in"
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_year,exact,list,0,1,0,0,"2006, 2003, 2002, 2006, 1987, 1995, 1982, 1944, 1964, 1973","2006, 2003, 2002, 2006, 1987, 1995, 1982"
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_year,levenshtein,list,0,1,0,0,"2006, 2003, 2002, 2006, 1987, 1995, 1982, 1944, 1964, 1973","2006, 2003, 2002, 2006, 1987, 1995, 1982"
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_source,exact,list,0,1,0,0,"The William H. Dantzler Symposium, Am J Physiol Renal Physiol, Physiol Rev, Am J Physiol Renal Physiol, Kidney Int, Am J Physiol Regul Integr Comp Physiol, Kidney Int, Zoologiska Bidrag Från Uppsala, Am J Physiol, Relationship of the Measured Osmolality in the Mammalian Renal Papilla to the Formation of a Concentrated Urine During Antidiuresis","The William H. Dantzler Symposium. Tucson, AZ, April 6-7., Am J Physiol Renal Physiol, Physiol Rev, Am J Physiol Renal Physiol, Kidney Int, Am J Physiol Regul Integr Comp Physiol, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_source,levenshtein,list,0,1,0,0,"The William H. Dantzler Symposium, Am J Physiol Renal Physiol, Physiol Rev, Am J Physiol Renal Physiol, Kidney Int, Am J Physiol Regul Integr Comp Physiol, Kidney Int, Zoologiska Bidrag Från Uppsala, Am J Physiol, Relationship of the Measured Osmolality in the Mammalian Renal Papilla to the Formation of a Concentrated Urine During Antidiuresis","The William H. Dantzler Symposium. Tucson, AZ, April 6-7., Am J Physiol Renal Physiol, Physiol Rev, Am J Physiol Renal Physiol, Kidney Int, Am J Physiol Regul Integr Comp Physiol, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_volume,exact,list,0,1,0,0,", 284, 82, 290, 31, 268, 22, 22, 207, ",", 284, 82, 290, 31, 268, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_volume,levenshtein,list,0,1,0,0,", 284, 82, 290, 31, 268, 22, 22, 207, ",", 284, 82, 290, 31, 268, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_fpage,exact,list,0,1,0,0,", F433, 205, F892, 621, R1087, 613, 249, 971, ",", F433, 205, F892, 621, R1087, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_fpage,levenshtein,list,0,1,0,0,", F433, 205, F892, 621, R1087, 613, 249, 971, ",", F433, 205, F892, 621, R1087, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_lpage,exact,list,0,1,0,0,", F446, 244, F896, 628, R1100, 625, 431, 978, ",", F446, 244, F896, 628, R1100, "
apha0202-0379.cermine.xml,apha0202-0379.nxml,reference_lpage,levenshtein,list,0,1,0,0,", F446, 244, F896, 628, R1100, 625, 431, 978, ",", F446, 244, F896, 628, R1100, "
